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Abstract 
 
The T4 nucleic acid (NA) ligases repair breaks in nucleic acids, which can be double-stranded 
DNA, RNA or a combination of both. The bacteriophage T4 has 3 NA ligases, one is a DNA ligase 
(T4Dnl) and two are RNA ligases: T4 RNA ligase 1 (T4Rnl1) and T4 RNA ligase 2 (T4Rnl2). These 
T4 DNA and RNA ligases are widely used as tools in a number of molecular biology techniques. 
A structural bias has been reported when the T4 RNA ligases are used in next generation 
sequencing (NGS) adapter ligation and there are issues with nucleic acid manipulation; these 
biochemical activities could be improved. Synthetic biology techniques were used to engineer a 
number of novel enzymes by combining the ligases with other proteins which have specific 
biochemical activities; and by mutating amino acid residues. A total of 22 novel enzymes have 
been constructed and tested to check changes in ligation activity and additional functions of the 
ligase fusions. This includes 8 ligases with specific amino acid changes to motif I, 4 ligases with 
nucleotide binding domain swaps, 3 adenylate kinase (AK)-T4 NA ligase fusions, 3 polynucleotide 
kinase (Pnk)-T4 NA ligase fusions and 3 fusions with truncated Mycobacterium smegmatis LigD 
(MSLigD) and the T4 NA ligases.  
 
Ligation analysis revealed that a number of the fusion ligases were functional, and exhibited 
novel biochemical activities. This included utilising a new co-factor for the AK-ligase fusions, 
where ADP was used instead of ATP for ligation. Lower quantities of AKRnl1 were required to 
achieve the same ligation as T4Rnl1, an interesting feature for industrial retail. The Pnk-ligase 
fusions correctly ligated substrates that could not be ligated by the original T4 NA ligases, where 
the DNA/RNA substrate break had 3’ phosphate instead of 5’ phosphate. The amino acid 
mutations indicated the published sequences for the conserved polypeptide motifs are often 
lacking important surrounding amino acids. Fusions of T4Dnl with truncated MSLigD offered a 
way to use higher concentrations of ATP for ligation, in high ATP concentrations MsLigD 
dissociates from the DNA and is unable to complete the ligation reaction. Optimisation studies 
need to be completed for the new functional ligase fusions and the modified T4 NA ligases, 
considering temperature, buffer constituents and reaction time. The ligases detailed in this body 
of work offer exciting examples of creating fusion multi-function enzymes with novel activities. 
These new ligases may become alternative tools for molecular techniques, especially in NGS 
adapter ligation. 
This PhD work is part of a BBSRC iCASE studentship with Inspiralis (Norwich Research Park 
Innovation Centre, Colney Lane, Norwich NR4 7GJ) who retail T4 nucleic acid ligases.  
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Chapter 1: General Introduction 
 
1.1 Molecular Biology  
Molecular biology has revolutionised our understanding of living systems. The central 
dogma, which describes the transfer of information at a molecular level, from nucleotide 
bases to amino acid  composition, to  determine protein structure (Crick, 1970), has been 
described as a keystone in molecular biology. Long before the discovery of DNA and 
RNA, scientists had categorised behaviours and traits, without any way to determine 
how the information for those heritable features was stored. The binomial naming 
system for organisms was developed by Carolus Linnaeus (Linnaeus, 1758) and it would 
be another 70 years before the first theory of evolution was published by Jean-Baptiste 
Lamarck (reviewed in Corsi, 2015). Another 50 years passed before Darwin wrote the 
Origin of Species and Alfred Wallace published theories about natural selection 
(reviewed in Shermer, 2002). Work continued, and Mendel’s experiments on hereditary 
traits paved the way for how DNA might be involved in heredity (reviewed in Olby, 
1994).  
 
1.1.1. The discovery of DNA 
Nucleic acid discovery and characterisation was happening alongside the development 
of the theory of evolution. In 1869 Friedrich Miescher isolated a mixture of 
macromolecules, one of which was later confirmed to be DNA, from leukocytes by 
precipitation using acidified solutions and ether and named the substance nuclein 
(Dahm, 2008). Miescher continued to analyse the substance and revealed its 
composition to contain Oxygen, Nitrogen, Hydrogen and large amounts of phosphoric 
acid – which was dissimilar to proteins that had already been discovered (Perutz, 1995; 
Dahm, 2008). The function of nuclein, or DNA, was still under debate, however, the 
discovery of DNA in germ cells led Miescher to think it might be involved in fertilisation 
(Reviewed in Dahm, 2008). In 1889 another scientist, Altmann, separated nuclein from 
all proteins in the cell precipitate and named the substance nucleic acid – although this 
was the same product isolated by Miescher (Pollister and Mirsky, 1943; Dahm, 2008).  
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The idea that proteins carried genetic information was not challenged until 1944, 
although Miescher had proposed this theory when working on nuclein, when it was 
suggested that in fact DNA was the molecule responsible for carrying genetic 
information (McCarty and Avery, 1946; Dahm, 2008). The discovery of the composition 
of DNA,  the bases adenine, thymine, guanine and cytosine and the variability of these 
bases between species (Chargaff, 1951; Dahm, 2008),  led to the research that would 
conclusively determine that DNA was genetic material (Hershey, 1952). It was finally the 
discovery of the structure of DNA in 1953 by Watson and Crick (Watson and Crick, 1953; 
Watson et al., 1953) along with work on the crystallographic data by Franklin and Wilkins 
(Franklin and Gosling, 1953; Wilkins, 1956; Klug, 1968) that allowed molecular biology 
as a research field to really take off.  
 
1.1.2. The Structure of DNA 
The DNA structure published in 1953 is a right-handed DNA helix (B-DNA), the strands 
rotate in a clockwise direction (Franklin and Gosling, 1953; Watson and Crick, 1953; Klug, 
1968). DNA is comprised of nucleotides, deoxyribose sugars and phosphate groups 
(Figure 1.1), the helical structure of DNA protects its nucleotides from environmental 
damage (Sinden, 1994). The DNA helix structure is caused by the complementarity of 
the four different nucleotides – adenine (A) with thymine (T); and guanine (G) with 
cytosine (C) (Figure 1.1) (Watson and Crick, 1953). This discovery supported previous 
findings in salmon sperm composition of equal amounts of A and T; and C and G 
(Chargraff et al., 1951; Travers and Muskhelishvili, 2015). The complementary nature of 
the nucleotides on each strand of the helix allow for replication of 2 identical copies. 
These copies are necessary for information transfer to RNA which encodes protein 
sequences (Travers and Muskhelishvili, 2015). The outside of the DNA helix is the 
negatively charged phosphate backbone. The phosphate groups on this backbone are 
attached to the adjacent deoxyribose sugars at the 5’ carbon and 3’ carbon positions 
and link the nucleotides (Figure 1.1) (Sinden, 1994). DNA is synthesised in the 5’ to 3’ 
direction: at the 5’ end, there is a single phosphate group at this end – 5’ PO4; the 3’ end 
and has a hydroxyl group – 3’ OH (Sinden, 1994). The complementarity of DNA strands 
results in the two strands running in opposite directions but they are only synthesised 
in the 5’ to 3’ direction (Figure 1.1).  
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Figure 1.1. The structure of double stranded DNA. The structure of double stranded DNA 
published in 1953, the sugar-phosphate backbone and complementary bases A (green) and T 
(red), C (yellow) and G (blue) are shown (Pray, 2008).  
 
There are other forms of helices, including a second form of the right handed helical 
structure: A-DNA (Sinden, 1994; Travers and Muskhelishvili, 2015). A-DNA is a shorter, 
more compact helix, B-DNA can revert to A-DNA at lower humidity (Travers and 
Muskhelishvili, 2015). DNA with a Left handed helix is referred to as Z-DNA, the strands 
turn in an anti-clockwise direction. Other variations to the DNA structure that have been 
reported, include bubbles – where the 2 strands separate forming a bubble in the 
structure; three stranded helices, called H-DNA and slipped loops – where a loop of 
nucleotides is on one of the strands (Travers and Muskhelishvili, 2015).  
 
1.1.3. DNA sequencing 
The identification of the structure of DNA steered researchers to develop the technology 
required to determine the order of nucleotides in this important structure. This 
technology did not develop quickly and in the beginning it was possible to measure the 
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composition of the different nucleic acids in deoxyribonucleotides (dNTPs) but not the 
order (Holley et al., 1961). The development of a technique using labelled dNTPs meant 
researchers could identify sequences (Sanger, Brownlee and Barrell, 1965) and using this 
method the first protein coding sequence  from the bacteriophage MS2 was reported 
(Jou et al., 1972; Heather and Chain, 2016). The first complete genome, 3569 residues 
in length, from the bacteriophage MS2 was sequenced and crucial sequences for viral 
maturation, including the protein coat and a replicase subunit, were identified (Fiers et 
al., 1976). The next step in making sequencing high throughput was the separation of 
nucleotides using electrophoresis and polyacrylamide gels and this technique was used 
to sequence the genome from the bacteriophage ΦX174 (Sanger and Coulson, 1975; 
Maxam and Gilbert, 1977; Sanger et al., 1977; Hutchison, 2007; Heather and Chain, 
2016). The next major advance in Sanger sequencing resulted in a more rapid and 
accurate method (Sanger, Nicklen and Coulson, 1977), the use of dideoxynucleotides 
(ddNTPS) to inhibit DNA polymerase made it possible to terminate the extended primers 
at specific residues. It was possible to run 4 reactions, each containing a specific ddNTP, 
rather than using radioactive labelled dNTPs (Figure 1.2). The use of fluorescently 
labelled ddNTPs made it possible to use all four in the same reaction – each base could 
be identified as a different colour (Sanger, Nicklen and Coulson, 1977).  
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Figure 1.2. Sanger Sequencing with electrophoretic separation. Four reactions are set up 
containing the primer, DNA polymerase and one fluorescently labelled ddNTP to truncate the 
DNA fragment. Each reaction undergoes electrophoresis to separate out the fragments from top 
to bottom, by size, and the sequence can be determined by the bands which fluoresce.  
 
This method won Sanger the Nobel Prize for Chemistry in 1980, this was shared with 
Walter Gilbert who developed a chemical sequencing method known as the Maxam-
Gilbert method and Paul Berg who studied the biochemistry of nucleic acids focussing 
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on recombinant DNA. The Maxam-Gilbert method does not use DNA polymerase to 
make fragments but instead involves radiolabelling the nucleotides and then cleaving 
the DNA next to the radiolabelled bases (Maxam and Gilbert, 1977; Heather and Chain, 
2016). In both methods the DNA fragments are run on a polyacrylamide gel to determine 
their length and ascertain the specific nucleotide positions (Heather and Chain, 2016). 
 
Improvements to primer extension detection using capillary electrophoresis allowed for 
Sanger sequencing automation (Ansorge et al., 1987; Swerdlow and Gesteland, 1990). 
DNA sequencing as a molecular technique has evolved from costly, time consuming 
methodologies to a high throughput automated technique which can deliver whole 
genome sequences in days and smaller bacterial genomes even quicker. The 
contribution of bioinformatics software and computing hardware developments has 
made the process more efficient; sophisticated bioinformatic software permits more 
complex analysis of larger genome sequences in a timely manner. Automation of the 
process for DNA sequencing resulted in accurate sequencing of smaller and smaller 
sequences, including sequencing short RNA molecules.  
 
1.1.4. Next Generation Sequencing 
Until completion of the human genome project, the sequencing technologies outlined 
previously were used. In the early 2000s it became clear that the Sanger approach had 
reached its limit and that the only way to make genome sequencing faster would be to 
begin making technological advances with high throughput machines. This resulted in 
high costs when technologies were first developed, but with optimisation and improved 
processes came new techniques – collectively called next generation sequencing (NGS). 
NGS methods are used to sequence a number of different sequences, including a type 
of small RNA called micro RNAs (miRNAs).  Small RNA (sRNA) molecules are non-coding 
RNA molecules that regulate gene expression by post-transcriptional gene silencing 
(Zhang, 2009).  Deep sequencing (where a genomic region is sequenced multiple times) 
is the gold standard used to profile these sRNA molecules within a genome and discover 
novel and closely related miRNA sequences (Jayaprakash et al., 2011).  
 
Chapter 1: Introduction  
21 
 
NGS is the collective term for a number of different sequencing technologies: Illumina 
sequencing, Roche 454 sequencing, Ion torrent (Proton/PGM sequencing) and SOLiD 
sequencing. These technologies developed from pyrosequencing (Heather and Chain, 
2016), which is a sequencing method that measures light production proportional to the 
levels of pyrophosphate made (Hyman, 1988). Nucleotides are added one at a time and 
each time a nucleotide is incorporated pyrophosphate is released and converted 
proportionally to ATP by ATP sulfurylase; this ATP then catalyses the conversion of 
luciferin to oxyluciferin which produces light (Cummings et al., 2013). The light intensity 
is proportional to the number of bases incorporated onto the template strand, any dNTP 
not incorporated is degraded before the next dNTP is added. 
 
Each different NGS technology identifies these sequences differently but all require 
ligation of the miRNA to an adapter. Both Illumina sequencing and 454 sequencing read 
optical signals as bases are added and use annealed adapters. For Illumina sequencing 
these adapters are fixed to a slide while in 454 they are attached to beads (Figure 1.3 A 
and B). Ion torrent sequencing measures the release of H+ ions when a dNTP is added to 
DNA. If the dNTP is the next base added, H+ ions are released; the H+ concentration is 
measured using a transistor and converted into a charge build up which is transmitted 
as a voltage charge (Merriman, R&D Team and Rothberg, 2012). An algorithm converts 
the voltage charge to a signal. The  signals, or lack of, emitted after each dNTP wash 
indicate no incorporation of the base, 1-mer incorporation, 2-mer incorporation etc. 
(Merriman, R&D Team and Rothberg, 2012). This method is similar to 454 sequencing in 
that the addition of dNTPs are measured one at a time (Figure 1.3 C). The NGS 
technologies allow for faster sequencing, washing with dNTPs can be done relatively 
quickly and the instruments were designed to automate the process and they can 
process multiple samples at one time.  
Chapter 1: Introduction  
22 
 
Figure 1.3. Next Generation Sequencing technologies. A) Illumina sequencing: 
fluorescently labelled nucleotides with a terminator attached allow detection of single 
nucleotide addition, the terminator and fluorescent signal are removed before the next cycle; 
B) 454 sequencing: single dNTPs are added separately, if incorporated a signal is released and 
the nucleotide order determined; C) Ion torrent sequencing: single dNTPs are added separately 
and the pH measured to determine if a base(s) was incorporated.  
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To discover mutations and new miRNAs it is necessary to sequence cDNA libraries using 
these NGS methodologies. The miRNA is isolated and fractionated by size, adapters are 
ligated to the 3’ end first and then the 5’ end. The miRNA undergoes reverse 
transcription and PCR amplification converting the adapter ligated miRNAs into cDNA 
clones required for NGS. The sequencing protocol varies depending on the sequencing 
technology used (Figure 1.3) (Hafner et al., 2008). It is possible to carry out the 
quantitative polymerase chain reaction (qPCR) to check the levels of the miRNAs; it 
should be noted that qPCR can only be used to quantify known miRNAs (Hafner et al., 
2008; Sorefan et al., 2012).  In some cases there is under or over representation of 
miRNA quantification with NGS when compared to qPCR or microarray data. For 
example, a pool of miRNAs in 3 different breast tissue samples were sent to 6 microarray 
platforms and compared to both NGS and qPCR, the miRNA expression and sequencing 
results varied depending on the platform used and the sensitivity of the platforms (Git 
et al., 2010). Sequence bias, when using ligases for adapter attachment has become a 
recent focus for researchers implementing these techniques. Ligase bias has been noted 
when using both of the T4 RNA ligases and a modified version of T4Rnl2. The bias was 
more prominent with the 5’ adapter ligation step (Hafner et al., 2011). Such bias of the 
ligases is usually with regards to DNA/RNA structure and not the sequence (Zamore and 
Haley, 2005). Despite these issues the NGS technologies are considered a cheaper, 
higher through put option compared to traditional Sanger sequencing. 
 
Knowledge about DNA and the associated DNA sequencing technologies has come a 
long way: sequencers are shrinking, nanopore sequencers are commercially available 
(Branton et al., 2008; Deamer, Akeson and Branton, 2016) and research has started 
looking at using DNA as a storage molecule for digital information (Grass et al., 2015). 
DNA sequencing technologies are developing constantly and nowadays determining a 
DNA sequence is often the first, easy step in the identification of proteins. However, the 
discovery of proteins and research into their function had started before the discovery 
of DNA. The term protein is now common place in molecular biology with some proteins, 
specifically enzymes, utilised as research tools.  
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1.1.5. Protein Discovery 
The first proteins, discovered in the late 1700s by Fourcroy, were albumin, fibrin and 
gelatin (Tanford and Reynolds, 2003). These were isolated from animal sources and 
sparked interest in understanding the composition of these molecules; researchers 
found different levels of nitrogen, oxygen, hydrogen, carbon and sulphur (Kossel, 1910; 
Tanford and Reynolds, 2003; Stanford, 2005). It was this compositional data that 
revealed similarities between the substances and they were classified under the name 
protein (Tanford and Reynolds, 2003). Work began to separate proteins from one 
another and elicit more information about their structures, and the discovery of the 
peptide bond and the different amino acids continued throughout the early 1900s 
(Kohler, 1973). In 1886, Zinnofsky discovered that for every iron atom in haemoglobin 
there are 600 carbon atoms – a much more complex molecule than previously studied 
proteins. In 1958, the first 3 dimensional (3D) structure of Myoglobin revealed proteins 
were much more complex than originally thought. The first myoglobin structure, with a 
resolution of 7 Å, showed densely packed regions of electrons and surprisingly lacked 
symmetry (Kendrew et al., 1958; Tanford and Reynolds, 2003; Balasubramanian and 
Ponnuraj, 2010). Protein symmetry is thought to provide stability to the protein, the 
majority of membrane-bound and soluble proteins are symmetrical oligomeric 
complexes with at least two identical subunits (Goodsell and Olson, 2000). The 
technologies required to visualise 3D protein structures needed to become more 
sophisticated and by 1960 structures with a resolution of 2 Å were achieved. The range 
of current protein identification technologies is vast and often researchers make choices 
about the technologies used based on cost, time constraints and the type of protein 
being purified. While fundamental work to look at naturally occurring proteins and 
understand their functions is incredibly important, it is also possible to make 
modifications to proteins by altering the DNA sequence that encodes them resulting in 
recombinant proteins. 
 
1.1.6. Modifying proteins 
Protein mutations can affect protein stability, function and interaction (Reva, Antipin 
and Sander, 2011). Often mutations include addition, removal or substitution of single 
amino acids, but molecular research has evolved to look at how changing protein 
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domains by altering specific amino acids affects the function of the protein. This can be 
especially important when characterising proteins involved in pathways that are 
incorrectly regulated in diseases.  
 
Site directed mutagenesis (SDM) is used to change specific amino acids by making base 
substitutions, insertions and deletions in the relevant gene (Kunkel, 1985). SDM can be 
used to study the effect of changes to nucleic acid sequence and how these changes 
impact the structure and function of the encoded proteins. The most commonly used 
SDM approach requires specific primers with the desired base modification 
(Metzenberg, 2002). These primers are used in PCR, whereby the sequence change in 
the primers replaces the original sequence and is incorporated into the amplicon. The 
PCR product can be treated with a mix containing a kinase, nucleic acid ligase (usually 
DNA but can RNA ligases can also be used) and the restriction enzyme DpnI. The kinase 
is used to firstly phosphorylate the DNA, so that the ligase is able to circularise the PCR 
product and then DpnI cleaves only the methylated template DNA (the newly 
synthesised DNA from PCR will not be cleaved), and after this treatment the product is 
ready for transformation into competent Escherichia coli (E. coli) cells (Metzenberg, 
2002). While  a relatively simple process, SDM is now used considerably less due to the 
reduced cost of whole plasmid synthesis (Carrigan, Ballar and Tuzmen, 2011). SDM, 
similar to synthetic biology techniques (see Section 1.2.), usually requires the use of 
synthetic oligonucleotides for PCR primers.  
 
Understanding the central dogma and how the order of nucleotides in DNA translate 
into proteins has contributed to vital, fundamental and innovative research and has 
helped in developing knowledge about living organisms (Heather and Chain, 2016). The 
ability to make modifications to DNA for the synthesis of novel proteins has transformed 
molecular biology into a more engineering based discipline - synthetic biology; this new 
branch of molecular biology allows for a more complex and innovative type of science.  
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 1.2. Synthetic Biology  
Developments in molecular biology, including more advanced sequencing technologies 
and better protein identification methods paved the way for synthetic biology. Synthetic 
biology is described as the engineering, design and assembly, of systems and the 
redesigning of existing biological systems, devices and biological parts (Check, 2005; 
Endy, 2005) with a  focus on solving specific problems. The principals involved in 
synthetic biology techniques are comparable to those used in engineering, and permit 
the design of novel biological systems in a systematic way (Serrano, 2007). Synthetic 
biology looks to assemble parts. The term ‘parts’ can be used to describe proteins, 
genes, amino acids and bases, and this can be achieved using different enzymatic 
molecular tools. It is worth remembering that the parts may need to be specific to the 
organisms. For example, differences in cell biology of eukaryotes and prokaryotes may 
mean that what works for one cell type may not work for the other. The most common 
techniques in synthetic biology utilise specific restriction enzymes and DNA ligases to 
achieve sequential joining of parts, to create a recombinant molecule. Synthetic biology 
is still a relatively new concept within biology and focus is often placed on the design of 
novel parts and their function (Knight, 2003; Serrano, 2007).  
 
The different synthetic biology methodologies are often described as genetic 
engineering, falling into two categories of experiments: either there is the construction 
of non-natural building blocks that mimic natural functions or the building blocks already 
available are used to generate combinations not found in nature (Khalil and Collins, 
2010). Different approaches can be used to achieve both of these goals, including 
BioBrick assembly, Gibson cloning and Golden Gate Cloning.  
 
1.2.1. Golden Gate Cloning 
A method with high success of ligating multiple molecular parts (DNA, RNA, ribosome 
binding sites, regulatory, protein coding, terminators and conjugates) is Golden Gate 
Cloning (GGC).  A plasmid containing 10 parts was successfully ligated (Engler et al., 
2009) using one restriction enzyme and one DNA ligase. GGC is another single tube 
method that yields nearly 100 hundred percent recombination and provides the means 
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to make larger constructs from multiple smaller fragments, e.g. 9 fragments were 
successfully ligated using the Golden Gate method to form a 1.17 kb linear product 
(Engler, Kandzia and Marillonnet, 2008). Current research using GGC has resulted in 
highly accurate cloning and has mostly been achieved using plant systems (Patron et al., 
2015). This technique relies on the use of type IIS restriction enzymes to create 
constructs without the scarring seen with other methodologies such as BioBrickTM 
assembly (Shetty, Endy and Knight, 2008). GGC uses type IIS restriction enzymes that are 
able to cut 4 nucleotides outside of their recognition site to create sticky ends. These 
ends can be flanked by any nucleotide sequence, which gives more than 200 different 
combinations for these 4 nucleotide overhang regions (Engler, Kandzia and Marillonnet, 
2008). The overhang regions can be specifically designed and as such can be arranged in 
an order that has already been pre-determined, this can be quite time consuming 
though as it has to be done carefully. 
 
GGC relies on digestion and then ligation to create parts that can be assembled into a 
vector (Figure 1.4). The parts are designed so that the type IIS restriction sites are 
directed towards the parts to give the predefined sticky ends. The parts and vector then 
undergo restriction digestion, which results in sticky ends and removes the type IIS cut 
site. The digested parts undergo ligation and if the cloning has been successful a 
transformation experiment should confirm the correct clones (Engler, Kandzia and 
Marillonnet, 2008). The primary advantage for this technique is that it is successful in 
avoiding the expensive and more time consuming efforts involved with molecular 
cloning, and can also be carried out as a one tube reaction, like Gibson cloning, rather 
than multiple cloning steps. All reagents are heated and cooled between 10 and 50 times 
to ensure the DNA parts are digested and ligated repeatedly; this methodology is highly 
successful because once ligated the fragments are held in the constructs and cannot be 
re-digested after they have been assembled (Engler et al., 2009). This whole process 
takes only 30 minutes and results in nearly 100 % cloning efficiency. The type IIS 
enzymes will cut at their recognition site regardless of the adjacent nucleotides; 
selection of appropriate type IIS enzymes will ensure the sequences only fit together 
one way, which means that in one reaction there is the possibility for the construction 
of multiple sticky end fragments (Engler et al., 2009).  
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Figure 1.4. GGC of gene fragments into a vector. Primers are designed for the addition of 
the BsaI restriction site. The restriction enzyme BsaI can be used to create 4 bp overhangs in the 
forward or reverse direction for ligation of multiple genes (red and purple) into a vector. The 
small arrows (pointing left and right) indicate the direction of the BsaI recognition sites (5’-3’) 
for sticky end creation. Once ligated the inserts lose the BsaI sites and the plasmid is correctly 
assembled.  
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GGC has been used to successfully create Transcription Activator-Like Effector nucleases 
(Cermak, Starker and Voytas, 2014) and to ligate 12 eukaryote transcriptional parts from 
plants (Patron et al., 2015). GCC offers a time saving technique to create recombinant 
DNA plasmids for protein analysis. The type IIS restriction enzymes are just one 
molecular tool used in GGC. All of the techniques that come under the umbrella term 
synthetic biology use a multitude of enzymes as tools.  
 
1.3. Enzymes as tools for molecular and synthetic biology 
Enzymes can be classified into six categories, which are determined by the reaction they 
catalyse (Boyce and Tipton, 2001). The six categories are defined as 1) oxidoreductases, 
2) transferases, 3) hydrolases, 4) lyases, 5) isomerases and 6) ligases (Boyce and Tipton, 
2001). Over the last 60 years, the specific properties of these different types of proteins 
have been exploited for molecular and synthetic biology purposes. A quick search on 
any number of scientific commercial companies with biotechnology products provides 
a multitude of molecular tools for cloning, protein expression and purification as well as 
DNA modifying enzymes. 
 
1.3.1. Protein Tags for purification 
A wide variety of protein fusions have been developed for the purpose of purification or 
visualisation of protein interactions and networks in the cell (Terpe, 2003; Kimple and 
Sondek, 2004; Michelson-Horowitz et al., 2005; Lowder et al., 2011). When selecting a 
purification tag for a protein it is important to consider its effects on protein yield and 
cost. The type of tag selected will depend on the protein being purified and the host 
organism used to synthesise large amounts of protein. Some of the common host 
systems used are E. coli, yeast, human HeLa cells or Drosophila, but other host systems 
are available (Michelson-Horowitz et al., 2005). The different positive and negative 
factors for each tag/protein and host system will impact tag/protein choice for 
purification of proteins.  
 
One common tag used for purification from E. coli host cells is the Poly HIS tag system. 
This technique was developed in the 1980s (Hochuli et al., 1988) and still remains one 
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of the most common forms of protein tagging for purification due to its low cost, ease 
of use and low impact on the protein (Kimple and Sondek, 2004).  The tag itself is a chain 
of at least six histidine amino acids at either the N- or C-terminus of the protein that will 
be purified and relies on interactions between the histidine tag and transition metal ions 
in the purification matrix (Porath et al., 1975).  
 
Glutathione S-transferase (GST) is another common form of tagging often used for 
purification of polypeptides (Smith and Johnson, 1988; Smith, 2000; Terpe, 2003). An 
attractive feature of GST tagging is the ability to cleave the tag from the protein of 
interest while bound to glutathione agarose, providing a convenient separation method 
(Smith, 2000). Tag cleavage can also be achieved with His-tagged proteins but is usually 
not thought to be necessary as the His-tag has no impact on the protein structure 
(Carson et al., 2007).  However, there are problems with GST tagging, the glutathione 
matrix has a finite number of uses, usually between 4 and 20 regenerations, making GST 
tagging a less favourable option for large yield protein purifications as the finite number 
of uses increases the associated cost.  
 
A highly utilised tagging system is the Streptavidin-Biotin interaction. Streptavidin is a 
protein that can bind 4 biotin molecules, the biotin molecule is bound to the molecule 
of interest and acts as a tag with a high affinity for the streptavidin column (Terpe, 2003). 
The tag is located at either the N- or C-terminus of the protein for purification and offers 
not only a method for purification but also a way to immobilise proteins to media, for 
example streptavidin-coated beads (Terpe, 2003; Michelson-Horowitz et al., 2005). This 
system, when compared to other tagging methods, yields higher quantities of purified 
protein but the resin is costly and would become a large expenditure when carrying out 
large scale purifications on an industrial scale (Michelson-Horowitz et al., 2005).   
 
A different type of tagging for proteins is the use of reporter tags which are not 
commonly used for protein purification. Reporter tags enable protein-protein 
interaction to be studied as well as protein synthesis (Kimple and Sondek, 2004). While 
not an ideal protein purification tag, β-galactosidase is an ideal protein colour marker. It 
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catalyses the hydrolysis of its substrate 5-bromo-4-chloro-3-indolyl-β-D-galactoside 
(commonly referred to as X-gal) to produce 5-bromo-4-chloro-indoxyl, which dimerizes 
spontaneously creating a detectable blue colour (Kimpton and Emerman, 1992; Kimple 
and Sondek, 2004; Padmanabhan, Banerjee and Mandi, 2011). Horseradish peroxidase 
(HRP) is a highly used protein that is commonly used for Western blotting and 
immunoassays to amplify the photometric signals in these assays (Krainer and Glieder, 
2015). HRP can be bound to antibodies and proteins and is detectable using a 
spectrometer (Kimple and Sondek, 2004). Alkaline phosphatase (ALP) is another useful 
reporter tag as it produces a purple colour when reacting with 5-bromo-4-chloro-3-
indolyl phosphate (Kimple and Sondek, 2004). ALP is commonly used in enzyme linked 
immunosorbent assays (ELISA) and blotting methods. ALP is not commonly used for 
purification as yield is usually low and the matrix for purification cannot be easily reused, 
which increases cost for purification (Michelson-Horowitz et al., 2005). There are a 
number of commercial kits readily available for conjugating ALP to a protein for 
reporting and it is often conjugated to primary antibodies for immunoblotting (Kimple 
and Sondek, 2004). A number of other tags are readily available which utilise different 
purification matrices, for example the maltose binding protein, c-myc tag and the FLAG 
peptide tag (Terpe, 2003; Kimple and Sondek, 2004). Different tags offer ways to 
increase protein solubility and improve protein stability, although this is often 
dependent on the protein of interest for purification. 
 
1.3.2 DNA modifying enzymes  
There are several different enzymes used for DNA modification, including but not limited 
to kinases, nucleases and ligases. These enzymes can be used in combination or on their 
own to achieve specific modifications to DNA and are common place tools in most 
molecular biology laboratories.  
 
1.3.2.1. Endonucleases 
Endonucleases, which cut within a DNA molecule that is provided, were first detected in 
the 1950s. Different rates of bacteriophage growth were noted in different bacteria 
infected with bacteriophages (Luria and Human, 1952). This role of restriction enzymes, 
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specifically Type I, in bacteriophage modification was shown at a biochemical level 
(Arber, 1965). There are four different groups (Type) of restriction endonuclease: Type 
I – multi subunit enzymes that randomly cut DNA away from the recognition site and are 
not used for DNA analysis (Roberts et al., 2003). Type II – cut at the specific sequence to 
produce distinct DNA fragments and are routinely used for DNA analysis (Roberts et al., 
2003). Type III – need two sequences in opposite directions on the same piece of DNA 
to cut (Type III cut outside of the recognition site sequence and often do not fully digest 
the DNA) (Roberts et al., 2003).  Type IV – cleave modified DNA, these cleave 30 bases 
away from the recognition site and are not well defined (Roberts et al., 2003). Type I 
and Type II restriction endonucleases can be further sub-categorised, with focus on the 
Type IIS and Type IIG subgroup for molecular and synthetic biology methodologies. The 
first Type II restriction enzyme, HindII, was purified from Haemophilus influenza, and 
could cleave T7 DNA (Smith and Welcox, 1970). The discovery of the recognition site 
sequence (Kelly and Smith, 1970) led to the many practical uses for type II restriction 
enzymes that are in place today.  
 
1.3.2.2. Exonucleases 
Exonucleases work differently from endonucleases and cleave nucleotides from the end 
of a polynucleotide chain. Each nucleotide is usually removed one at a time and 
exonucleases are vital for genome stability (Mason and Cox, 2012). There are a number 
of types of exonuclease which are named after their specific activities, this includes 5’-
3’, 3’-5’ and poly (A) specific 3’-5’ exonucleases (Mukherjee et al., 2004). Exonucleases 
are also valuable tools in molecular biology, specifically after PCR to degrade primers or 
to degrade single stranded DNA from nucleic acid mixtures (Werle et al., 1994; Nabavi 
and Nazar, 2005).  
 
1.3.2.3. Kinases 
Bacteriophage T4 polynucleotide kinase (Pnk) is another DNA modification enzyme that 
is routinely used in molecular biology. Pnk was first discovered in the 1960s when 
purified from E. coli infected with the bacteriophage T4 (Richardson, 1965). Pnk carries 
out the removal of 3’ phosphate groups and the addition of phosphate to the 5’ OH 
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terminus (Wang and Shuman, 2001; Wang, Lima and Shuman, 2002).  Historically Pnk 
was used during cloning, its ability to remove phosphate and correctly prime ends of 
DNA for ligation has made it a useful biotechnology tool and this will be discussed in 
more detail in Chapter 5.  
 
1.3.2.4. Nucleic Acid Ligases 
Nucleic Acid (NA) Ligases are used in cloning for recircularization of plasmids and 
insertion of genes into plasmids to create recombinant DNA. Discovery of DNA (see 
Section 1.1.1) sparked the beginning of molecular biology and while this discovery is one 
of the most important, it is not the only discovery that has contributed to the molecular 
biology field and cloning techniques used today. The study of E. coli cells infected with λ 
phages, enterobacteria phages that infect E. coli, showed that a repair system was able 
to circularise the DNA (Gellert, 1967) and, thus, DNA ligases were discovered although 
at this time their uses in biotechnology were limited. The T3, T4, T7 and E. coli DNA 
ligases are all commercially available for DNA modification. The T4 ligases are usually 
used for blunt and sticky end ligation, nick repair, cloning and adapter ligation. One of 
the most common uses for T4 DNA ligase is recircularization of plasmids or addition of 
new DNA into plasmids as recombinant DNA. More recently the T4 RNA ligases isolated 
from bacteriophage T4  have been used in NGS for adapter ligation to miRNAs (Thomson, 
Bracken and Goodall, 2011). The T4 ligases in vivo are involved in DNA and RNA repair 
systems by repairing nicks in DNA and RNA by phosphodiester bond formation (Bullard 
and Bowater, 2006).  
 
 1.4. DNA and RNA repair systems 
DNA and RNA repair are fundamental molecules involved in a number of reactions 
within an organism or cell (Tomkinson and Levin, 1997; Wilkinson, Day and Bowater, 
2001). DNA damage can be caused either by metabolic activity or by external factors, 
and repair systems aim to mend the damaged DNA or RNA often ensuring cell survival 
(Hustedt and Durocher, 2017). There are different types of damage that can happen to 
the DNA structure; exogenous damage may be caused by oxidation, alkylation or base 
hydrolysis while external damage may be caused by chemicals, UV light, ionising 
radiation or increased temperature. Each of these damage the DNA in different ways; 
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oxidation, alkylation and ionising radiation result in either altered bases, abasic sites (no 
purine or pyrimidine at the position) or a single stranded break and are repaired via base 
excision repair (BER) (Houtgraaf, Versmissen and van der Giessen, 2006; Jackson and 
Bartek, 2009). Polycyclic aromatic hydrocarbons and UV light cause strand cross-linking 
and DNA adducts (where the DNA is bound to a cancer causing chemical) this damage is 
repaired by nucleotide excision repair (NER) (Houtgraaf, Versmissen and van der 
Giessen, 2006). A third type of repair pathway, mismatch repair (MMR) occurs when 
replication errors result in base mismatches or small insertions or deletions (Houtgraaf, 
Versmissen and van der Giessen, 2006). Ionising radiation and alkylation can also lead 
to cross links or double stranded breaks (DSBs) which require recombinational repair, 
either homologous recombination (HR) or non-homologous end joining (NHEJ) (Drabløs 
et al., 2004; Houtgraaf, Versmissen and van der Giessen, 2006; Jackson and Bartek, 
2009). HR results in accurate DSB repair while NHEJ is mutagenic. HR uses a DNA 
template that is not damaged and uses nucleotides to repair the original DNA sequence; 
NHEJ modifies the broken DNA ends and ligates the break, often generating insertions 
or deletions (Mao et al., 2008) 
 
Some of the types of damage that may happen to DNA can also happen to RNA, including 
alkylation  and radiation damage (Bellacosa and Moss, 2003). RNA alkylation, also 
termed N- alkylation, where adducts are formed at the N- atoms in RNA bases, are 
repaired by BER or by oxidative demethylases (Drabløs et al., 2004). One enzyme from 
E. coli, AlkB, and its human homologs have been identified as playing a key role in RNA 
alkylation repair by directly reversing the damage by demethylating methylated RNA 
bases (Bellacosa and Moss, 2003). The pathways for RNA repair are not as well studied 
or established in the literature, but one study noted it was possible to complement the 
RNA repair process in yeast by using T4 RNA ligase 1 and T4 polynucleotide kinase 
(Schwer et al., 2004) indicating RNA repair in different organisms have shared 
evolutionary mechanisms.  
 
The repair pathways mentioned for both DNA repair and RNA repair use a number of 
different enzymes, notably ligases in the final phosphodiester bond formation step, for 
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repair (Jackson and Bartek, 2009). These phosphodiester bond forming enzymes can be 
categorised into three different enzyme sub-classes based on the molecule repaired: 
DNA ligases, RNA ligases and mRNA capping enzymes. These ligases and mRNA capping 
enzymes are also part of a super family of nucleotidyl transferases. Ligases were 
originally classified as either DNA or RNA ligases, but as new enzymes have been 
identified it appears this classification system requires more work and often ligases are 
being grouped by their substrate specificity (Popow, Schleiffer and Martinez, 2012). In 
this body of work, groups of NA ligases will be described as Dnl-like, Rnl1-like or Rnl2-
like families and are discussed in more detail below. 
 
1.4.1. Nucleotidyl transferase conserved motifs  
DNA ligases, RNA ligases and mRNA capping enzymes are often described as a super 
family of nucleotidyl transferases. Nucleotidyl transferases are characterised by 6 
conserved peptide motifs: motifs I, III, IIIa, IV,  V and VI, which play a role in the catalytic 
activity of the enzymes in this family (Shuman and Schwer, 1995; Doherty, 1999). These 
motifs vary significantly between the DNA ligases, RNA ligases and mRNA capping 
enzymes, including the T4 ligases (Table 1.1), which show little motif similarity. Motif I 
(K-x-H/D/N-G, where x refers to any amino acid) is essential for ligase function, it 
contains the lysine residue that binds the AMP that is essential for the ligation activity, 
and is found in all members of this family. The Shuman research group have carried out 
a number of mutagenesis studies (see section 3.1.3) comparing each of the T4 ligases 
and their motifs to homologous ligases. They identified conservation of all motifs in 
T4Dnl, motifs I, IV and V in T4Rnl1 and motifs I-V in T4Rnl2 (Table 1.1)(Shuman and 
Schwer, 1995; Ho and Shuman, 2002; Wang et al., 2003; Yin, Ho and Shuman, 2003; 
Nandakumar et al., 2004). DNA ligases and mRNA capping enzymes also have the 
addition of an oligonucleotide binding (OB) fold in the C-terminal region, also described 
as motif VI, which is missing in all members of the Rnl1-like and Rnl2-like families (Pascal, 
2008).  
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Table 1.1. Conserved polypeptide motifs of the T4 NA ligases. The amino acid sequences 
for each conserved motif in T4Dnl, T4Rnl1 and T4Rnl2. Where there is no sequence (-), the ligase 
does not contain this motif. These sequences are conserved when the ligases are aligned against 
other Dnl- Rnl1- or Rnl2- like ligases. 
 
1.4.2. The ligation reaction 
The ligation reaction carried out by DNA and RNA ligases has 3 main steps: enzyme 
adenylation, transfer of AMP to the 5’ end of the DNA and formation of the 
phosphodiester bond (Figure 1.5) (Nandakumar, Shuman and Lima, 2006). Ligases 
require cofactors to join the strands of nucleic acids, with the cofactor either NAD+ or 
ATP providing the adenylate group. Current literature suggests that functional DNA 
ligases using NAD+ are only found in bacteria, while ATP-dependent ligases are abundant 
in all domains of life. The first step of the ligation reaction is enzyme adenylation. This 
step involves the formation of the ligase-AMP intermediate and requires magnesium as 
a cation for the reaction.  The DNA/RNA ligase binds to the α-phosphorus of ATP (if ATP 
is the cofactor required by the ligase) (Shuman, 2009), generating pyrophosphate 
(Figure 1.5, Step 1)(Ho et al., 2004; Chauleau and Shuman, 2013). The second step is 
AMP transfer, which can at times be problematic because it is the step closest to 
equilibrium and, as such, has a highly reversible nature (Figure 1.5, Step 2) (Cherepanov 
and De Vries, 2003). This step leads to the formation of the DNA/RNA-adenylate 
intermediate by transferring the AMP from the ligase-adenylate to the 5’-PO4 of the 
DNA/RNA (Ho et al., 2004; Shuman, 2009). The final step is referred to as strand joining, 
whereby the ligase catalyses the formation of the phosphodiester bond and releases 
AMP (Figure 1.5 Step 3) (Ho et al., 2004; Popow, Schleiffer and Martinez, 2012). 
 
Ligase Motif I Motif III Motif IIIa Motif IV Motif V Motif VI 
T4Dnl KADGAR VLIDGELV KFQVWDYVP EGIIL LYKFK PIAIRLREDK 
T4Rnl1 KEDGSL - - EGYVA HFKIK - 
T4Rnl2 KIHGTN YQVFGEFA FYVFDIIV EGYVL AIKCK - 
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Figure 1.5. The 3-step ligation reaction pathway of T4 DNA and RNA ligases with ATP 
as the co-factor. Step 1: Ligase-AMP formation via the Lysine residue in motif I, pyrophosphate 
is released; Step 2: AMP transfer to create the 5’ phosphate of the broken DNA/RNA strand, this 
is DNA adenylate; Step 3: nick sealing catalysis of the 5’ phosphate and 3’ OH via phosphodiester 
bond formation (Shuman, 2009).  
 
1.5. Bacteriophage T4 Ligases 
The bacteriophage T4 is a renowned source for commercially available enzymes, 
including polynucleotide kinase, DNA polymerase and DNA and RNA ligases. These 
enzymes have wide spread applications across molecular microbiology, genetics and 
gene expression, demonstrating how studying the T4 phage has been vital in developing 
biological concepts. The bacteriophage T4 has a genome of  168,903 bases, encoding 
300 probable genes (Miller et al., 2003). The number of genes coding for proteins is 
thought to be 289, although some genes code for more than one protein, and of the 289 
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possible proteins 156 have been characterised (Armstrong, Brown and Tsugita, 1983; 
Miller et al., 2003). Three of these proteins are NA ligases: T4 DNA ligase (T4Dnl), T4 RNA 
ligase 1 (T4Rnl1) and T4 RNA ligase 2 (T4Rnl2). 
 
1.5.1. T4 DNA ligase 
The bacteriophage T4 has one DNA ligase (T4Dnl) which is coded for by gene 30, gp30. 
The molecular weight of T4Dnl is 55.3 kDa and it uses ATP as its co-factor (Armstrong, 
Brown and Tsugita, 1983). When T4Dnl was first purified, its capacity as a ligase was 
identified and subsequently it is now a highly used tool in molecular biology techniques 
(Weiss and Richardson, 1967). Mutational studies, where E. coli was infected with T4 
phages containing a defective copy of T4Dnl, demonstrated that T4Dnl is required for 
phage growth (Gellert, 1967; Karam and Barker, 1971). In E. coli cells deficient in the 
bacterial host ligase, complementation of T4Dnl resulted in recovery of ligase function 
(Wilson and Murray, 1979). The crystallographic structure of a number of DNA ligases 
are known but there is no crystallographic structure available for T4Dnl (at the time of 
submission of this work a structure for T4Dnl was published, discussed in section 7.2); 
however, DNA sequencing has helped in identifying the conserved polypeptide motifs 
for this ligase. The OB fold in T4Dnl appears to be the region that provides the enzyme 
specificity for DNA ligases and mRNA capping enzymes and its conformational change is 
essential for step I of the enzymatic reaction in some DNA ligases.  While the OB fold is 
absent in Rnl1 and Rnl2 families it is thought they may undergo a similar conformational 
change to T4 DNA ligase allowing the lysine in motif I to interact with ATP (Doherty, 
1999; Sriskanda, 2002). T4Dnl can seal nicks in single stranded breaks when both strands 
are DNA, or RNA and DNA when the 3’-OH part of the break is RNA and the 5’-phosphate 
is DNA (Bullard and Bowater, 2006).  
 
1.5.2. T4 RNA Ligase 1 
T4Rnl1 is one of two RNA ligases from the bacteriophage T4, it has a molecular weight 
of 43.5 kDa and was first purified from E. coli infected with the bacteriophage T4 (Silber, 
Malathi and Hurwitz, 1972). It is part of a sub group of proteins called Rnl1-like proteins, 
which can be found across the plant and fungi domains (Ho and Shuman, 2002). T4Rnl1 
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is encoded by gene 63 in the T4 genome and is involved in catalysing tail fibre 
attachment (TFA) during phage formation and nick sealing during infection of E. coli 
(Snopek et al., 1977; Hall et al., 1980). TFA involves a number of different proteins, 
T4Rnl1 performs the last step in attaching the long tail fibre to the baseplate (Wood et 
al., 1978; Leiman et al., 2003). The role of T4Rnl1 in this assembly process was further 
confirmed when attachment of tail fibres to tail-fibreless T4 particles increased 50-fold 
when T4Rnl1 was present compared to mutants absent in T4Rnl1 (Wood et al., 1978; 
Leiman et al., 2010). Its ligation activity is separate to its function in TFA (Miller et al., 
2003) and appears to be an adapted response mechanism utilised when the phage 
infects E. coli (El Omari et al., 2006). 
 
During bacteriophage infection with T4, E. coli cells activate two restriction enzymes – 
EcoprrI and a tRNA lysine specific anticodon nuclease (Penner et al., 1995). These two 
enzymes are involved in recognition of the stp polypeptides found on the surface of the 
T4 bacteriophage (Penner et al., 1995; Blanga-Kanfi et al., 2006), resulting in cleavage of 
the tRNA anti-codon loop at the lysine residue, preventing further T4 infection (Amitsur, 
Levitz and Kaufmann, 1987). The T4 phage has evolved a system to counter this: T4 Pnk 
repairs the ends of the nicked tRNA and then T4Rnl1 seals the break in the anti-codon 
loop, allowing for further maturation of viral proteins and continued phage infection 
(Penner et al., 1995; Uzan and Miller, 2010; Popow, Schleiffer and Martinez, 2012).  
 
T4Rnl1 is notably different from the other T4 ligases, in that it is missing two of the 
conserved polypeptide motifs, III and IIIa (Table 1.1) (Figure 1.5). Site directed 
mutagenesis of specific conserved amino acids in T4Rnl1 showed essential residues 
located in the active site, notably Lys-99, Gly-102, Lys-118, Glu-227, Gly-228, Lys-240 
and Lys-242. These residues are also conserved in the motifs in the active sites of DNA 
ligases, mRNA capping enzymes and T4Rnl2 (Wang et al., 2003). Specifically the Lysine 
residues (99, 240 and 242) are essential for ligation but not for the phosphodiester bond 
formation, indicating their role in the first step of ligation – adenylation (Wang et al., 
2003). T4Rnl1 is able to ligate a range of DNA/RNA substrates, but in all instances the 3’-
OH strand must be RNA (Bullard and Bowater, 2006).  
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Figure 1.6. Crystallographic structure of T4Rnl1. T4Rnl1 with the nucleotidyl transferase 
conserved polypeptide motifs highlighted, motif I (red), motif IV (blue) and motif V (green), 
which form the nucleotide binding pocket. The metal ions calcium (pale pink sphere) and 
magnesium (black sphere) are located in the nucleic acid binding pocket. Illustrated using 
CCP4MG software (PDB 2C5U).  
 
1.5.3. T4 RNA Ligase 2 
T4Rnl2 is the second RNA ligase from the bacteriophage T4 and Rnl2-like proteins can 
be found in all phylogenetic domains (Shuman and Lima, 2004). It is encoded by the gene 
24.1 and has a molecular weight of 37 kDa. The in vivo function of T4Rnl2 is still 
unknown, however, it is thought to be involved in guided RNA repair in mRNAs, 
encompassing mRNA repair as part of RNA ligation (Ho et al., 2004). T4Rnl2 is more 
similar to T4Dnl as it has all of the conserved polypeptide motifs for the nucleotide 
binding pocket, I, III, IIIa, IV and V (Figure 1.6) (Yin, Ho and Shuman, 2003; Shuman and 
Lima, 2004). Mutagenesis of conserved amino acids identified a number of essential 
residues: Glu-34, Asn-40, Arg-55, Glu-99, Phe-119, Asp-120, Glu-20 and Lys-209 (Yin, Ho 
and Shuman, 2003). Each of these amino acids are found in the conserved polypeptide 
motifs, or close to the nucleotide binding pocket. The N- terminal region is responsible 
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for steps 1 and 3 in the ligation reaction, but the C- terminal region is required for step 
2 (Yin et al., 2004). 
 
The DNA/RNA substrate specificity of T4Rnl2 lies somewhere between T4Dnl and 
T4Rnl1. It is capable of ligating nicks between double stranded substrates where both 
strands either side of the nick are DNA – like T4Dnl; but T4Rnl2 can also do this with 
double stranded RNA substrates and substrates with combinations of DNA and RNA – 
like T4Rnl1 (Bullard and Bowater, 2006). When the substrates are combinations of DNA 
and RNA, T4Rnl2 joins RNA 3’-OH/DNA 5’-PO4 (Bullard and Bowater, 2006; Chauleau and 
Shuman, 2013). As a molecular tool T4Rnl2 is often used in NGS adapter ligation, and a 
truncated version of T4Rnl2, amino acids 1-249, has been shown to ligate 5’ adenylated 
adapters to 3’ ends of RNA more effectively than T4Rnl1. Despite this, adapter ligation 
remains a problematic step in next generation sequencing of micro RNAs (Viollet et al., 
2011) and attempts to rectify this have included lengthening the adapters (Sorefan et 
al., 2012) but other than truncating T4Rnl2 no attempts to modify the ligases have been 
made.  
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Figure 1.7. Crystallographic structures of T4Rnl2. T4Rnl2 with the adenylation domain 
motifs highlighted, motif I (red), motif III (orange), motif IIIa (pink), motif IV (blue) and motif V 
(green) The magnesium ions (black spheres) are located in the nucleic acid binding pocket. PDB 
file 2HVQ illustrated using CCP4MG software. 
 
1.5.4. Problems with the T4 ligases 
As stated above, the T4 ligases are valued molecular biology tools and structure bias 
with these ligases has been noted and become a well discussed issue. This is especially 
prevalent when ligating adapters for NGS (Zhuang et al., 2012). The enzymes of choice 
for this ligation are usually either a combination of T4Rnl1 and T4Rnl2 or just T4Rnl1 
used twice (Sorefan et al., 2012). Substrate specificity experiments for both T4Rnl1 and 
T4Rnl2 have shown that both are capable of ligating a wider range of substrates than 
T4Dnl, and that the complementary strand could be either DNA or RNA for both of these 
ligases (Bullard and Bowater, 2006). Quantitative analysis of miRNAs, using pre-
adenylated DNA adapters, showed that the T4 RNA ligases are not biased to sequence, 
but instead the secondary structure of the 3’ end of DNA/RNA (Zhuang et al., 2012). A 
number of studies have looked at this bias further and have primarily focussed on 
altering the adapters used for ligation in NGS. Using a pool of adapters, instead of a 
single sequence, improved ligation efficiency and reduced bias (Xu et al., 2015). Another 
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major concern with the use of these ligases in NGS is the possibility of circularisation of 
the 3’ adapter and concatamerisation of the input RNA, although this can be limited if 
there is a surplus of miRNA adapter and other factors, like temperature and time, remain 
constant (Hafner et al., 2011; Sorefan et al., 2012). For NGS, ligases have already 
undergone modification to recognise only adenylated RNA, which has helped in 
developing the necessary cloning techniques (Sorefan et al., 2012). Some bias is 
expected when carrying out these sequencing techniques because of the nature of 
enzymatic reactions (Hafner et al., 2011).  
 
1.6 Research Aims 
There has been a notable effort to reduce the bias seen in NGS adapter ligation, although 
it could be useful to tailor the bias in such a way to favour specific results. It may be 
possible with the use of molecular and synthetic biology techniques to create novel NA 
ligases with altered conserved motifs and additional domains that could have specific 
functions. By substituting specific amino acids in motif I, swapping conserved domains 
and creating chimeric ligases it may be possible to create NA ligases with improved 
phosphodiester bond formation with different or new substrates. It may also be possible 
to address differences in substrate specificity by mutating specific amino acids in motif 
I since the lysine residue in motif I is responsible for interactions with ATP and other 
residues in motif I interact directly with the DNA/RNA substrate (Nandakumar, Shuman 
and Lima, 2006).  
 
The aims of this research were to modify the T4 RNA ligases resulting in novel ligases 
with novel or different substrate specificity and ligation activity. A total of 22 new 
versions of the T4 NA ligases are detailed in this body of work. The specific modifications 
to the genes or plasmids are detailed in individual chapters as a number of different 
techniques were used to create different variants. These new ligases include specific 
mutations to motif I in each of the T4 ligases, domain swapping/addition to the T4 RNA 
ligases and ligase-fusions with adenylate kinase, polynucleotide kinase and 
Mycobacterium smegmatis LigD; further background information about each of these 
enzymes can be found in the relevant chapter.   
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Chapter 2: Materials and Methods 
 
This chapter details the different experimental procedures used during this project. The 
bacterial strains and plasmids used, cloning procedures, purification methodologies and 
the ligation assay used to determine the activity and specificity of the ligases are 
included in this chapter. Specific methods for mutations and activity are included within 
the relevant results chapter.  
 
2.1 Bacterial cell preparation and growth 
2.1.1 Bacterial Strains 
All bacterial strains used (Table 2.1) were grown either in Luria-Bertani (LB) liquid media 
or on inverted LB solid agar plates (Chapter 2.5.2) at 37 °C, unless stated otherwise. The 
LB liquid media contained 100 µg/ml Ampicillin, to determine positive transformant 
selection for protein purification procedures. Chloramphenicol was also added to final 
concentrations of 50 µg/ml.  
 
2.1.2 Competent cell preparation  
Both α-select and BL21 pLysS E. coli competent cells were made by streaking a stock of 
bacteria onto an LB agar plate (a selective plate containing chloramphenicol for BL21 
pLysS cells), this was grown overnight at 37 °C. A 5 ml selective LB media was inoculated 
with a single colony from this plate and grown overnight at 37 °C with shaking at 200 
rpm. Then a second set of two 50 ml LB selective media were sub-cultured using 500 µl 
of the overnight culture and grown at 37 °C with shaking at 200 rpm until the OD600 
reached 0.5. The cells were pelleted by centrifugation at 4500 rpm using the Beckman 
Coulter Allegra 25R bench top centrifuge for 5 minutes at 4 °C, the supernatant was 
discarded. All steps were then performed at 4 °C, 40 ml of ice-cold TFB1 (Table 2.5) was 
used to resuspend the cell pellets. These were incubated on ice for 5 minutes then 
centrifuged at 4500 rpm for 5 minutes. The supernatant was discarded and the cells 
resuspended in 2 ml of ice-cold TFB2 (Table 2.5) and incubated on ice for 45 minutes. 
The cells were then quick frozen with liquid nitrogen and stored at -80 °C in 200 µl 
aliquots. Both Novagen and Bioline E. coli competent cells were used as per the 
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instructions provided by the manufacturer, with three different E. coli strains being used 
(Table 2.1). Once transformed the cells were plated out onto LB solid agar plates 
containing 100 µg/ml Ampicillin and 50 µg/ml Chloramphenicol (for DE3 strains) and 
incubated at 37 °C overnight. 
 
Table 2.1. Details of the 3 different E. coli strains used throughout this project and 
where they were purchased from.  
E. coli Strain Brand Genotype 
Rosetta (DE3) pLysS Novagen F– ompT hsdSB (rB– mB– ) gal dcm pRARE (CamR) 
BL21 (DE3) pLysS Invitrogen 
 
F- ompT hsdSB (rB– mB–) gal dcm (DE3) pLysS (CamR) 
Alpha select bronze Bioline F- deoR endA1 recA1 relA1 gyrA1 hsdR17(rk-, mk+) 
supE44 thi-1 phoA ∆(lacZYA-argF)U169 80lacZ∆M15 λ- 
 
2.2 DNA procedures 
2.2.1 The pET vector system 
The pET system uses bacteriophage T7 machinery to control gene transcription (Studier 
and Moffatt, 1986). The pET system used for DNA and protein expression for all proteins 
was pET-16b; pET-16b has Ampicillin antibiotic resistance, His-Tag addition at the N-
terminus, uses the T7 promotor and terminator to elicit gene control and can be induced 
using IPTG. All T4 nucleic acid (NA) ligases and variants of these ligases were modified 
and expressed using the pET16b vector, unless stated otherwise. The T4 NA ligases were 
already available on the pet16b vector (Figure 2.1 A, B and C) (Bullard and Bowater, 
2006).  
 
2.2.2 General Molecular Biology 
Experimental protocols for gene modification and plasmid construction are given in 
specific chapters. Each set of plasmids containing the modified ligase genes was 
prepared differently and requires a separate methods section specific to the chapter to 
describe and explain the protocols required.  
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Figure 2.1. The construct already available to express T4Dnl (Bullard and Bowater, 2006); 
on the pET16b plasmid denoted pRB255. The T4Dnl gene (dark green) is between the NdeI and 
BamHI restriction sites. The plasmid map was generated using SnapGene software.  
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Figure 2.2. The construct already available to express T4Rnl1 (Bullard and Bowater, 2006); 
on the pET16b plasmid denoted pRB256. The T4Rnl1 gene (orange) is between the NdeI and 
BamHI recognition sites. The plasmid map was generated using SnapGene software.  
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Figure 2.3. The construct already available to express T4Rnl2 (Bullard and Bowater, 2006); 
on the pET16b plasmid denoted pRB257. The T4Rnl2 gene (blue) is between the NdeI and BamHI 
recognition sites.  The plasmid map was generated using SnapGene software.  
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2.2.3 The plasmids used and generated during the project. 
Table 2.2. Description of the plasmids used and generated, with details of modification 
made to the plasmid. All of the plasmids generated in this body of work were confirmed by 
sequencing.  
Plasmid Name Description Provider 
pRB255 pET16b + T4Dnl D. Bullard  
pRB256 pET16b + T4Rnl1 D. Bullard  
pRB257 pET16b + T4Rnl2 D. Bullard  
pRB551 pUC57 + E. coli Adenylate Kinase (Adk) Genscript  
pRB552 pET16b vector + T4Dnl (pRB255) + E. coli Adk 
at the N- terminus,  
This project 
pRB553 pET16b vector + T4Rnl1 (pRB256) + E. coli Adk 
at the N- terminus 
This project 
pRB554 pET16b vector + T4Rnl2 (pRB257) + E. coli Adk 
at the N- terminus 
This project 
pRB555 pET16b vector + T4Rnl1 (pRB256) with motif I 
from T4Rnl2 (KEDGSL to KIHGTN) 
This project 
pRB556 pET16b vector + T4Rnl2 (pRB257) with motif I 
from T4Rnl1 (KIHGTN to KEDGSL) 
This project 
pRB557 pET16b vector + T4Rnl1 (pRB256) with OB 
domain from T4Dnl replacing the C-terminus 
(residues 242-374 from T4Rnl1 replaced with 
OB domain from T4Dnl residues 368 -487). 
This project 
pRB558 pET16b vector + T4Rnl2 (pRB257) with OB 
domain from T4Dnl replacing the C-terminus 
(residues 227-334 from T4Rnl2 replaced with 
OB domain from T4Dnl residues 368 -487). 
This project 
pRB559 pUC57 + T4 Polynucleotide Kinase (Pnk) Genscript 
pRB560 pET16b vector + T4Dnl (pRB255) + T4 Pnk at 
the N- terminus of the ligase 
This project 
pRB561 pET16b vector + T4Rnl1 (pRB256) + T4 Pnk at 
the N- terminus of the ligase 
This project 
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pRB562 pET16b vector + T4Rnl2 (pRB257) + T4 Pnk at 
the N- terminus of the ligase 
This project 
pRB563 pET16b + T4Rnl1 (pRB256) D101H mutation This project 
pRB564 pET16b + T4Rn2 (pRB257) H37D mutation This project 
pRB565 pET16b + T4Dnl (pRB255) R164L  mutation This project 
pRB566 pET16b + T4Dnl (pRB255) R164N mutation This project 
pRB567 pET16b + T4Rnl1 (pRB256) L104R mutation This project 
pRB568 pET16b + T4Rnl1 (pRB256) L104N mutation This project 
pRB569 pET16b + T4Rnl2 (pRB257) N40R mutation This project 
pRB570 pET16b + T4Rnl2 (pRB257) N40L mutation This project 
pRB571 pUC57 + Mycobacterium smegmatis LigD Genscript 
pRB572 pET16b + MSLigD (minus ligase) + T4Dnl 
(MSLigD with T4Dnl as ligase part on pRB255) 
This project 
pRB573 pET16b + MSLigD (minus ligase) + T4Rnl1 
(MSLigD with T4Rnl1 as ligase part on pRB256)  
This project 
pRB574 pET16b + MSLigD (minus ligase) + T4Rnl2 
(MSLigD with T4Rnl2 as ligase part on pRB257)  
This project 
pRB575 pET16b + full length MSLigD This project 
pRB576 pET16b + Pnk gene This project 
 
2.2.2 Plasmid extraction 
Plasmids were extracted from 5 ml overnight liquid LB cultures with the appropriate 
selective antibiotic, these were inoculated from positive transformants. The Qiagen 
QiaPrep Spin Miniprep kit Quick Stick Protocol was used as per the manufacturer 
instructions. A Thermo Scientific Nanodrop One was used to determine the plasmid 
concentration.   
 
2.2.4 Agarose gel electrophoresis 
The agarose gels used for DNA and restriction enzyme digest analysis were 1 % TAE 
agarose gels run in 1x TAE buffer (Table 2.5). The gels were made by heating 1 g of 
Melford molecular biology grade agarose powder in 100 ml 1x TAE buffer to 100 ⁰C in a 
conical flask with a sponge stopper. To visualise the gels 5 µl of 10 mg/ml ethidium 
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bromide was added to the TAE/agarose mixture and the gel poured into a casting tray 
with a comb insert in place. Once set the gel was positioned into a gel tank containing 
1x TAE buffer, the DNA samples mixed with 5x loading dye were loaded into wells. Hyper 
Ladder 1kb (Bioline) was used as a ladder. The gels were run at 100 V, 95 mA for between 
2 hours and 2.5 hours. The gels were visualised and imaged under UV light using the 
BioRad ChemiDoc XRS System. 
 
2.2.5 Agarose gel purification 
The required DNA fragments were cut out of the agarose gel and the DNA extracted 
using the Bioline Isolate II PCR & Gel Kit. The manufacturer’s protocol was followed, the 
amount of DNA in each sample was quantified using the Thermo Scientific Nanodrop 
One.   
 
2.2.6 Restriction enzyme digestion to analyse positive transformants 
On all plasmids the new recombinant or mutated ligase genes were between the NdeI 
(upstream of the N- terminus) and BamHI (downstream of the C-terminus) cut sites. The 
enzymes required for restriction digestion were purchased from ThermoFisher 
Scientific. A stock solution containing 6.25 µl of BamHI, 6.25 µl of NdeI and 12.5 µl of FD 
Buffer (ThermoFisher Scientific) was made, 3 µl of this was added to 12 µl of up to 1 µg 
purified plasmid DNA and incubated at 37 °C for 2.5 hours. The DNA fragments from 
digestion were analysed using agarose gel electrophoresis where gels contained 
ethidium bromide and were visualised using UV. 
 
2.2.7 Bacterial Transformation 
Plasmids were transformed as follows: 50 µl of chemically competent E. coli cells were 
incubated with 1 ng of plasmid DNA on ice for 30 minutes. The cells were heat shocked 
at 42 °C for 30 seconds and immediately returned to ice for a further 5 minutes. To the 
cell suspension, 950 µl SOC media (Novagen) was added and the cells incubated at 37 
°C, 300 rpm for 60 minutes to allow for recovery. From the recovered cells, 100 µl was 
spread onto selective LB plates and inverted for incubation at 37 °C overnight. When 
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using the Novagen/Bioline chemically competent cells manufacturer’s instructions were 
followed.  
 
2.2.8 DNA Sequencing 
Plasmids were sequenced by Eurofins Genomics (i54 Business Park, Wolverhampton, 
UK) and required 100 ng/µl for accurate sequencing results, 15 µl was required for each 
sequencing reaction. The primers used were the T7 Promotor Forward primer and the 
T7 Terminator Reverse primer, these were supplied by Eurofins Genomics.  
 
2.2.9 Oligonucleotides 
Oligonucleotides were ordered with specific sequences from Eurogentec (The Square, 
Southampton, UK). Nuclease free water was used to resuspend the oligonucleotides to 
a final concentration of 100 µM and these were then stored at -20 °C. 
 
Table 2.3. The oligonucleotide sequences from Eurogentec. These sequences in different 
combinations make the standard 8 substrates and the hairpin substrate required for the ligation 
assays; ‘+Flu’ – addition of fluorescein or ‘+P’ – addition of phosphate, denotes a specific 
modification at the 5’ position. The 18 b and 15 b oligonucleotides were used to make a hairpin 
substrate which mimics the structures ligated in vivo by T4Rnl1.  
Backbone Oligo Name Sequence 
DNA LigSub1 (8b) +Flu 5’ -GGC-CAG-TG- 3’ 
LigSub2 (12b) + P 5’ -AAT-TCG-AGC-TCG- 3’ 
LigSub1+2comp (20b) 5’ -CGA-GCT-CGA-ATT-CAC-TGG-CC- 3’ 
DNAtRNALysSub2 (18b) + P 5’ -TTT-AAT-CAA-TTG-CGA-CCC- 3’ 
RNA RNALigSub1 (8b) + Flu 5’ -GGC-CAG-UG- 3’ 
RNALigSub2 (12b) + P 5’ -AAU-UCG-AGC-UCG- 3’ 
RNALigSub1+2comp (20b) 5’ -CGA-GCU-CGA-AUU-CAC-UGC-CC- 3’ 
RNAtRNALysSub1 (15b) + Flu 5’ -GGG-UCG-CAG-UUG-ACU- 3’ 
 
2.2.9.1 Oligonucleotide substrate preparation  
A number of double stranded substrates were made (Table 2.3 and Table 2.4). The 
oligonucleotides were either 8 bases fluorescently labelled at the 5’ end, 12 bases with 
a phosphate attached at the 5’ part of the nick or 20 bases used as the complementary 
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strand. These 3 oligonucleotides were added together in a tube, at the ratio of 1:2:3, 
with 1.5 nmoles of LigSub1 (the fluorescently labelled strand) 3 nmoles of LigSub2 
(strand with phosphate) and 4.5 nmoles of LigSub1+2 (complementary strand). This 
resulted in a final concentration of 15 µM LigSub1 in a final volume of 100 µl (Figure 2.4, 
Table 2.4), this concentration was the rate determining factor in the total amount of 
substrate that could be ligated. To the tube 10 µl of 10x TE Buffer (Table 2.5) was added. 
The tubes were heated to 95 °C for 5 minutes and left to cool overnight covered with 
aluminium foil to prevent inactivation of the fluorescein.  
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Figure 2.4. Ligation substrate formation at a ratio of 1:2:3 of the different 
oligonucleotides. The limiting oligonucleotide is LigSub1 (blue strand) which has fluorescein 
attached at the 5’ position.  
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Table 2.4. The different DNA and RNA oligonucleotide components for the 8 standard 
double stranded substrates used in the end point ligation assay. The sequences for 
LigSub1 8 b (blue), LigSub2 12 b (red) and LigSub1+2 20 b (purple) were the same for each 
substrate (Table 2.3). The ligases were incubated with these 8 different substrates, buffer and 
ATP to ascertain whether they could ligate the nick between LigSub1 and LigSub2.  
Name Substrate (filled = DNA, hatched = RNA) 
Substrate 1 5’ 3’ 
3’ 5’  
Substrate 2 5’ 3’ 
3’ 5’ 
Substrate 3 5’ 3’ 
3’ 5’ 
Substrate 4 5’ 3’ 
3’ 5’ 
Substrate 5 5’ 3’ 
3’ 5’ 
Substrate 6 5’                                                                      3’ 
3’ 5’ 
Substrate 7 5’ 3’ 
3’ 5’ 
Substrate 8  5’ 3’ 
3’ 5’ 
 
2.3 Protein Procedures 
2.3.1 Protein expression in E. coli 
For protein expression the plasmid DNA was transformed into BL21 pLysS (DE3) cells. 
Selective LB media was inoculated with 1/100th volume of overnight liquid culture, this 
was incubated at 37 °C, 180 rpm until an OD600 of 0.5 was obtained. 
 
2.3.2. IPTG induction 
The cultures containing the pET-16b vector were then induced with 0.5 mM IPTG and 
incubated at 30 °C for 4 hours. The cells were pelleted by centrifugation at 6000 rpm for 
30 minutes in the Avanti J-26XP centrifuge with the 8.1000 rotor and the supernatant 
discarded. The whole cell pellets were stored at -20 °C until required.  
 
2.3.3. Synthesis of Recombinant Proteins 
The pellets were recovered and resuspended in 20 ml 20 mM Tris 100 mM NaCl (pH 7.5). 
The resuspended cells were lysed by sonication, 10 times for 10 seconds with a 30 
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second recovery period on ice. The soluble and insoluble fractions were separated by 
centrifugation at 40,000 rpm for 40 minutes at 4°C using the Beckman Optima XL-100K 
Ultracentrifuge with the 70Ti rotor. The supernatant was collected for protein 
purification; the pellet was discarded.  
 
2.3.4. His-tag affinity chromatography for protein purification  
A 5 ml HiTrapTM Chelating HP column (GE Healthcare Life Sciences, Amersham Place, 
Little Chlafont, UK) was used to purify the His-tagged proteins. The column was 
equilibrated using 25 ml water to remove the storage 20 % ethanol from the column, 50 
ml 1x binding buffer, 50 ml 1x charge buffer and 25 ml 1x binding buffer (see Table 2.5 
for all buffer components). The soluble fraction from the cell lysis had 100 µl removed 
(labelled as S1) and the rest of the sample was filtered through a 0.45 µm filter and 
loaded onto the column, the flow through from adding the soluble fraction was collected 
(labelled S2). For all further steps a 0.2 µm filter was used. A further 25 ml of 1x binding 
buffer was run through the column and the eluate collected (S3). The column was 
washed with 75 ml of 1x Wash Buffer and the eluate collected (S4). Finally 1x Elution 
Buffer was run through the column and the first 2 x 2 ml eluates collected (F1 an F2) and 
then 1 ml fractions collected (F3 – F10). This process was carried out at 4 °C. The column 
was then stripped using 50 ml 1x strip buffer and sealed for storage in 20 % ethanol (as 
per the manufacturer’s instructions) at 4 °C. The fractions collected were analysed by 
SDS-PAGE and the fractions containing purified protein underwent buffer exchange.  
 
2.3.5. Buffer exchange 
The fractions containing protein were run through a disposable PD-10 column (GE 
Healthcare) to remove the imidazole and other salts. The PD-10 column was used as per 
the manufacturer’s instructions for the gravity method. The proteins were eluted into 
3.5 ml 20 mM Tris 100 mM NaCl (pH7.5) and flash frozen using liquid nitrogen before 
being stored at -80 ⁰C. 
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2.3.6. Sodium dodecyl sulphate-Polyacrylamide Gel Electrophoresis 
Sodium dodecyl sulphate (SDS) gels were made as per the Sambrook and Russel (2001) 
protocol. The gels were made to a 10 % polyacrylamide concentration. All purification 
fractions underwent SDS-PAGE to assess which fraction contained the purified ligase 
proteins. To visualise the proteins, the gels were stained using Expedeon InstantBlue for 
a minimum of 30 minutes. 
 
2.3.7. Western Blot Analysis 
The iBlotii system from Invitrogen was used, as per the manufacturer’s instructions with 
the mini PVDF mini transfer stacks. After transfer for 7 minutes, the membrane was 
blocked using 1 % milk blocking solution (0.5 g milk powder in 50 ml TBS) for 1 hour 
whilst shaking at 4 °C. The membrane-milk solution had 2 µl of antibody added, the 
antibody used was monoclonal anti-poly histidine peroxidase antibody (from mouse). 
This was incubated overnight on the shaker at 4 °C. The following day, the membrane 
was washed using three washes with TBS-T and then two with TBS (Table 2.5). The 
membrane was covered with Thermoscientific Super Signal West Pico Chemillumiescent 
substrate, made up by combining 4 ml of stable peroxide solution and 4 ml of 
luminol/enhancer solution. The membrane was soaked for four minutes and imaged 
using the SynGene G:Box imager and GeneSys software.  
 
2.3.8. Calculating protein concentration 
The protein concentrations were calculated using the Protein Assay Microassay 
procedure from Bio-Rad and the absorbance measured at 595 nm using the Jenway 7315 
Spectrophotometer. The absorbance of bovine serum albumin (BSA) samples with a 
known protein concentration (0, 1.25, 2.5, 5 and 10 µg/ml) were measured and plotted 
to create a standard curve. The absorbance of the purified protein samples were 
measured at different dilutions – 1/10, 1/100 and 1/1000 and the protein concentration 
obtained from the standard curve. The protein concentration was multiplied by the 
dilution factor to calculate the final protein concentration. 
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2.3.9. Protein storage 
After glycerol was added to a final concentration of 20 % (v/v), the proteins were stored 
at -80 °C. To prevent the effects of freeze/thawing on the protein, the total amount was 
split into 500 µl aliquots, which were then further separated into 50 µl aliquots at first 
use.  
 
2.4 Ligation Assay Analysis 
Ligase activity assays were carried out to check the activity of all proteins. The assay 
assesses whether the ligase is able to create a bond between an 8-mer and 12-mer 
oligonucleotide (Figure 2.5). Formation of the 20-mer oligonucleotide was detected 
using FAM detection of the fluorescein attached to LigSub1. As such it was necessary to 
keep the substrates covered and away from light to prevent fluorescein inactivation. 
 
 
Figure 2.5. Schematic of the ligation reaction in the ligation assays. Detection of 
successful ligation requires the fluorescein at the 5’ end of LigSub1. When ligation is successful 
the fluorescently tagged molecule increases from 8 bases to 20 bases in length.  
 
2.4.1 End point ligation assay 
For the end point assay, 8 different double stranded substrates made with different 
combinations of DNA and RNA were used to check ligation activity. For each substrate 
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reaction 1 µl 10x ligation buffer, 45 pmol of substrate and 70 pmol ligase were 
combined. Sterile nuclease free water was added to make the total volume 10 µl. The 
tubes were incubated at 37 °C for one hour while shaking at 250 rpm. At the end of the 
incubation 10 µl of 1x stop solution (Table 2.5) was added. The samples were heated to 
100 °C for 5 minutes at the end of the incubation period and analysed using urea-PAGE 
denaturation, a 15 % urea-polyacrylamide gel was used (see Section 2.4.3).  
 
2.4.2 Time course ligation assay 
The time course ligation assay was performed using double stranded substrate 7. All 
ligases were able to ligate this substrate meaning substrate components were 
eliminated as a factor for differences in ligation. The assay was prepared as follows: 540 
pmol of double stranded substrate, 6 µl 10x ligation buffer, 2 pmol T4Dnl or T4Rnl2 (or 
mutated versions of these ligases) or 600 pmol T4Rnl1 (or mutated versions of this 
ligase) or specified amounts. The final volume was made up to 60 µl using nuclease free 
sterile water. The reaction was incubated at 37 °C for one hour, with 5 µl aliquots 
removed and added to 5 µl 1x stop solution at the time points 0, 1, 2, 3, 4, 5, 10, 15, 20, 
15 and 30 minutes. The different time point samples were heated to 100 ⁰C for 5 
minutes and analysed using urea-PAGE denaturation gels.  
 
2.4.3 Urea-polyacrylamide gel electrophoresis analysis  
The ligation reaction samples were analysed using urea-PAGE, the gels were made to   
15 % polyacrylamide. Preparation for a single gel was as follows: 2.5 ml 30 % bis-
acrylamide was combined with 0.5 ml 10x TBE and 2.4 g urea, this was shaken overnight 
until all urea has dissolved. Distilled water was added to make the total volume up to 5 
ml. Finally 12.5 µl of 25 % ammonium persulphate and 7.5 µl of TEMED were added and 
the gels cast and left to set. The urea-PAGE gels were run in Bio-Rad Mini-PROTEAN© 
Tetra Cell Systems. The gels were heated for 30 min at 400 V using 0.5x TBE Buffer, the 
wells were cleaned with 0.5x TBE buffer to remove any excess urea before samples were 
loaded. The gels were run at 400 V until the dye front ran to the bottom of the gel, 
approximately 20 minutes. The gels were then imaged using a Typhoon FLA 9500 (GE 
Healthcare Life Sciences, Little Chalfont, Buckinghamshire, UK), with the FAM, 
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fluorophore detection setting. The images were then exported into ImageJ software, 
each lane was selected and the gel bands quantified using the measure tool. This 
provides 2 peaks, one for the ligated band and one for the non-ligated band. Each peak 
is selected with the wand tool to give a value for the contrast of each band compared to 
the background. These values were used to calculate the percentage of ligation which 
was converted into pmol – 540 pmol of substrate was used in total.  
 
2.5 Media and Buffers 
2.5.1 Media for bacterial growth 
Luria-Bertani Media, pH 7: 1 % (w/v) tryptone, 0.5 % (w/v) yeast extract, 1 % (w/v) 
NaCl in 1L of distilled water. The pH was altered to 7 using 10M NaOH.  
Luria-Bertani Agar: as above with 1.5 % (w/v) agar.  
SOC Media: as provided by Novagen.  
 
2.5.2 Media additions 
The following stock solutions were prepared, filter sterilised using a 0.2 µm filter and 
kept at -20 °C.  
Ampicillin, 100 mg/ml stock in sterile distilled water. Added to the media at a final 
concentration of 100 µg/ml. 
Chloramphenicol, 34 mg/ml stock in ethanol. Added to the media at a final 
concentration of 50 µg/ml. 
Isopropylthio-β-D-galactoside (IPTG), 100 mM stock solution. Added to the media at a 
final concentration of 0.5 mM. 
Kanamycin, 100 mg/ml stock solution in sterile distilled water. Added to the media at a 
final concentration of 100 µg/ml.  
L-Arabinose, 1M stock solution. Added to the media at a final concentration of 5 mM.  
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2.5.3 Buffers 
Table 2.5. A list of buffers and their components used throughout this body of work.  
Buffer Chemical Components 
10x SDS Running Buffer 248 mM Tris, 1.92 M glycine, 1 % w/v SDS 
Dilute to 1X for running SDS-PAGE gels 
10x Tris-borate-EDTA 
(TBE)  
0.9 M Boric Acid, 0.9 M Tris, 20 mM EDTA 
10x Tris-EDTA (TE) 0.89 M Tris, 20 mM EDTA 
1x  Ligation Stop Solution 20 ml deionised formamide, 400 µl 0.5 M EDTA, 40 µl 1 M 
NaOH, 20 mg bromophenol blue 
1x Tris-acetate-EDTA (TAE) 40 mM Tris, 20 mM Acetic Acid, 1 mM EDTA 
4x SDS-PAGE Loading dye 200 mM Tris-HCl pH6.8, 8 % (w/v) SDS, 0.4 % (w/v) 
bromophenol blue, 40 % (w/v) glycerol, 400 mM β-
mercaptoethanol 
6x DNA loading dye 10 mM Tris-HCl pH 7.6, 0.03 % bromophenol blue, 0.03 % 
xylene cyanol FF, 60 % glycerol, 60 mM EDTA 
4x Strip buffer 2 M NaCl, 80 mM Tris-HCl pH 7.9, 400 mM EDTA 
8x Binding Buffer 4 M NaCl, 160 mM Tris-HCl pH 7.9, 40 mM Imidazole 
8x Charge buffer 400 mM NiSO4 
8x Elution Buffer 2 M NaCl, 80mM Tri-HCl pH 7.9, 4 M Imidazole 
8x Wash Buffer 4 M NaCl, 160 mM Tris-HCl pH 7.9, 480 mM Imidazole 
1x Tris-buffered saline 
(TBS) 
50 mM Tris pH 7.5, 150 mM NaCl 
1x Tris-buffered saline + 
tween (TBS-T) 
50 mM Tris pH 7.5, 150 mM NaCl, 0.1 % Tween 20 
10x Ligation buffer 500 mM Tris-HCl, 100 mM MgCl, 100 mM DTT 
Dilute to 1x for ligation reaction 
10x Ligation buffer + ADP 500 mM Tris-HCl, 100 mM MgCl, 100 mM DTT, 10 mM ADP 
Dilute to 1x for ligation reaction 
10x Ligation buffer + ATP 500 mM Tris-HCl, 100 mM MgCl, 100 mM DTT, 10 mM ATP 
Dilute to 1x for ligation reaction 
Ammonium molybdate-
sulphuric acid solution 
12.14 M ammonium molybdate tetrahydrate, 1 M sulphuric 
acid 
Ferrous sulphate solution 388 mM Ferrous (II) sulphate, 2 drops 98 % H2SO4 
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Chapter 3: Domain Swaps and Mutational Analysis of 
Motif I in the T4 NA Ligases 
 
3.1 Introduction 
3.1.1 Conserved motifs in nucleic acid ligases 
The conserved polypeptide motifs (I, IIIa, IIIb, IV, V and VI) that characterise the 
nucleotidyl transferase family are highly conserved, however only some of the amino 
acids in these motifs are conserved across the entire family (Figure 3.1) (Shuman and 
Lima, 2004). Before the discovery of T4Rnl2, motif I was denoted as KX(D/N)GXX 
(Shuman and Schwer, 1995; Timson, Singleton and Wigley, 2000), with the lysine residue 
identified as being responsible for creating the Lys-AMP intermediate necessary for 
ligation (Shuman and Schwer, 1995). Motif I in Rnl2-like ligases does not follow this 
KX(D/N)GXX model (motif I in T4Rnl2 specifically is KIHGTN) and motif I is now described 
as KXXGXX (Popow, Schleiffer and Martinez, 2012).  
 
Figure 3.1. The T4 NA ligases and their conserved polypeptide motif amino acid 
sequences. The conserved amino acid residues are shown in each motif for T4Dnl, T4Rnl1 and 
T4Rnl2. Amino acids are designated following standard single letter abbreviations the numbers 
between motifs indicate the number of amino acids between the motifs. 
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These motifs are essential for the ligation reaction and line the nucleotide binding 
pocket. Motifs IIIa and IV in T4Rnl2 provide a hydrophobic environment which traps the 
nucleotide leaving the α-phosphate visible for interaction with the lysine in motif I 
(Shuman and Lima, 2004). The literature for T4Rnl1 often does not include a motif III or 
IIIa. One study stated motif IIIa, TYLDGDEI, was present when aligned against DNA 
ligases (Wang et al., 2003), however this motif in T4Rnl1 is not in close proximity to the 
binding pocket (Figure 3.2) and most literature states only motifs I, IV and V are present 
in T4Rnl1.  
Figure 3.2. The nucleotide binding pocket in T4Rnl1. The conserved motifs are highlighted 
as follows: motif I (red), proposed motif IIIa (pink) (Shuman and Schwer, 1995), motif IV (blue), 
and motif V (green) with magnesium (black sphere) and calcium (teal sphere); PDB file 2C5U 
illustrated using the software CCP4MG. Mg2+ ions are essential for ligation of nucleic acids and 
ensure correct orientation of the phosphate, while high concentrations of calcium are essential 
for crystallisation of T4Rnl1 and do not directly interact with the ligase (El Omari et al., 2006).  
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The conserved motifs that make up the nucleotidyl transferase family can be open to 
some interpretation. It is very clear that motifs I, III, IIIa, IV, V and VI (OB domain) are 
highly conserved amongst members of the family – DNA ligases, RNA ligases and mRNA 
capping enzymes. It is important to consider each of these subsets individually and 
assess residue conservation amongst Dnl-like proteins, Rnl1-like proteins and Rnl2-like 
proteins (Figures 3.3, 3.4 and 3.5).  
 
3.1.2 Previous mutational analysis of motif I in the T4 ligases 
Both nucleotidyl transferase domains found in T4Rnl1 and T4Rnl2 are located at the N-
terminus and contain α-helices that flank antiparallel β-sheets (El Omari et al., 2006). 
The conserved motifs in T4Rnl1 are motif I, IV and V; there is a notable absence of motifs 
III and IIIa. The crystallographic structure of T4Rnl1 has been solved and the amino acid 
residues involved in nucleotide binding and phosphodiester bond formation have been 
identified (El Omari et al., 2006). The ligation reaction requires enzyme-adenylate and 
RNA-adenylate intermediates and the motifs present in T4Rnl1 are involved in the 
formation of these intermediates (Wang et al., 2003). Not only are the Lys99 and Gly102 
residues in motif I conserved, also conserved are Glu227 and Gly228 in motif IV and 
Lys240 and Lys242 in motif V that are vital for T4Rnl1 function. Glu227 interacts with 
calcium in the solved crystallographic structure, this calcium comes from the high 
concentrations needed in the crystallisation buffer and the site that would usually be 
occupied by Mg2+ (El Omari et al., 2006; Wang, Schwer and Shuman, 2006). The stacking 
action of this residue and Tyr 246 increases the Van der Waals contact and contribute 
to the catalysis of steps 2 and 3 in the ligation reaction (Figure 1.5) (Wang, Schwer and 
Shuman, 2006). Lys240 and Lys242 are needed for step 1 of the ligation reaction (Figure 
1.5) and interact with the phosphate of ATP (Wang, Schwer and Shuman, 2006). There 
is homology between the side chains of the residues conserved in T4Rnl1 and amino 
acids required for DNA ligases and mRNA capping enzymes but this is low (Shuman and 
Schwer, 1995).  
 
The Asn40 and Glu34 residues essential for T4Rnl2 function are not conserved in T4Rnl1. 
There are five C-terminal residues that are crucial for T4Rnl2 activity: Lys35, Glu99, 
Phe119, Glu204 and Lys 227; these are unique to T4Rnl2 and are necessary for the C-
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terminal interaction with RNA during the ligation reaction (Ho et al., 2004). The N-
terminal of T4Rnl2 contains seven residues crucial for function: Tyr5, Arg33, Lys54, 
Gln106, Asp135, Arg155 and Ser170 (Nandakumar et al., 2004). The crystal structure of 
T4Rnl2 bound with AMP identified Tyr5 as the residue that makes contact with the 
adenosine ligand and forms a number of bonds with other residues in the motifs of 
T4Rnl2 (Nandakumar et al., 2004). Ser170 and Glu34 interactions help stabilise 
conformation in motif I allowing adenylate binding and reaction catalysis (Nandakumar 
et al., 2004). Arg33, Asp135 and Arg155 form a network of interactions that stabilise the 
nucleotidyl transferase binding pocket (Nandakumar et al., 2004). Lys54 and Gln106 do 
not interact with the AMP phosphate but instead form part of T4Rnl2’s RNA binding 
surface (Nandakumar et al., 2004). 
 
When considering the structural similarities between the two T4 RNA ligases it is notable 
that only T4Rnl2 has all of the conserved motifs of nucleotidyl transferases and could be 
described as being more similar to T4Dnl. For all 3 of the T4 NA ligases where they have 
the same motifs, there are some amino acids that are always conserved therefore it is 
likely that these conserved motifs are indicative of a shared nucleotidyl transfer 
mechanism (Shuman & Lima, 2004).  
 
3.1.3 RNA ligase alignments and suggested mutations to motif I  
The motif I residues are well conserved among Dnl-like, Rnl1-like and Rnl2-like proteins. 
When comparing motif I in both T4Rnl1 and T4Rnl2, the histidine and aspartate residues 
are always conserved in these two different groups of proteins. Comparing histidine to 
aspartate, it is noted that the two amino acids have some similarities and differences: 
histidine is often a polar amino acid, it can become positively charged at pH 5 (Rötzschke 
et al., 2002) and has been described as an amino acid that does not substitute well with 
other amino acids (Betts and Russell, 2003). By contrast, aspartate is polar and charged 
usually preferring to be on the surface of proteins (Betts and Russell, 2003). These 
differences in properties may have an effect on the DNA or RNA substrates that the T4 
RNA ligases can work with. Previously, when studying T4Rnl2, the Histidine (H) at 
position 37 was changed to both alanine (A) and aspartate (D) creating new variants of 
Chapter 3: Domain Swaps and Mutational Analysis of Motif I in the T4 NA ligases 
68 
 
the ligase T4Rnl2 H37A and H37D (Ho and Shuman, 2002). Of these two new ligases, 
only H37D was still able to function as a ligase and circularise a single stranded RNA 
product (Ho and Shuman, 2002). It was also concluded from this study that the histidine 
is not important for the first step of adenylation in ligation, but rather for the second 
step where the phosphodiester bond is formed (Ho and Shuman, 2002; Yin, Ho and 
Shuman, 2003).  
 
These observations raised the question of whether this change from histidine to 
aspartate would affect the type of double stranded substrate the T4Rnl2 could repair 
and whether the same would be true for T4Rnl1 when changing the aspartate at position 
101 to histidine. When considering the amino acids in motif I in the 6th position in the 
motif – arginine for T4Dnl, leucine for T4Rnl1 and asparagine for T4Rnl2, it was again 
noted that these residues are always conserved (Figures 3.3, 3.4 and 3.5). The residues 
in this position in the T4 DNA and RNA ligases interact directly with the ribose sugar 
(Shuman & Lima, 2004). Therefore, it was hypothesised that substituting these residues 
with other amino acids (Table 3.1) could result in a change in interaction with the ribose 
sugar, ultimately changing the substrate profiles of the T4 NA ligases.  
 
 
 
 
 
 
 
 
 
 
 
Chapter 3: Domain Swaps and Mutational Analysis of Motif I in the T4 NA ligases 
69 
 
T4Dnl       MILKILNEIASIGSTKQKQAILEKNKDNELLKRVYRLTYSRGLQYYIKKWPKPGI-ATQS 59 
T4Rnl1      -MQELFNNLMELCKDSQRKFFYS--DDVSASGRTYRIFSY-NYA-SYSDWLLPD------ 49 
T4Rnl2      ----MFKKYSSLENH----------YNSKFIEKLYSLG------LTGGEWVAREKIHGTN 40 
              Motif I 
 
T4Dnl       FGMLTLTDMLDFIEFTLATRKLTGN-AAIEELTGYIT--DGKKDDVEVLRRVMMRDLECG 116 
T4Rnl1      -------------------------------------------------------ALECR 54 
T4Rnl2      FSLIIERDKVTC-------AKRTGPILPAEDFFGYEIILKNYADSIKAVQDIM----ETS 89 
                                                               
 
T4Dnl       ASVSIANKVWPGLIPEQPQMLASSYDEKGINKNIKFP—-AFAQLKADGARCFAEVRGDEL 174 
T4Rnl1      GIMFEMDGEKPVRIASRPMEKFFNLNENPFTMNIDLNDVDYILTKEDGSLVSTYLDGDEI 114 
T4Rnl2      --------------AVVSYQVFGEFAGPGIQKNVDYGDKDFYVFDIIVT----------- 124 
                              Motif IIIa      Motif IIIb/Motif I 
 
T4Dnl       DDVRLLSRAGNEYLGLDLLKEELIKMTAEARQIHPEGVLIDGELV-YHEQVK-KEPEGLD 232 
T4Rnl1      L----FKSKGSI-------K--------SEQALMANGILMNINHHRLRDRLKELAEDGFT 155 
T4Rnl2      ------TESG-------------------------------------------------- 128 
                                                 Motif IIIa            
 
T4Dnl       FLFDAY-PENSKAKEFAEVAESRTASNGIANKSLKGTISEKEAQCMKFQVWDYVPLVEIY 291 
T4Rnl1      ANFEFVAPTNRIVLAYQEMK------------IIL--LNVRE-----NETGEYISYDDIY 196 
T4Rnl2      ----------------------------------------------------DVTYVDDY 136 
            Motif IIIb  
 
T4Dnl       SLPAFR----LKYDVRFSKL------EQMTSGYDKVILI-------------ENQVVNNL 328 
T4Rnl1      KDATLRPYLVERYEIDSPKWIEEAKNAENIEGYVAVMKDGSHFKIKSDWYVSLHSTKSSL 256 
T4Rnl2      MMESFC----NTFKFKMAPLLGRGKFEEL-------IK-----------------LPNDL 168 
                 Motif IV    Motif V 
 
T4Dnl       DEAKVIYKKYIDQGLEGIILKNIDGLWENARSKNLYKFKEVIDVDLKIVGIYPHRKDPTK 388 
T4Rnl1      DNPEKLFKTIIDGASDDLKA-----MY----ADDEYSYRKIEAFETTYLK--------YL 299 
T4Rnl2      DSVVQDYNFTVDHA--GL-VDANKCVWNAEAKGEVFTAEG-----YVLKPCYPS----WL 216 
                        Motif V    Motif IV 
 
T4Dnl       AGGFILE-----SECGKIK---------VNAGSGLKDKAGVKSHELDRTRI--------- 425 
T4Rnl1      DRALFLVLDCHNKHCGKDRKTYAMEAQGVAKGAGMDHLFGIIMS---------------- 343 
T4Rnl2      RNGNRVAIKCKNSKFSEKKKSDKPIKAKVELSEADNKLVGILACYVTLNRVNNVISKIGE 276 
                 Motif V  
 
T4Dnl       ------MENQNYYIGKILECEC-NGWLKSDGRTDYVKLFLPIAIRLREDKTKANTFEDVF 478 
T4Rnl1      -------LYQGYDSQEKVMCEI-EQNFL-----KNYKKFIPEGY---------------- 374 
T4Rnl2      IGPKDFGKVMGLTVQDILEETSREGITLTQ--ADNPSLIKKELVKMVQDVLRPA-WIELV 333 
        Motif VI 
 
T4Dnl       GDFHEVTGL  487 
T4Rnl1      ---------  374 
T4Rnl2      -------S-  334 
Figure 3.3. Clustal Omega alignment of the T4 ligases to each other. The three T4 ligases 
T4Dnl, T4Rnl1 and T4Rnl2 do not align well to each other, this is highlighted by a lack of 
alignment with the conserved polypeptide motifs - motif I (dark yellow), IIIa (light blue), IIIb 
(purple), IV (yellow), V (green) and VI (blue). Motif IIIb (pink) of T4Rnl2 aligns to motifs I (dark 
yellow) of both T4Dnl and T4Rnl1 and motif IV (yellow) of T4Rnl2 doesn’t align to the two other 
ligase sequences.  
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Human  IDGLFVACRHSEARFIARSLSGRLRLGLAEQSVLAALSQAVSLTPPGQEFPPAMVDAGKGKTAEARK 493 
CVDnl  ------------------------------------------------------------------- 0 
T7Dnl  ------------------------------------------------------------------- 0 
T4Dnl  -D-----FIEFT-----LATRKLTGNAAIE-----ELT---G--------------YITDGKKDDV- 102 
AFSDnl KDAVAEIFTKFF-----VE----EGAVRIS-----KMTRVTE--------------GKNLGKKNAT- 93 
                         
                              
Human  TWLEEQGMILKQTFCEVPDLDRIIPVLLEHGLERLPEHCK------LSPGI------PLKPMLAHPT 548 
CVDnl  ------------------------------------------------------MAI-TKPLLAATL 12 
T7Dnl  -----------------------------------------------------MMNIKTNPFKAVSF 14 
T4Dnl  ---------------------EVLRRVMMRDLE---CGASVSIANKVWPGLIPEQ----PQMLASSY 141 
AFSDnl ---------------------TVVHQAFKDALSKYNRHARQKRGAHTNRGMIPPMLVKYFNIIPKTF 139 
 
Human  RGISEVLKRFEEA--AFTCEYKYDGQRAQIHALEG--GEVKIFSRNQEDNTGKYP--DIISRIPKIK 609 
CVDnl  E--N-----IEDVQFPCLATPKIDGIRSVKQT--------QMLSRTFKPIRNSV--------MNRLL 56 
T7Dnl  V--ESAIKKALDNAGYLIAEIKYDGVRGNICVDNT--ANSYWLSRVSKTIPALEHLNGFDVRWKRLL 77 
T4Dnl  D--EKGINKNIKF--PAFAQLKADGARCFAEVRGDELDDVRLLSRAGNEYLGLD---LLKEELIKMT 201 
AFSDnl F--EEE------T--DPIVQRKRNGVRAVACQQGD--GCILLYSRTEKEFLGLD---NIKKELKQLY 191 
 Motif I 
 
Human  L----PSVTSFILDTEAVA-----------------WDREK----------------KQIQPFQVLT 639 
CVDnl  T---ELLPEG--SDGEISIEGATFQDTTSAVM----------------------------------- 83 
T7Dnl  NDDRCFYKDGFMLDGELMVKGVDFNTGSGL--LRTKWTDT-KNQEFHEELFVEPIRKKDKVPFKL-- 139 
T4Dnl  AEARQIHPEGVLIDGELVYHEQVKKEPEGLDFLFDAYPENSKAKEFAEVAES--RTASNGIANKSLK 266 
AFSDnl L----FIDVRVYLDGELYLHRKPLQ—----WIAGQ-------------ANA--KT------------ 222 
      Motif III 
 
Human  TRKRKEVDASEIQVQVCLYAFDLIYLNGES--LV----REPLSRRR---QLLRENFVETEGEFVFAT 697 
CVDnl  -------TGHKMYNAKFSYYWFDYVTDDPLK-----KYIDRVEDMKNYITVHPHILEHAQVKIIPLI 138 
T7Dnl  -------HTGHLHIKLYAILPLHIVESGEDCDVMTLLMQEHVKNML---PLLQE--YFPEIEWQAAE 194 
T4Dnl  GT-ISEKEAQCMKFQVWDYVPLVEIYSLPA---FRLKYDVRFSKLE---QMTSG--YD---KVILIE 321 
AFSDnl -------DSSELHFYVFDCFWS-DQLQMPS---NKR--QQLLTNIF---KQKED--LT---FIHQVE 268 
       Motif IIIa 
 
Human  SLDTKDIEQIAEFLEQSVKDSCEGLMVKTLDVDATYEIAK---RSHNWLKLKKDYLDGVGDTLDLVV 761 
CVDnl  PVEINNITELLQYERDVLSKGFEGVMIRKPD--GKYKFGRSTLKEGILLKMKQFK------DAEATI 197 
T7Dnl  SYEVYDMVELQQLYEQKRAEGHEGLIVKDPM--CIYKRGK----KSGWWKMKPEN------EADGII 249 
T4Dnl  NQVVNNLDEAKVIYKKYIDQGLEGIILKNID--GLWENAR----SKNLYKFKEVI------DVDLKI 376 
AFSDnl NFSVKNVDEALRLKAQFIKEGYEGAIVRNAN—GPYEPGY-NNYHSAHLAKLKPLL------DAEFIL 337 
     Motif IV   Motif V       
    
Human  IGAYLGRGKRAGRYGGF---LLASYDEDSEELQAICKLGTGFSDEELEEHHQS-LKALVLPSPRPYV 824 
CVDnl  ISMTALFKNTNTKTKDNFGYSKRST-HKSGKVE-----------EDVMGSIEVDYDGVV----F-SI 247 
T7Dnl  QGLVWGTKGLANE-GKVIGFEV--L-LESGRLVNATNISRALMDEFTETVKEATLSQWGFFSPY-GI 311 
T4Dnl  VGIYPHRKDPTKA-GGF---IL--E-SECGKIK--VNAGSGLKDKAGVKSHELDRTRIMENQNY-YI 433 
AFSDnl VDYTQGK-KGKDL-GAI---LW--V-CELPNKK-----------RFVVTPKHL-----TYADRY--- 367 
 
Human  RIDGAVIPDHWLDPSAVWEVKCADLSLSPIYPAARGLVDSDKGISLRFPRFIRVREDKQPEQATTSA 891 
CVDnl  GTG----FDAD-QRRDFWQNKESYI--GKMVKF--KYFEMGSKDCPRFPVFIGIRHEEDR------- 298 
T7Dnl  GDN----DACTINPYDGWACQISYM--EE-----------TPDGSLRHPSFVMFRGTEDNPQEKM-- 359 
T4Dnl  GKI----LECECNGWLKSDGRTDYV--KLFLPIAIRLREDKTKANTFEDVF GDFHEVTGL------ 487 
AFSDnl ---------------------------ALFQKLTPALFKKHLYGKELTVEY AELSPKTGIPLQARA 364 
                                       Motif VI 
Figure 3.4. Sequence alignment for T4Dnl and T4Dnl-like proteins. Alignment of E. coli 
bacteriophage T4 DNA ligase (T4Dnl), Human DNA ligase I residues 268 – 419 (Human), E. coli 
bacteriophage T7 DNA ligase (T7Dnl), African Swine fever DNA ligase (AFSDnl) and Chlorella virus 
ATP-dependent Dnl (CVDnl). The conserved polypeptide motif I (dark yellow), IIIa (light blue), 
IIIb (purple), IV (yellow), V (green) and VI (blue). The 100 % conserved residues (grey) and highly 
conserved resides (teal) are shown. Alignments were performed using Clustal Omega, 
https://www.ebi.ac.uk/Tools/msa/clustalo/, amino acids are designated following standard 
single letter abbreviations. 
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AeH1   -----MQSIKELYQNLINLCVDD-NTKFYFAETVTSLGTKVRIFDYHVAGYNDWIRPDAMASRGIMF  61 
RB16   ----------------MKLCNET--ECFYFIDQKTVMQTHVRIFNYRMASYSDWLKPGALECRGIMF  49 
KP15   MTKAQTKIINTLYKQLMQLCGES--ETFFFVDQVTVMGTPVRIFNYRMASYTDWLKPGALECRGIMF  65  
KVP40  ------MTTQELYNHLMTLTEDA-EGKFFFADHISPLGEKLRVFSYHIASYSDWLLPGALEARGIMF  60  
Rnl1   --------MQELFNNLMELCKDS-QRKFFYSDDVSASGRTYRIFSYNYASYSDWLLPDALECRGIMF  58 
RB69   --------MEKLYYNLLSLCKSSSDRKFFYSDDVSPIGKKYRIFSYNFASYSDWLLPDALECRGIMF  59 
JS10   --------MIELYDNLMTLVKNSTKSKFFFKDFQSALGVNYRIFSYNYASYSDWLEDGALECRGIMF  59 
 
AeH1  EMNGE-IPVRIMSRPMDKFFNYSEVIGWEKLETAGNMKMPDLN--KIAYVIDKRDGSLISTYLDISGE 126      
RB16  AMDGD-TPVKLVSRPMEKFFNYAEVKAWEALKEAPVTIG-----DTVVDVMIKEDGSLISTFCDS--- 108 
KP15  EMDGD-TPVSIISRPMEKFFNYAEVKAWEALNESPIELG-----E-VLDVMIKEDGSLISTFLDG--- 123 
KVP40 QLDEQDKMVRIVSRPMEKFFNLN---------ENPFTMDLDLT--TTVQLMDKADGSLISTYLTG--- 114 
Rnl1  EMDGE-KPVRIASRPMEKFFNLN---------ENPFTMNIDLN--DVDYILTKEDGSLVSTYLDG--- 111 
RB69  EMDGE-TPLRIASRPMEKFFNLN---------ENPFTLSIDLN--DVKYLMTKEDGSLVSTYLDG--- 112 
JS10  EMDEN-GPVRIAARPMQKFFNLD---------ENPLTIGLDLSQENIDLVMAKEDGSLISTFMDR--- 114 
                                                           Motif I 
 
AeH1  -IKNLLLKSKASIRSNQANDASVWLYQEDHKDLLEFCTAYAENGFTVNMEWTAPHNQIVLCYNEHQL 192 
RB16  --GYLGVKSKASVQSEQAMDAMSVIQ--SNRALFDRLTELVVDGFTVNMEYVAPTNRIVIGYQDPAV 171 
KP15  -GFL AVKSKGSVKSEQAMDAQSVLM--ANRELLTRLTEIAKENYTVNMEYVSPKNRIVVGYDSPDL 186 
KVP40  –ENFALKSKTSIFSEQAVAANRYIKLPENRDLWEFCDDLTQAGCTVNMEWCAPNNRIVLEYPEAKL 179 
Rnl1  --DEILFKSKGSIKSEQALMANGILMNINHHRLRDRLKELAEDGFTANFEFVAPTNRIVLAYQEMKI 176 
RB69  --NMVRFKSKGSIKSDQAASATSILLDINHKDLADRLLELCNDGFTANFEYVAPSNKIVLTYPEKRL 177 
JS10  --QYLSVKSKGSIHSSMVHDSLRFLRLPENEAFAARLEEITKAGYTCNLEYVSPTNRIVLAYQETNL 179 
 
AeH1  RILNIRHNETGEYVDFGELQKDPTFV--KYAADFFEVP-GDGKAWIDEVYQMTGIEGFVVVMEDYQ 255 
RB16  VILNIRNNDTGEYVDYQDIFADSVLR--PFLVEREKIEVTDLDAFITEAYTKEGFEGYVIKT-DKG 234 
KP15  RILNVRHNITGEYIPYDELFADALLR--AYLVKRENIEVLDLDAFAKEAYQNEGFEGYVVLT-TKG 246 
KVP40 VILNIRDNETGDYVSFDDIPLPALMRVKKWLVDEYDPETAHVDDFVEKLRATKGIEGMILRLANGQ 245 
Rnl1  ILLNVRENETGEYISYDDIYKDATLR--PYLVERYEID---SPKWIEEAKNAENIEGYVAVMKDGS 237 
RB69  ILLNIRDNNTGKYIEYDDIYLDPVFR--KYLVDRFEAP---EGDWVPGVKSSTNIEGYVAVMKDGS 238 
JS10  ILLNVRNNETGEYIPYAELFKDGALR--KHLVKSYELT---EGDFVDNIRKQEGIEGFIFVLKDGT 240 
                                                             Motif IV    
 
AeH1  MFKLKTDWYVALHHTKDSINNSERLIYACAENCTDDLRQMFRDDENSLQKIEIFDNHFRDVVMDAM 321 
RB16  FVKAKTNWYVNLHRTKDSINNNKDLFLNIVENTVDDLKQMFLDDMYALKKIDAFETLFLDSLNRLT 300 
KP15  FVKIKTNWYVNLHRTKDSITNNKDLFLNIVENTVDDLKQLFSSDLVSLKKIDDFEKLFLDSLNRLS 315 
KVP40 SVKIKTQWYVDLHSQKDSVNVPKKLVTTILNNNHDDLYALFADDKPTIDRIREFDSHVSKTVSASF 311 
Rnl1  HFKIKSDWYVSLHSTKSSLDNPEKLFKTIIDGASDDLKAMYADDEYSYRKIEAFETTYLKYLDRAL 303 
RB69  HFKLKTDWYVALHTTRDSISSPEKLFLAIMNGASDDLKAMYADDEFSFKKVELFEKAYLDFLDRSF 304 
JS10  FFKLKTAWYSALHHTKDSINNNERLFEVVVAGGTDDLRGLFSTDSFAIEKINAFERIHLDYLEQSL 306 
     Motif V 
 
AeH1  KKLTEMEAYEKYRGRRDYAINMNNDFK--NERHWFNIAMQMFAQRP-DFSMTDEIVAVIKKYPKTF 384 
RB16  AKAFQSIEDTKGKSRKDYAIALSSDLTP-DGRIIFGPMMRYFDDTD-KQKLVDNIVALMAKNYEQF 364 
KP15  AKAFKAIEDNKGKSRKDFAISLSADLSN-DGRIIFGPLMKYFEETD-PQKLVDRIIEMMVKNYDQF 379 
KVP40 HAVSQFYVKNRHMSRKDYAIAGQKALK----PWEFGVAMIAYQKKT-VEGVYEALVGAYLKRPELL 372 
Rnl1  FLVLDCHNKHCGKDRKTYAMEAQGVAKGAGMDHLFGIIMSLYQGYDSQEKVMCEIEQNFLKNYKKF 369 
RB69  YICLDAYDKHKGKDRKTYAIEAQAICKGAQSPWLFGIIMNLYQGGS-KEQMMTALESVFIKNHKNF 369 
JS10  ALLEAAYSQLKGRDRKDYAVTGQLILK—-DFPGLFSILMQAYVDGINYDTVMDQINSVFLKNHKAQ 370 
 
AeH1  IPKGY------- 389 
RB16  IPEEYK------ 370 
KP15  IPEQYK------ 385 
KVP40 IPEKYLNEA--- 381 
Rnl1  IPEGY------- 374 
RB69  IPEGY------- 374 
JS10  IPEKYLKEIVIE 382 
Figure 3.5. Sequence alignment for T4Rnl1 and T4Rnl1-like proteins. Alignment of 
Aeromonas virus (AeH1) RnlA, E.coli bacteriophage 16 (RB16) RnlA, Klebsiella bacteriophage 15 
(KP15) RNA ligase I, Vibrio bacteriophage 40(KVP40) RnlA, E. coli bacteriophage T4 RNA ligase I 
(Rnl1), E. coli bacteriophage 69 (RB69) RnlA and E. coli bacteriophage JS10 (JS10) RnlA. The 
alignment shows conserved polypeptide motif sequences for motif I (dark yellow), motif IV 
(yellow) and motif V (green), 100 % conserved residues (grey) and highly conserved residues 
(teal). Alignments performed using Clustal Omega, https://www.ebi.ac.uk/Tools/msa/clustalo/, 
amino acids are designated following standard single letter abbreviations. 
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TBMP2     LLFVGGDGSIFERYTEIDNSNE-RRINALKGCGMFEDEWIATEKVHGANFGIYSIEGE---  71  
TBMP1     YMPLPNDQSDFSPYIEIDLPSE-SRIQSLHKSGLAAQEWVACEKVHGTNFGIYLINQG--- 101 
LmR1      YMPLPRNQEDFSAYTEIDLPTE-TRIDAIRRTGIASQEWVACEKVHGTNFSIYLINES---  56 
KVP40L2   --------MSFVKYTSLENSYRQAFVDKCDMLGV--REWVALEKIHGANFSFIVEFKPNEA  51 
T4Rnl2    ---------MFKKYSSLENHYNSKFIEKLYSLGLTGGEWVAREKIHGTNFSLIIERDKVT-  51 
Rb69L2    ---------MFKKYSSLENHYNSKFIEKLYTNGLTTGVWVAREKIHGTNFSLIIERDNVT-  51 
                                                     Motif I 
 
TBMP2     -----KMIRYAKRSG----IMPPNEHFFGYHILIPELQRYVTSIREMLCEKQK--KKLHV 120 
TBMP1     ---DHEVVRFAKRSG----IMDPNENFFGYHILIDEFTAQIRILNDLLKQKYGLS-RVGR 153 
LmR1      ------EVRFAKRSG----IMDPSENFFGYHLLIDDFTAQVRALCALLKRKYGVTGRMGR 116 
KVP40L2   QDGAEFTVTPAKRTSTIGANVMGDYDFYGCTSVVEAHTAKMEAISNWLWARGIINVG-ET 110 
T4Rnl2    ---------CAKRTG----PILPAEDFFGYEIILKNYADSIKAVQDIMETSAV-----VS   93 
Rb69L2    ---------CAKRTG----PILPAEDFYGYEIVLKKYDKAIKTVQKFMYTARA-----VS   93                                                     
 
TBMP2     VLINGELFGGKYDHPSVPKTRKTVMVAGKP---RTISAVQTDSFPQYSPDLHFYAFDIKY 177 
TBMP1     LVLNGELFGAKYKHPLVPKSEKWCTLPNGKKFPIAGVQIQREPFPQYSPELHFFAFDIKY 213 
LmR1      VVLHGELFGAKYKHPLVPKSTKWCTLPNKKRIPISGVEIQSEPFPQYSPELHYFAFDVKY 166 
KVP40L2   IIVYGELAGKG---------------------------VQKEV---NYGDKDFWAYDILL 140 
T4Rnl2    YQVFGEFAGPG---------------------------IQKNV---DYGDKDFYVFDIIV 123 
Rb69L2    YQVFGEFAGGG---------------------------IQKGV---DYGEKDFYVFDILI 123 
         Motif IIIa                                          Motif IIIb 
 
TBMP2     KETEG-GDYTTLVYDEAIELFQRVPGLLYARAVIRGPMSKVAAFDVE--RFVT----T-- 228 
TBMP1     SVSGAEEDFVLLGYDEFVEFSSKVPNLLYARALVRGTLDECLAFDVE--NFMT----P-- 265 
LmR1      SVSGAEEDVVLLPFDDFTEVCSQVPNLLYAKPLVRGTLDECLAFDVE--NFIT----P-- 218 
KVP40L2   PETGK-----FLDWDVVLEACEF-AKVKTTHEIARGTLDELLRIDPLFRSF----HTPA- 189 
T4Rnl2    TTESGD--VTYVDDYMMESFCNT-FKFKMAPLLGRGKFEELIKLPNDLDSVVQDYNFTVD 180 
Rb69L2    NTESGD--NTYLTDYEMQDFCNE-FGFKMAPMLGRGTFDSLIMIPNDLDSVLAAYNATAS 180 
 
TBMP2     IPPLVGMGNYPL------TGNWAEGLVVKHSRLGMAGFDPKG-PTVLKFKCTAFQEIS 279 
TBMP1     LPALLGLGNYPL------EGNLAEGVVIRHVRRGDPAVEKHNVSTIIKLRCSSFMELK 317 
LmR1      LPALLGLGNYPL------EGNLAEGVVIRHVRRGDPAVESSGVSTIIKLRCSSFMELK 270 
KVP40L2   --------------DVDGDN-VAEGFVVKQLRN--EKRLHNGSRAILKVKNDKFKEKK 230 
T4Rnl2    HAGLVDANKCVWNAEAKGEVFTAEGYVLKPC-Y--PSWLRNGNRVAIKCKNSKFSEKK 235 
Rb69L2    -EDLVEANNCVFDANVIGDN-TAEGYVLKPC-F--PKWLPNGTRVAIKCKNSKFSEKK 233 
                                Motif IV              Motif V 
 
TBMP2     TDRAQGPRVDEM-RNVRRDSIN--RAGVQLPDLESIVQDPIQLEASKLLLNHVCENRLK 335 
TBMP1     HPGKQKELKETFIDTVRSGALRRVRG--NVTVISDSMLPQVEAAANDLLLNNVSDGRLS 374 
LmR1      HPGKQQELKATFLDTVRAGALQRVRRGKKVTVLADSMLPKLEAAANALLLNNVSEGRLS 329 
KVP40L2   NKAGKTPR-----------------A--------AVVLTEEQEKLHAAFSCYLTENRLR 264 
T4Rnl2    K-SDKPIK-----------------A--------KVELSEADNKLVGILACYVTLNRVN 268 
Rb69L2    K-SDKPIK-----------------T--------QVPLTEIDKNLLDVLACYVTLNRVN 266 
 
TBMP2     NVLSKIGTEPFEKEEMTPDQLATLLAKDALKDFLKDTEPSI---VNIPVLIRKDLTRY 390 
TBMP1     NVLSKIGREPLLSGEVSQVDVVLMLAKDALKDFLKEVDSLV---LNTTLAFRKLLITN 429 
LmR1      NVLSKIGREPLLTGDVKQEDVVLMLAQDALKDFLKETDPVV---LNTSLSFRKTLIRS 384 
KVP40L2   NVLSKLETVTQKQ----FGMISGLFIKDAKDEFERDELNETAIARDDWDVIKRSLTN- 317 
T4Rnl2    NVISKIGEIGPKD----FGKVMGLTVQDILEETSREGITLT--QADNPSLIKKELVK- 319 
Rb69L2    NVISKIGTVTPKD----FGKVMGLTVQDILE   TSREGIVLT—-TSDNPNLVKKELV 316 
 
TBMP2     VIFESRRLVCSQWKDILKRQSPDFSE-------------  416 
TBMP1     VYFESKRLVEQKWKELMQEEAAAQSEAIPPLSPAAPTKG  469 
LmR1      VYFAAEELLQGEWKRVMDRLKASQAEIDAAAA—AQEKA 424 
KVP40L2   ---IANEILRKNWLDILDGNF------------------ 335 
T4Rnl2    ---MVQDVLRPAWIELVS--------------------- 334 
Rb69L2    R----MVQDVLRPAWIELVS-------------------- 332 
Figure 3.6. Sequence alignment of T4Rnl2 and T4Rnl2-like proteins. Alignment of 
Trypanosoma brucei RNA editing ligases 1 and 2 (TBMP1 and TBMP2), Leishmania major RNA 
editing ligase 1 (LmR1), Vibrio bacteriophage 40 RNA ligase 2 (KVP40L2), E.coli bacteriophage T4 
RNA Ligase 2 (T4Rnl2), E. coli bacteriophage 69 RNA ligase 2 (RB69L2). The alignment shows the 
conserved motifs I (dark yellow), IIIa (light blue), IIIb (purple), IV (yellow), V (green) and VI (blue). 
The 100 % conserved residues (grey) and highly conserved residues (teal). Alignments 
performed using Clustal Omega, https://www.ebi.ac.uk/Tools/msa/clustalo/ amino acids are 
designated following standard single letter abbreviations. 
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3.1.4. Golden Gate Cloning and the OB domain swaps 
A noticeable difference between the T4 RNA ligases and T4Dnl is the OB domain, which 
contains motif VI, as this domain is missing from both T4Rnl1 and T4Rnl2. The motif in 
the OB domain is not involved in nick sealing but does contribute to self-adenylation 
(Timson, Singleton and Wigley, 2000).  As the OB domain is always missing from Rnl1- 
and Rnl2-like proteins, it was decided that addition of this to T4Rnl1 and T4Rnl2 may 
yield ligases with improved adenylation capacity, which could improve ligation yield. To 
move the OB domain, a technique called Golden Gate Cloning (see Section 1.2.3) was 
used to create the recombinant plasmids.  
 
3.2 Changes to the T4 nucleic acid ligases 
Motif I has been well studied and its involvement in phosphodiester bond formation 
well tested. It was, therefore, sensible to begin alterations to the T4 ligases within this 
motif. The T4 NA ligases were aligned to each other and Dnl-, Rnl1- or Rnl2-like proteins 
(Figures 3.3, 3.4 3.5 and 3.6) using the Clustal Omega software (available at 
http://www.ebi.ac.uk/Tools/msa/clustalo/). The different ligase sequences were taken 
from www.uniprot.org and the ligases were selected randomly while trying to ensure a 
good spread of different ligases from different organisms. After performing amino acid 
alignments of the T4 RNA ligases it was proposed that the aspartate (D101) and histidine 
(H37) residues in motif I for T4Rnl1 and T4Rnl2, respectively, are always conserved 
(Figures 3.4 and 3.5) and might be responsible for the differences seen in substrate 
specificity of the two T4 RNA ligases. An equivalent residue in motif I for DNA ligases is 
not as highly conserved (Figure 3.3). 
 
3.2.1 Site Directed Mutagenesis of pRB255, pRB256 and pRB257 
The DNA sequence for motif I in T4Dnl is 5’ AAAGCTGATGGAGCTCGG 3’, the motif I for 
T4Rnl1 is 5’ AAAGAAGACGGGTCTTTG 3’ and the motif I for T4Rnl2 is 5’ 
AAGATTCACGGCACAAAT 3’. For each of the different amino acid substitutions and to 
swap motif I (Table 3.1), site directed mutagenesis PCR was carried out (Table 3.2). The 
primers were designed to introduce amino acid changes to motif I, from the original 
amino acid to the amino acid seen in another ligase (see Table 3.1). The site directed 
mutagenesis was carried out using the New England Biolabs (NEB) Q5-site directed 
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mutagenesis kit. The NEB protocol provided was followed, for PCR the annealing 
temperatures see Table 3.2.  The plasmids used for mutagenesis were pRB255, pRB256 
and pRB257 (T4Dnl, T4Rnl1 and T4Rnl2, respectively) (Bullard and Bowater, 2006). 
 
Table 3.1. The altered motif I sequences for the different T4 NA ligases. The part of the 
sequence that will be changed is highlighted in red. 
New Ligase Name T4 Ligase before 
mutation 
New Motif I sequence 
5’ – 3’ 
D101H T4Rnl1 AAAGAACACGGGTCTTTG 
H37D TRnl2 AAGATTGACGGCACAAAT 
R164L T4Dnl AAAGCTGATGGAGCTTTG 
R164N T4Dnl AAAGCTGATGGAGCTAAT 
L104R T4Rnl1 AAAGAAGACGGGTCTCGG 
L104N T4Rnl1 AAAGAAGACGGGTCTAAT 
N40R T4Rnl2 AAGATTCACGGCACACGG 
N40L T4Rnl2 AAGATTCACGGCACATTG 
T4Rnl1M1 T4Rnl1 CGTGAAAAGATTCACGGCACAAATTTC 
T4Rnl2M1 T4Rnl2 CTAACAAAAGAAGACGGGTCTTTGGTA 
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Table 3.2. The primers required for amino acid substitutions to motif I sequences. The 
primer sequences were generated using the NEB Base Changer tool, available at 
http://nebasechanger.neb.com/. 
Primer 
Name 
Primer Sequence Annealing 
Temperature 
D101HF AAC-AAA-AGA-AcA-CGG-GTC-TTT-G 57 °C 
D101HR AGA-ATA-TAA-TCA-ACA-TCG-TTT-AAA-TC 
H37DF TGA-AAA-GAT-TgA-CGG-CAC-AAA-TTT-CTC-ATT-G 66 °C 
H37DR CGA-GCT-ACC-CAC-TCC-CCA 
R164LF TGA-TGG-AGC-Ttt-gTG-TTT-TGC-TG 57 °C 
R164LR GCT-TTT-AAC-TGA-GCA-AAG 
R164NF TGA-TGG-AGC-Taa-tTG-TTT-TGC-TGA-AGT-TAT-
TAG 
57 °C 
R164NR GCT-TTT-AAC-TGA-GCA-AAG 
L104RF AGA-CGG-GTC-Tcg-gGT-ATC-AAC-TTA-TTT-AG 60 °C 
L104RR TCT-TTT-GTT-AGA-ATA-TAA-TCA-ACA-TCG 
L104NF AGA-CGG-GTC-Taa-tGT-ATC-AAC-TTA-TTT-AG 58 °C 
L104NR TCT-TTT-GTT-AGA-ATA-TAA-TCA-ACA-TC 
N40RF TCA-CGG-CAC-Acg-gTT-CTC-ATT-GAT-TAT-TGA-G 56 °C 
N40RR ATC-TTT-TCA-CGA-GCT-ACC 
N40LF TCA-CGG-CAC-Att-gTT-CTC-ATT-GAT-TAT-TG 56 °C 
N40LR ATC-TTT-TCA-CGA-GCT-ACC 
T4Rnl1M1F CGG-CAC-AAA-TTT-CTC-AAC-TTA-TTT-AGA-CGG-
TGA-TG 
59 °C 
T4Rnl1M1R TGA-ATC-TTT-TCA-CGA-ATA-TAA-TCA-ACA-TCG-
TTT-AAA-TCG  
T4Rnl2M1F CGG-GTC-TTT-GGT-ATC-ATT-GAT-TAT-TGA-GCG-
TGA-TAA-AGT-GAC 
67 °C 
T4Rnl2M1R TCT-TCT-TTT-GTT-AGA-GCT-ACC-CAC-TCC-CCA-CC 
 
The PCR product was treated with a kinase, ligase, DpnI (KLD) mix and then transformed 
into Bioline α-select bronze cells as per the manufacturer’s instructions. The cell 
suspension was spread onto LB-agar plates containing 100 µg/ml Ampicillin and 
incubated at 37 °C overnight. On the following day colonies were selected for overnight 
culture in 10 ml LB selective media.  
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3.2.2. Golden Gate Cloning to add the OB domain to the T4 RNA ligases 
Addition of the OB fold from T4Dnl was carried out using the GGC enzyme BsaI, the BsaI 
recognition site was added into the gene sequences at the beginning of the T4 RNA 
ligases, at the position where the OB fold would be inserted and at the end of the OB 
fold allowed for insertion of the OB domain (Figure 3.7). The primers were designed to 
include a 4 nucleotide overhang sequence for the fragments to enable ligation of 
fragments in the correct order (Table 3.3) (Appendix 1). The vector used was the MEGGA 
plasmid (Marcus Edwards Golden Gate Assembly) pBad vector induced using arabinose, 
with a C–terminal His tag, obtained from Dr Marcus Edwards. This vector was selected 
as it already contained the BsaI cut sites required to insert the new recombinant genes. 
Primers were designed to amplify regions of the T4 ligases at the gene level with the 
addition of the BsaI cut site.  
 
Figure 3.7. Addition of the OB domain to the T4 RNA ligases. Sequences designed so that 
the C-terminal sequence from T4Dnl replaced the C-terminal sequences for both T4Rnl1 and 
T4Rnl2. The arrows represent addition of a BsaI cut site, the arrow colours correspond to the 
overhang sequences that ensured the correct order of the fragments.    
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 Table 3.3. The primers designed for addition of the BsaI cut sites.  
 
The following reactions were set up to add the BsaI cut site (Appendix 1) and amplify 
regions of the T4 RNA ligases, the MEGGA backbone and to also amplify only the OB 
domain from T4Dnl. The following were combined: 25 µl NEB Q5 Hot start High Fidelity 
2x Master Mix, 2.5 µl 10 µM Forward Primer, 2.5 µl 10 µM Reverse Primer, 1 µl of 1-25 
ng DNA (T4 RNA ligase or T4 Dnl for the OB Fold) and 18 µl water. For the primers and 
PCR conditions see Tables 3.3 and 3.4.  
 
Table 3.4. The PCR conditions for GGC fragment amplification.  
Reaction Step Temperature (°C) Time (s) 
Initial 
Denaturation 
98 30 
Denaturation 98 10  
Repeat for 30 
cycles. 
Annealing 58 – RNA ligases and OB fold, 62 for 
MEGGA backbone 
30 
Extension 72 300 
Final Extension  72 300 
 
 
Primer Name Sequence (5’-3’) 
T4 Dnl OB fold 
Forward 
T4DnlBsaIOBF TGG-TCT-CTG-AAG-TAA-TTG-ATG 
-TTG-ATT-TAA-AAA-TTG-TAG-GAA-
TTT-ATC-C 
T4 Dnl OB fold 
Reverse 
T4DnlBsaIOBR TGG-TCT-CTG-ATG-GGA-TCC-TCA-
TAG-ACC-AGT-TAC-CTC-AT 
T4 Rnl1 Forward T4Rnl1BsaIF TGG-TCT-CTA-CCC-ATG-CAA-GAA-
CTT-TTT-AAC-AAT-TTA-ATG-GAA-
CTA-TG 
T4Rnl1 Reverse + OB T4Rnl1BsaIOBR TGG-TCT-CTC-TTC-CTT-AAT-TTT-
AAA-ATG-AGA-ACC-ATC-TTT-CAT-
CAC-AG 
T4 Rnl2 Forward T4Rnl2BsaIF TGG-TCT-CTA-CCC-ATG-TTT-AAA-
AAG-TAT-AGC-AGT-CTT-GAA-AAT-
CAT-TAC 
T4 Rnl2 Reverse + 
OB 
T4Rnl2BsaIOBR TGG-TCT-CTC-TTC-CTT-GCA-TTT-
AAT-CGC-TAC-ACG-ATT-TCC 
MEGGA_HIS_F MEGGA backbone 
His tag Forward 
CAT-CAT-CAC-CAT-CAC-CAT-TGA-
GTT-TAA-ACG-GTT-TC 
MEGGA_RBS_R MEGGA backbone 
Ribosome binding 
site Reverse 
GGG-TAT-GTA-TAT-CTC-CTT-CTT-
AAA-GTT-AAA-CAA-AAT-TAT-TTC 
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After the PCR, DpnI digestion was carried out to remove the original template, as per 
the ThermoFisher DpnI manual. The reaction was scaled up 4x to incorporate higher 
concentrations of DNA fragments for the GGC reaction. PCR clean-up was carried out 
using the Bioline Isolate II PCR and Gel Kit as per the instructions provided. The DNA was 
eluted using molecular grade nuclease free sterile water instead of the elution buffer 
provided. The DNA concentration of the samples was determined using Nanodrop 
Quantification. For the GGC reaction ratios of 1:3:3 for the MEGGA vector : RNA ligase : 
OB domain were added to 1.5 µl T4 DNA ligase buffer, 1.5 µl cut smart buffer, 1 µl BsaI 
and 1 µl ThermoFisher T4DNA ligase and underwent the cycling conditions in Table 3.5. 
The product from the Golden Gate reaction was transformed into Bioline α-select 
bronze cells (see Section 2.2.6). 
 
Table 3.5. GGC cycling conditions.  
Reaction Step Temperature (°C) Time (min) 
BsaI Digestion  37 3  
Repeat for 25 
cycles. 
T4 Ligation of Strands 16 4 
BsaI Deactivation  50 5 
T4 DNA Ligase 
Deactivation  
80 5 
 
The assembled T4Rnl1OB and T4Rnl2OB genes were then transferred into the pET16b 
vector system by addition of the NdeI and BamHI cut sites (N- and C- terminus 
respectively) using PCR and the Q5 Site Directed Mutagenesis Kit (New England Biolabs) 
as per the manufacturer’s instructions. For the primers and annealing temperatures see 
Table 3.6. The PCR fragments were then digested using NdeI and BamHI and ligated into 
the pET16b vector (see 2.2.5). The ligation product was transformed into α-select bronze 
cells (Bioline) (see Section 2.2.6). 
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Table 3.6. Primers and Annealing temperatures to add the T4 RNA ligases + OB 
domains to the pET16 vector system. The bold and underlined bases indicate the 
introduction of NdeI (CATATG) and BamHI (GGATCC) cut sites.   
Primer  
Name 
Primer Sequence 
 5’-3’ 
Annealing 
Temperature 
557+NdeI F tcgtCATATGcaagaactttttaacaatttaatggaacta
tgtaaggatt 
65 °C 
557+BamHI R ccgaGGATCCtcatagaccagttacctcatgaaaat 
558+NdeI F tcgtCATATGtttaaaaagtatagcagtcttgaaaatcat
tacaactctaaattta 
65 °C 
558+BamHI R ccgaGGATCCtcatagaccagttacctcatgaaaat 
 
3.2.3. Plasmid Isolation and Mutation Confirmation 
The plasmids were isolated using the Qiagen QiaPrep Spin Miniprep kit (see Section 
2.2.2) as per the manufacturer’s instructions. Samples were sent to Source Bioscience 
(Nottingham Business Park, Nottingham, NG86PX), for Sanger sequencing, the results 
were analysed using the BioEdit software. Once the amino acid substitution was 
confirmed the new plasmids were transformed into competent BL21 pLysS cells (see 
Section 2.2.6) for protein expression and purification. The motif swap plasmids pRB555, 
pRB556, pRB557 and pRB558 were also confirmed using colony PCR.  
 
3.2.4 Colony PCR 
Colony polymerase chain reaction uses a single colony from an organism to amplify DNA 
fragments. The technique uses a single colony and does not require the isolation of pure 
DNA (Cao et al., 2009). The bacterial DNA was prepared by isolating one bacterial colony 
from the selective LB agar plate. This colony was resuspended in 10µl of sterile water 
and then heated for 5 minutes at 100 °C. To 12.5 µl 2x My Taq Red Mix (Bioline) the 
following was added: 1 µl Forward Primer (10 µM), 1 µl Reverse Primer (10 µM), 1 µl 
bacterial DNA from heated solution and 9.5 µl water. The cycling conditions in Table 3.7 
and the primers from Table 3.8 were used. After PCR the samples were kept at 4 °C, until 
analysis was carried out using 1 % agarose gels.  
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Table 3.7. The Cycling Conditions for the colony PCR to determine successful mutants. 
Reaction Step Temperature (°C) Time (s) 
Initial 
Denaturation 
95 60 
Denaturation 95 30  
Repeat for 35 
cycles. 
Annealing Dependent on primers used 30 
Extension 72 90 
Final Extension  72 300 
 
Table 3.8. The different primers to confirm motif I and the OB domain swaps.  
Mutant Check Primer Sequence (5’-3’) 
 
Motif I switch 
256 Motif I CTA-ACA-AAA-GAA-GAC-GGG-TCT-TTG-
G 
257 Motif I CGT-GAA-AAG-ATT-CAC-GGC-ACA-AAT-
TTC 
T7 Terminator GCT-AGT-TAT-TGC-TCA-GCG-G 
 
OB fold 
addition 
 
T4 Rnl1 Forward TGG-TCT-CTA-CCC-ATG-CAA-GAA-CTT-
TTT-AAC-AAT-TTA-ATG-GAA-CTA-TG 
T4 Rnl2 Forward TGG-TCT-CTA-CCC-ATG-TTT-AAA-AAG-
TAT-AGC-AGT-CTT-GAA-AAT-CAT-TAC 
T4 Dnl OB fold 
Reverse 
TGG-TCT-CTG-ATG-GGA-TCC-TCA-TAG-
ACC-AGT-TAC-CTC-AT 
 
3.2.5. Protein Synthesis and Purification 
To synthesise the new ligase enzymes the plasmids were transformed (see Section 2.2.6) 
into BL21 DE3 E. coli cells (Table 2.1). Proteins were expressed using either 0.5 mM IPTG 
or 0.5 mM arabinose (T4Rnl1OB and T4Rnl1OB) and purified using a Hi-Trap Chelating 
column (see Sections 2.3.1 – 2.3.6). For proteins that were insoluble under these 
conditions, different concentrations of IPTG or arabinose (0 mM – 10 mM) were used at 
different incubation temperatures (10 °C – 30 °C). The amount of protein was quantified 
using the Bradford assay (see Section 2.3.8).  
 
3.2.6. Ligation Assays 
The end point ligation assay (see Section 2.4.1) was carried out to assess whether the 
new soluble ligases could still effectively ligate breaks between the DNA/RNA 
substrates. If the ligases could ligate substrate 7, the initial rate was also determined 
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using the time course ligation assay (see Section 2.4.2). The ligation assays were 
analysed using urea-PAGE (see Section 2.4.3).  
 
3.3 Analysis of the modified T4 NA ligases 
3.3.1 Sequence Analysis of New Gene Constructs 
To confirm the gene sequences contained the new modified motif I sequences or 
contained motif swaps (Figures 3.9 and 3.10), the plasmids were sent for Sanger 
sequencing at Eurofins (i54 Business Park, Valiant Way, Wolverhampton, WV9 5BG, UK). 
 
3.3.1.1 Colony PCR for Preliminary Sequence Analysis  
Colony PCR was carried out to check for possible positive transformants for motif swaps 
before plasmids were purified and sent for sequencing. Colonies that showed a positive 
result from the colony PCR (Figure 3.8) underwent plasmid extraction (see Section 2.2.2) 
and these were then sent for Sanger sequencing. The gene sequences for all mutated 
proteins were successfully prepared (Figures 3.9 and 3.10).   
 
 
Chapter 3: Domain Swaps and Mutational Analysis of Motif I in the T4 NA ligases 
82 
 
 
Figure 3.8. Colony PCR analysis for motif swap analysis. Identification of positive clones, a 
band is seen where the colony contains both the ligase N- terminus and the OB domains, 
analysed using 1 % TAE agarose gels;  A) pRB556 positive transformants for motif I from T4Rnl1 
(pRB256) and negative controls with no band; B) pRB555 positive transformants for motif I from 
T4Rnl2 (pRB257) and negative controls with no band; C) pRB557 transformants containing both 
T4Rnl1 N- terminus (pRB256) and the OB domain from T4Dnl, a light band is seen with pRB256 
as this contains only the N- terminus for T4Rnl1; D) pRB558 transformants containing both 
T4Rnl2 N- terminus (pRB257) and the OB domain from T4Dnl, a light band is seen for pRB257 as 
it contains only the N- terminus for T4Rnl2.  
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Figure 3.9. Sequence analysis for each of the mutations made to the T4 nucleic acid 
ligases. Plasmids were sequenced using the T7 forward and T7 terminator reverse primers by 
Eurofins Genomics. The sequences received from Eurofins were aligned to the original ligase 
gene sequences A) pRB565, B) pRB566, C) pRB567, D) pRB568, E) pRB569, F) pRB570, G) pRB563 
and H) pRB564. The shaded regions show where sequence mutations were made.  
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Figure 3.10. Sequence analysis for the motif switch plasmids. The sequences from 
Eurofins were aligned to the original sequences for the RNA ligases and the T4Dnl OB domain A) 
pRB555 and pRB256 aligned, motif I (highlighted) has been successfully changed; B) pRB556 and 
pRB257 aligned, motif I (highlighted) has been successfully changed; pRB557 aligned to pRB256 
N- terminus (D) and pRB255 OB domain (E); pRB558 aligned to pRB257 N- terminus (E) and 
pRB255 OB domain (F).  
 
3.3.2 Protein Solubility and Purification 
Using the new DNAs that contain the mutated gene sequence, numerous attempts were 
made to purify soluble T4Rnl2M1, but the protein remained insoluble under different 
conditions for protein synthesis. As such this protein was not purified and further 
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analysis was not conducted. The motif swap proteins T4Rnl1OB and T4Rnl2OB were 
synthesised from both the MEGGA vector and also the pET16b system, it was unclear 
whether T4Rnl2OB was insoluble in the pET16b system, the soluble fraction was purified 
and the fractions analysed using 10 % SDS PAGE (data not shown) but no purified protein 
was seen. The mutated forms of T4Rnl2 remained insoluble from both systems (Figures 
3.11 and 3.12) and further analysis was not conducted. T4Rnl1M1 and T4Rnl1OB were 
soluble and were purified (Figure 3.13) but did not have ligation activity (data not 
shown). The ligases with amino acid substitutions to motif I were soluble and were 
purified (Figure 3.14) for end point and time course ligation analysis (Figures 3.15 – 
3.18). The time course analysis was carried out for both 30 and 60 minute with aliquots 
removed at different time points (Figure 3.18) to determine the reaction end point.  
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Figure 3.11. Solubility analysis from the MEGGA plasmid arabinose induction for 
T4Rnl1OB and T4Rnl2OB. Arabinose induction with the MEGGA plasmid for both proteins at 
30 °C for 4 hours, analysed using 10 % SDS- A) T4Rnl1OB was soluble (predicted MW 41.7 kDa), 
B) T4Rnl2OB (predicted MW 39.3 kDa) was insoluble at all arabinose concentrations.  
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Figure 3.12. Solubility Analysis for T4Rnl1OB and T4Rnl2OB with the pET16b plasmid 
and IPTG induction. Induction with 0.5 mM IPTG at 30 °C for four hours, the soluble and 
insoluble fractions were analysed using 10 % SDS-PAGE; A) T4Rnl1OB was soluble while it 
remained difficult to determine whether B) T4Rnl2OB was soluble or insoluble, the soluble 
T4Rnl2OB fraction was purified (data not shown) but no protein was seen. 
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Figure 3.13. Purification Analysis of T4Rnl1M1 and T4Rnl1OB. Purification fractions for A) 
T4Rnl1M1 fractions 3-10 and B) T4Rnl1OB fractions 1-10, analysed using 10 % SDS PAGE. The 
purification fractions for T4Rnl1OB have high levels of pure protein when compared to 
T4Rnl1M1, as seen by the concentrated banding across fractions 3-10 (B).  
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Figure 3.14. Purification fractions of the amino acid substitutions to motif I in the T4 
NA ligases. Ni Hi-trap purification analysed using 10 % SDS PAGE, protein purification elution 
fractions 1- 10 for point mutations made to each of the T4 ligases. The expected molecular 
weight for each ligase is: A) R164L 55.2 kDa, B) R164N 55.2 kDa, C) L104R 43.5 kDa, D) L104N 
43.5 kDa, E) N40R 37.6 kDa F) N40L 37.6 kDa, G) D101H and H) H37D 37.6 kDa. The expected 
sizes of each ligase are: T4Dnl 55 kDa, T4Rnl1 43 kDa and T4Rnl2 37.5 kDa (gels for wild type 
proteins are shown in Figure 4.9). 
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3.3.3. Ligation Activity Analysis 
All proteins purified as soluble were checked for ligation activity using end point ligation 
(see Section 2.4.1) with double stranded substrates 1-8. In some instances the new 
ligase proteins showed no ligation activity (data not shown) and no further analysis was 
carried out on these ligases. Where proteins demonstrated ligation activity with 
substrate 7, time course ligation analysis (see Section 2.4.2) was also carried out.  
 
3.3.3.1. End Point Ligation  
End point ligation of all soluble proteins was attempted with double stranded substrates 
1-8 and the hairpin substrate (see Section 2.4.1). The hairpin substrate mimics the tRNA 
anticodon loop that T4Rnl1 repairs during E. coli infection. The ligases with motif swaps, 
T4Rnl1M1 and T4Rnl1OB, showed no activity for the end point ligation assay (data not 
shown) and no further analysis was carried out with these proteins. The motif I 
substitution proteins demonstrated ligation activity (Figures 3.15 and 3.16), with the 
exception of L104R. The only ligase able to improve ligation yield was H37D with 
substrate 7 (Figure 3.16). Some of the new ligases had a severe reduction in total amount 
of ligated product: R164N with both substrates 1 and 7; D101H especially with substrate 
2 and all T4Rnl2 mutants could no longer ligate substrate 1 (Figure 3.16). As substrate 7 
was the substrate that all of the T4 ligases can ligate (Bullard and Bowater, 2006), this 
substrate was used to consider whether the rate of ligation for the mutated ligases could 
be calculated. When tested with the hairpin substrate L104N was the only protein to 
successfully ligate this substrate (Figure 3.17).  
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Figure 3.15. End point ligation analysis of ligases with substitutions to motif I. Urea 15 
% polyacrylamide denaturing gels for end point ligation at 37 °C for 30 minutes A) T4Dnl R164L, 
B) T4Dnl R164N, C) T4Rnl1 L104R, D) T4Rnl1 L104N, E) T4Rnl2 N40R, F) T4Rnl2 N40L, G) T4Rnl1 
D101H and H) T4Rnl2 H37D with 20 base oligonucleotide DNA/RNA substrates 1-8 (Table 2.4). 
In all cases ligation is indicated by the bands that migrate more slowly through the gels. The 
ligated products containing RNA run slightly slower than those containing just DNA, this is a 
known phenomenon but all substrates when ligated are 20 bases in size  (Bullard and Bowater, 
2006).  
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Figure 3.16. The percentage of ligation for each ligase with each of the double 
stranded 20 base substrates (1-8). Quantitative analysis of the ligation data from Figure 
3.15; A) T4Dnl, R164N and R164L; B) T4Rnl1, L104N, L104R and D101H; and C) T4Rnl2, H37D, 
N40L and N40R. Quantification was carried out using the ImageJ software.  
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Figure 3.17. Hairpin End Point Ligation. Ligation of the hairpin substrate (45 pmol) with the 
T4 nucleic acid ligases (70 pmol) and the mutated versions of the ligases, incubated at 37 ⁰C for 
one hour.  
 
3.3.3.2 Time Course Ligation  
Time course ligation analysis (See 2.4.2) was carried out with substrate 7 (Table 2.4) and 
analysed using Urea-PAGE analysis (2.4.3) for quantification using ImageJ software. The 
ligases tested for initial rate analysis (Figure 3.18) were H37D and N40L, as these ligases 
appeared able to ligate the same total amount of substrate 7 as T4Rnl2 in the end point 
analysis (Figure 3.16). The rates of ligation for H37D and N40L were compared to T4Rnl2 
(Table 3.9) and N40L had 10-fold less activity with substrate 7.  
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Figure 3.18. Initial rate analysis of T4Rnl2, H37D and N40L. Reactions over 30 and 60 
minutes with substrate 7, at 37 °C and repeated in triplicate, with error bars showing the 
standard deviation for each time point. A) Examples of a time course experiments with T4Rnl2 
using 15 % urea-PAGE for both 30 and 60 minutes; B) time course analysis, the gels are visualised 
using ImageJ software and the bands quantified to give the amount ligated as a rate.  
 
Chapter 3: Domain Swaps and Mutational Analysis of Motif I in the T4 NA ligases 
95 
 
Table 3.9. Rates of nick joining in double stranded substrate 7. Rates of ligation for 
T4Rnl2, H37D and N40L, experiments were repeated in triplicate and the standard deviation is 
shown.  
Ligase Rate of Ligation at 37 ⁰C 
(mol nicks joined/mol protein/min) 
T4Rnl2 26.28 (+/- 7.95) 
H37D 23.8 (+/- 1.16) 
N40L 2.94 (+/- 0.18) 
 
3.4 Discussion  
The results from this work yielded varied results, each motif I mutation gave different 
results and the motif swaps gave unexpected results for each RNA ligase. It is apparent 
that when working with the 3 different T4 NA ligases, a one-approach fits all does not 
work especially when trying to compare conserved sequences. The gene sequences for 
the T4 NA ligases are quite dissimilar to each other, there is some similarity but it is 
important to consider residues outside of the polypeptide motifs. The bioinformatics 
alignments for the T4 ligase sequences (Figures 3.3, 3.4 and 3.5) showed a number of 
highly conserved amino acids surrounding the motifs that are not mentioned in the 
literature. This raised the question about whether these contribute to the substrate 
specificity profiles for the different ligases and have involvement in the nucleotide 
binding pocket.  A good example of this from the alignment data is motif I (Figures 3.3, 
and 3.5). Motif I is often described in literature as KxxGx, originally it was KxDGx but the 
discovery of T4Rnl2 meant that the 3rd position in this motif is not always aspartate. 
From the alignment data it would seem appropriate to make motif I a longer chain of 
amino acids and where this chain starts depends on the different ligase sub family. For 
example, in T4Rnl1 motif I has previously been identified as KEDGSL, but when aligned 
with other Rnl1-like proteins from other bacteriophages it appears that other residues 
downstream of these 6 are also always conserved. This was also seen in motif I of T4Rnl2 
and Rnl2-like proteins, where the amino acids either side of motif I are always 
conserved. The motifs were originally identified by mutational analysis to specific amino 
acids and by modifications to the DNA/RNA substrates (Sriskanda and Shuman, 1998; 
Ho and Shuman, 2002; Wang, 2002; Nandakumar and Shuman, 2004; Nandakumar, 
Shuman and Lima, 2006). The interaction of the amino acids within the motifs, with 
DNA/RNA substrates was further investigated by crystallographic studies (Ho et al., 
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2004; Nandakumar, Shuman and Lima, 2006; Pascal, 2008). It would be possible to study 
the motifs and their interactions further using computational software to improve 
predictions. Phylogenetic data of bacterial ATP-dependent DNA ligases identified a 
distinct group of ligases – LigE that were likely from bacteriophages originally 
(Williamson, Hjerde and Kahlke, 2016).  
 
3.4.1. Motif I swaps – T4Rnl1M1 and T4Rnl2M1 
These modified forms of ligases were incredibly difficult to purify and for T4Rnl2M1 it 
was not possible to purify soluble protein. The activity assay was carried out with 
T4Rnl1M1 but no activity was detected. This sparks further questions about which 
amino acids need to be conserved for ligation activity. The amino acids selected for the 
motif I swap included two amino acids upstream and one downstream of the 6 residues 
in motif I. In the case of T4Rnl1 it is likely that as these residues are also always conserved 
although not included in the published motif sequence, they are necessary for ligation 
activity and interaction with other residues in the nucleotide binding pocket. 
 
3.4.2. OB fold domain additions – T4Rnl1OB and T4Rnl2OB 
To decide how much of the OB fold from T4Dnl was used the theoretical structure for 
T4Dnl was created using Phyre2 software (Appendix 2). This was not a definitive 
structure and was mostly modelled on a human DNA ligase. The similarity between 
these two sequences was low as Human DNA ligase I is much bigger than T4Dnl, but 92 
% of the residues from T4Dnl were modelled with 100 % confidence against Human DNA 
ligase I. The N- terminus of both RNA ligases was selected, up to the end of the 
adenylation domain. The part taken from T4Dnl starts at the end of its adenylation 
domain to the end of the C- terminus, a region that includes the OB fold but also most 
of the C- terminus from the T4 DNA ligase. Mutations to motif VI in the DNA ligase from 
Chlorella virus reduced ligation capacity and demonstrated that motif VI is needed for 
adenylation (Sriskanda and Shuman, 1998). The insolubility seen by T4Rnl2OB is likely 
caused by the addition of such a large domain, a more directed approach at adding only 
motif VI to the T4 RNA ligases is likely to be better although deciding exactly where to 
place this motif remains problematic. While this large addition did not affect the 
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solubility of T4Rnl1OB, it did result in a complete loss of ligation activity. The GGC 
technique made recombinant gene and plasmid construction straightforward and 
reduced the possibility of false cloning. The arabinose induction trial for T4Rnl1OB 
showed the protein was in the soluble fraction and the SDS-PAGE showed a clear band 
where the protein was but no ligation activity was observed.    
 
3.4.3. Single amino acid substitutions  
Specific amino acid mutations in motif I resulted in soluble protein for purification. All 
of these new ligases were active but did not demonstrate a different substrate profile 
or vary in the rates of activity. In all instances the changes to amino acids in motif I 
resulted in either a total loss of ligation activity or reduced activity. Modified versions of 
T4Dnl – R164N and R164L both resulted in reduced ligation activity, neither could ligate 
to the same total ligation amount as T4Dnl (Figure 3.16). For substitutions of T4Rnl1, 
both D101H and L104N remained functional; L104R was completely inactive with all 
versions of the double stranded substrates and could no longer ligate the hairpin 
substrate while D101H and L104N showed a decrease in total ligation (Figures 3.15 C 
and 3.16). The T4Rnl2 variants H37D and N40L were still able to ligate and showed a 
similar substrate profile as T4Rnl2, although all new ligases lost the capacity to ligate 
substrate 1 – double stranded DNA (Figure 3.15). When considering substrate 7 for rate 
analysis, N40R was not able to ligate this substrate as effectively in end point ligations 
and was not considered for rate analysis. The end point ligations used 45 pmol of 
substrate with 70 pmol of ligase, so it is possible that the amino acid mutagenesis to the 
T4 ligases has caused a shift in KM and that the ligases are no longer saturated with 
substrate. It would therefore be useful to determine the Vmax for each of the T4 ligases 
and also each of the variants of these ligases to see if Vmax is reached. A high KM would 
indicate a low substrate affinity and that a greater amount of substrate is required to 
reach Vmax. The amount of substrate wasn’t changed when testing these new ligases, if 
the new ligases could not ligate the amount the original T4 ligases ligated then no further 
analysis was carried out. A higher KM for these new ligases may mean that 45 pmol of 
substrate was not enough to saturate and the ligase would not be able to reach Vmax.  
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The rate of ligation for H37D is comparable to T4Rnl2 (Table 3.9, Figure 3.18) and the 
substitution to aspartate does not adversely affect ligation with double stranded 
substrate 7. The rate of ligation for N40L was reduced when compared to T4Rnl2 (Table 
3.9) suggesting the substitution of asparagine to leucine impacts on either interaction 
of the enzyme with AMP or the substrate. Asparagine is polar, usually found on protein 
surfaces and can form hydrogen bonds. Leucine is hydrophobic and does not form 
hydrogen bonds (Betts and Russell, 2003) and, therefore, likely affects the protein 
structure for the nucleotide binding pocket in N40L. The composition of the nucleotide 
binding pocket of T4Rnl1 changes in steps 1 and 3 of the ligation reaction (Figure 1.5) 
(Wang, Schwer and Shuman, 2006). Residues in the motifs of both T4Rnl1 and T4Rnl2 
are responsible for hydrogen bonding when repairing breaks in DNA and RNA 
(Nandakumar, Shuman and Lima, 2006; Wang, Schwer and Shuman, 2006).  
 
3.5. Conclusions 
To conclude, the T4 NA ligases have poor overall sequence similarity to each other and 
the bioinformatics alignment of sequences similar to the T4 RNA ligases showed a 
number of additional regions outside of the conserved motifs that are also conserved 
and may be important. A better approach to alter ligase activity and specificity would be 
to look at proteins from the T4Rnl1- and T4Rnl2-like families that ligate under different 
conditions or ligate different substrates and take a similar amino acid substitution 
approach to change the amino acids involved in particular activities. Specific residues in 
similar ligase proteins have been studied and the aspartate residue in motif I of T4Rnl1 
is likely involved in AMP transfer to the nucleotide (Shuman and Lima, 2004). An attempt 
was made to mutate the aspartate in human DNA ligase 1 to glutamate, asparagine and 
glutamine resulting in loss of enzyme activity (Kodama, Barnes and Lindahl, 1991) and  
also the aspartate in DNA ligase from Thermus thermophillus is required for 
deadenylation (Luo and Barany, 1996). 
 
It is difficult to decide modifications for T4Dnl as there is no structure available for this 
ligase. While a theoretical model was made (Appendix 2), it is modelled against human 
DNA ligase I; however the model aligns all of the T4Dnl sequence to part of human DNA 
Chapter 3: Domain Swaps and Mutational Analysis of Motif I in the T4 NA ligases 
99 
 
ligase – a much larger ligase. Without a crystallographic structure for this enzyme it is 
difficult to know how the motifs interact in the nucleotide binding pocket – even with 
solved structure for the T4 RNA ligases it is noted that these pockets are very different 
and have specific amino acid interactions for ligation activity. Thus, the T4 NA ligase 
genes are dissimilar and, as such, should be treated as separate groups of enzymes.  
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Chapter 4: Construction and Analysis of Adenylate 
Kinase-Ligases 
4.1 Introduction  
4.1.1 Tagged and Fusion Proteins 
The addition of amino acids and proteins to other proteins is a widely used tool for a 
number of processes, including purification and improving visibility and solubility of 
proteins. Common tags include Histidine for protein purification, Streptavidin/Biotin 
and alkaline phosphatase (Kimple and Sondek, 2004). A number of coloured tags have 
also been developed to improve visualisation of proteins; fluorescent tags, for example 
fluorescein and green fluorescent protein, allow visualisation of tagged proteins under 
specific wavelengths of light. While all of the tagging systems mentioned in section 1.3.1 
offer a way to purify and visualise proteins, they do not offer a way to further enhance 
the function of the protein being purified. Often additional functions are not desirable 
as it would be difficult to determine what properties could be attributed to the protein 
of interest instead of the tag. However, where proteins are relatively well studied, the 
addition of a tag that provides a secondary function to the protein may be of interest; 
and as such these new fusions would result in multi-function enzymes.  
 
4.1.2 Fusion proteins for improved activity  
Fusion proteins to date have often focussed on taking domains from proteins and 
attaching these to other functional proteins. Recently advances have been made in 
combining binding sites from monoclonal antibodies to improve therapeutic efficacy 
(Holliger and Hudson, 2005). Another study used gold-binding peptide (GBP) fusions for 
detection of the Hepatitis B virus (Zheng et al., 2010). When considering the T4 nucleic 
acid ligases, attempts have been made to improve the activity of T4Dnl by fusing it to a 
number of other proteins.  Creating a fusion of T4Dnl with NF-ĸB p50 and T4Dnl bound 
to an artificial chimeric transcription factor improved ligation by 160 % (Wilson et al., 
2013). The addition of adenylate kinase to improve the solubility of T4Dnl has previously 
been studied (Liu et al., 2015), an additional benefit of this protein-protein fusion was 
that the ligation buffer could contain ADP instead of ATP for  phosphodiester bond 
formation  (Liu et al., 2015).  
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4.1.3 ATP degradation in buffers 
The addition of adenylate kinase (AK) to the N-terminus of T4 DNA ligase improved 
solubility of the protein (Liu et al., 2015). While solubility of T4Dnl is not primarily an 
issue, it is notably harder to get the same levels of soluble protein for the T4 RNA ligases. 
There was also the issue with different amounts of soluble protein after individual 
preparations for purifications (Nordlund et al., 2008) and this can also be seen when 
purifying the T4 NA ligases. Addition of AK to help improve solubility was thought to be 
a way to ensure maximum amounts of soluble T4 nucleic acid ligases. The real interest 
in this chimeric construction was the possibility that the ligases would be able to use 
ADP as a co-factor as well as ATP, offering a novel function to the T4 RNA ligases.  
 
ATP degradation in buffers is often used as a plausible reason for a decrease in ligase 
activity. This is usually remedied by making up new buffer with fresh ATP, while not 
overly time consuming this can become problematic when using large quantities of 
buffer or carrying out time dependent ligation. ATP breaks down to inorganic phosphate 
and ADP/AMP (Poldolsky and Morales, 1956; Hulett, 1970). ATP degradation at different 
temperatures and pH provide information on the best buffer storage conditions (Hulett, 
1970) and while this helps to reduce issues with buffer, it could be better to provide an 
enzyme that could restore ADP to ATP for ligation. 
 
It would be beneficial to both consumers and companies to produce a ligase that can 
work regardless of this degradation process, especially the T4 NA ligases which have 
varied rates of activity with different substrates (Bullard and Bowater, 2006). The 
adenylate kinase-T4Dnl ligase chimera has already been created (Liu et al., 2015) and 
while the study demonstrates that both portions of the new enzyme work, nothing was 
reported on the rates and whether ADP works as well as ATP for phosphodiester bond 
formation. The AK-T4 RNA ligases as chimeric enzymes have not been made previous to 
this work and are novel variants of the enzymes. 
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4.1.4 Adenylate Kinase 
Adenylate kinase (AK) is a nucleoside monophosphate (NMP) kinase which belong to a 
family of enzymes called phosphotransferases. In E. coli, AK is involved in the catalysis 
of AMP and ATP from ADP intermediates using magnesium as a cofactor (Glaser, Nulty 
and Vagelos, 1975; Saint Girons et al., 1987; Müller et al., 1996). The enzyme is 
comprised of 3 domains – the CORE domain, the LID domain and the AMP/NMP binding 
domain (Hayward, 2004) and has a mass of 23,585 Da (Figure 4.1) (Saint Girons et al., 
1987). The CORE domain is the part of the protein that remains fixed during phosphate 
movement, the LID domain covers the phosphates in the active site and the NMP binding 
domain is the binding site for AMP (Müller et al., 1996). Adenylate kinase has the ability 
to transfer a phosphate group resulting in the reversible conversion of AMP + ATP to 
2ADP. A structural conformational change occurs when adenylate kinase is bound to the 
substrate, from open to closed (Figure 4.2) (Müller et al., 1996; Metzenberg, 2002; 
Snow, Qi and Hayward, 2007). 
 
                  10         20         30         40         50 
MRIILLGAPG AGKGTQAQFI MEKYGIPQIS TGDMLRAAVK SGSELGKQAK  
        60         70         80         90        100 
DIMDAGKLVT DELVIALVKE RIAQEDCRNG FLLDGFPRTI PQADAMKEAG  
        110        120        130        140        150 
INVDYVLEFD VPDELIVDRI VGRRVHAPSG RVYHVKFNPP KVEGKDDVTG  
        160        170        180        190        200 
EELTTRKDDQ EETVRKRLVE YHQMTAPLIG YYSKEAEAGN TKYAKVDGTK  
        210  
PVAEVRADLE    KILG              
Figure 4.1. The protein sequence for E. coli adenylate kinase (AK). AK has 3 domains: the 
CORE domain (green), the AMP binding domain (red) and the LID domain (blue). Amino acids 
are designated following the standard single letter abbreviations.  
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Figure 4.2. The crystallographic structure of AK. The crystal structure of Adenylate kinase 
with the CORE domain (green), AMP binding domain (red) and LID domain (blue) highlighted. 
Adenylate kinase has two different conformational states, when a NMP is bound, regions 
between the 3 domains bend; the open state (left) when unbound and the closed state (right) 
with AMP (yellow spheres) bound (Müller and Schulz, 1992). PDB files 1AKE and 1ANK illustrated 
using CCP4MG software. 
 
When in the closed, bound conformation, adenylate kinase has 5 conserved arginine 
residues: Arg36, Arg88, Arg123 Arg156 and Arg167 that are involved in substrate binding 
(Yan, Shi and Tsai, 1990; Berry et al., 2006). Arg36 is in the AMP binding domain, Arg123 
is in the LID domain, the other conserved arginine residues sit between the three 
domains. Structural data suggested that Arg36, Arg88 and Arg156 are involved in AMP 
binding and Arg123 interacts with ADP in the  nucleotide binding site (Berry et al., 2006). 
When Arg138 was changed to lysine, the mutant adenylate kinase had a decrease in Kcat 
by a factor of 104, it is thought Arg138 is involved in transition state stabilisation (Yan, 
Shi and Tsai, 1990). The Asp89 residue holds the Mg2+ cofactor required by AK via two 
water molecules (Abele and Schulz, 1995; Schlauderer, Proba and Schulz, 1996). 
The idea of using adenylate kinase as a solubility tag (Liu et al., 2015) was repeated for 
the T4Dnl and the two T4 RNA ligases to determine if there was any effect on the protein 
solubility and substrate specificity of the ligases. When considering the sequence and 
structure of adenylate kinase it was necessary to note that the 3 domain sequences are 
at the N- terminus of the protein (Müller et al., 1996), joining another enzyme at this 
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point would likely prevent LID domain movement rendering the adenylate kinase 
portion of the new chimeric enzyme inactive. The new AK-ligases were tested with 8 
double stranded substrates and the hair-pin substrate to check if the addition of AK at 
the N- terminus of each of the T4 NA ligases affected the ligases substrate profile. The 
rates of the new ligases were also determined with both ATP and ADP in the buffer.  
 
4.2 Construction of Adenylate kinase ligases   
4.2.1 Recombinant Plasmid Construction 
Three new plasmids were designed (pRB552, pRB553 and pRB554) with the adenylate 
kinase gene sequence at the N- terminus of each of the T4 ligases. These plasmids were 
made using restriction digestion and ligation. The adenylate kinase gene (Adk) was pre-
ordered and synthesised in pUC57 (denoted pRB551) with the addition of NcoI and NdeI 
cut sites to allow for insertion into the plasmids containing the T4 nucleic acid ligase 
(pRB255, pRB256 and pRB257). 
 
4.2.1.1 Restriction Digestion  
To create the fragments required for the recombinant plasmids, the T4 ligase plasmids 
(pRB255, pRB256 and pRB257) and synthesised adenylate kinase (pRB551) underwent 
double digestion with NcoI and NdeI (ThermoFisher). The double digestion is specific to 
the formation of these recombinant plasmids and was set up as follows: 10 µl plasmid 
DNA (up to 1 µg), 10 µl sterile water, 1.25 µl NcoI, 1.25 µl NdeI and 2.5 µl ThermoFisher 
FD buffer. This was then incubated at 37 °C for up to 2.5 hours. To confirm digestion had 
been successful the samples were analysed on a 1 % agarose gel with 5 µl of 10 mg/ml 
ethidium bromide.  
 
4.2.1.2. Gel Extraction 
The double digested fragments containing the linearised vector and ligase for plasmids 
pRB255, pRB256 and pRB257; and the gene fragment for Adk underwent DNA extraction 
using the Bioline Isolate II PCR & Gel Kit. The manufacturer’s protocol was followed, the 
amount of DNA in each sample was quantified using the Thermo Scientific Nanodrop 
one quantification system.  
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4.2.2. Ligating the Adenylate Kinase Gene to the N- terminal of the T4 ligases 
To determine the ratio of vector to insert the following equation was used, this 
equation gives the ng of insert required for the specified ratio: 
 
(𝑛𝑔 𝑣𝑒𝑐𝑡𝑜𝑟 𝑥
𝑘𝑏 𝑖𝑛𝑠𝑒𝑟𝑡
𝑘𝑏 𝑣𝑒𝑐𝑡𝑜𝑟
)  𝑥 (
𝑚𝑜𝑙𝑎𝑟 𝑟𝑎𝑡𝑖𝑜 𝑜𝑓 𝑖𝑛𝑠𝑒𝑟𝑡
𝑚𝑜𝑙𝑎𝑟 𝑟𝑎𝑡𝑖𝑜 𝑜𝑓 𝑣𝑒𝑐𝑡𝑜𝑟
) 
 
This equation gives the amount of insert required in ng for a 1:1 ratio. The calculation 
was carried out for 1:1, 1:2, 1:3, 1:4 and 2:6. For the ligation reactions 50 ng of vector 
was used. The total sample volume for the ligation reaction was 8 µl, made up to this 
volume with nuclease free water. To this 1 µl of NEB T4 DNA ligase and 1 µl of 10x 
ligation buffer (Table 2.5.3) was added. The samples were incubated at 16 °C overnight. 
This was repeated for each ligation ratio for pRB255, pRB256 and pRB257 with adenylate 
kinase as the insert. The following day the total volume of ligation reaction was 
transformed into 50 µl Bioline α-select bronze cells, following the Bioline transformation 
procedure.  
 
To confirm whether AK had been added to the N- terminal as a tag, the plasmid was 
extracted (See 2.2.2) and sent for Sanger sequencing at Eurofins. Once the sequence 
was confirmed (Figure 4.4), the new plasmid DNA was transformed into BL21 pLysS E. 
coli cells for protein expression and purification. The new plasmids were denoted 
pRB552, pRB553 and pRB554 (Figures 4.3, 4.4 and 4.5) for the T4 DNA ligase, RNA ligase 
I and RNA ligase II, with adenylate kinase as the N- terminal tag, respectively. 
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Figure 4.3. The vector map for the fusion of AK and T4Dnl to form AKDnl (pRB552). The 
AK (Adk) gene is between the NcoI and NdeI restriction sites and the T4Dnl gene between the 
NdeI and BamHI restriction sites. This maps was created using the SnapGene software. 
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Figure 4.4. The vector map for the fusion of AK and T4Rnl1 to form AKRnl1 (pRB553). 
The AK gene (Adk) was between the NcoI and NdeI restriction sites and the T4Rnl1 gene between 
the NdeI and BamHI restriction sites. This map was created using the SnapGene software. 
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Figure 4.5. The vector map for the fusion of AK and T4Rnl2 to form AKRnl2 (pRB554). 
The AK gene (Adk) between the NcoI and NdeI restriction sites and the T4Rnl2 gene between 
the NdeI and BamHI restriction sites. This map was created using the SnapGene software. 
 
4.2.3. Protein Characterisation 
For protein induction and synthesis from 1 L of selective media see Chapter 2 – 2.3.1, 
2.3.2 and 2.3.3, Western blot analysis was carried out on the new AK-ligases to confirm 
the 10x his tag was still present when the new, larger proteins were expressed (see 
2.3.7). This tag is required for protein purification using the Ni-Hi Trap column. The 
proteins were purified using a Ni Hi-Trap column (See 2.3.4) and desalted using a pd10 
column (see 2.3.5). SDS-PAGE was used to determine the correct fractions for desalting 
from protein purification, fractions F3-F5 were selected for all AK-ligases (Figure 4.7) and 
also to confirm the increase in size of the AK-ligases when compared to the original 
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ligases (Figure 4.6) (see 2.3.6). The concentration of the AK-ligases was determined using 
the Bradford micro assay (see 2.3.8). 
 
4.2.4. Characterisation of biochemical activities 
The activity of these new ligases was observed using the end point ligation assay and 
the rates calculated using the time course ligation assay (see methods 2.4.1 and 2.4.2). 
To confirm activity of the adenylate kinase part of the fusion was functional, the end 
point ligation assay was set up (see 2.4.1) using 3 different buffer conditions – buffer 
without cofactor, buffer with ADP and buffer containing ATP.  The original T4 ligases are 
unable to ligate the break in the double stranded substrates when using ADP as the co 
factor in the buffer, if the adenylate kinase part of the new chimeric enzymes was 
functional then the conversion of ADP to ATP would allow the ligase half of the chimera 
to successfully ligate the breaks and form a phosphodiester bond. The time course 
reaction was also set up with ADP as the co-factor to determine the rate of ligation when 
relying on the AK part of the chimera to provide the ATP for phosphodiester bond 
formation.  
  
4.3 Adenylate kinase Ligase Activities 
4.3.1 Confirmation of AK-T4 Ligase DNA constructs 
To confirm the Adk gene had been successfully incorporated into the plasmid, the new 
plasmids were sent for Sanger sequencing at Eurofins. The new plasmids and pRB255, 
pRB256 and pRB257 were also digested using the restriction enzymes NcoI and BamHI. 
The digested plasmids were analysed using agarose gels containing ethidium bromide. 
The new AK-ligase plasmids were then compared to the original size of the T4 ligase 
plasmids.  
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Figure 4.6. Sequence analysis of the new AK-ligases. A) AKDnl, B) AKRnl1 and C) AKRnl2 
using the BioEdit software. Alignment shows the AK-ligase sequences, the original T4 ligase 
sequence (pRB255, pRB256 or pRB257) and the Adk gene sequence. The gene size increase was 
also confirmed using restriction enzyme digestion with both NcoI and BamHI (D). The expected 
sizes were: T4Dnl 1473 bp, AKDnl 2183 bp, T4Rnl1 1134 bp, AKRnl1 1844 bp, T4Rnl2 1014 bp 
and AKRnl2 1724 bp.  
 
4.3.2 Protein purification  
The induced AK-ligases were soluble (Figure 4.7) and the shift in ligase size was clear, 
the expected sizes were: AKDnl – 78.8 kDa, AKRnl1 – 67.1 kDa and AKRnl2 – 61.2 kDa 
(Figure 4.6). As the addition of AK has previously been reported to improve solubility of 
T4Dnl (Liu et al., 2015) it was necessary to check whether the addition of AK affected 
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IPTG induction for protein purification (Figure 4.7). This may affect the amount of 
protein purified for the AK ligases. The concentration of protein from different 
purification preparations of the T4 NA ligases and the AK ligases (Table 4.1) showed 
some differences, however these are not consistent and are not reproducible.  
 
Table 4.1. Differences in the concentration of purified protein for the T4 ligases and 
AK-ligases. Protein purified from 1 L of pelleted E. coli cells induced with 0.4 mM IPTG at 0.5 
OD600. Protein concentrations were calculated using the Bradford’s Assay protocol (See 2.3.8). 
Ligase Protein Concentration (mg/ml) 
Prep 1 Prep 2 
T4 Dnl 6.69 2.08 
AK-Dnl 2.94 6.95 
T4 Rnl1 3.77 2.59 
AK-Rnl1 2.04 4.97 
T4 Rnl2 3.64 2.37 
AK-Rnl2 9.2 6.46 
 
There are noted differences between the 2 protein preparations for each ligase which is 
a phenomenon that has been reported before for other proteins (Nordlund et al., 2008). 
The addition of AK to each of the ligases did not conclusively appear to impact the 
concentration of protein purified using the purification procedure detailed in this work.  
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Figure 4.7. IPTG induction trials of the T4 and AK ligases. Each induction was carried out 
with either 0.5 mM IPTG (A) or 1 mM IPTG (B) as detailed in section 2.3.2. The cells were lysed 
via sonication and the soluble and insoluble fractions separated by centrifugation. The insoluble 
pellet was resuspended in 20 ml 20 mM Tris 100 mM NaCl (pH 7.5). The soluble and insoluble 
fractions were analysed using SDS-PAGE.  
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Figure 4.8. Protein purification analysis using 10 % polyacrylamide SDS-PAGE. Elution 
fraction 3-10 from the protein purifications (see section 2.3.4) were analysed by SDS-PAGE for 
A) AKDnl, B) AKRnl1 and C) AKRnl2 to determine whether protein was successfully purified. The 
expected sizes of each ligase are: AKDnl 78 kDa, AKRnl1 67 kDa, and AKRnl2 61 kDa. 
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Figure 4.9. SDS-PAGE (10 % polyacrylamide) analysis of the T4 ligases and the modified 
AK-ligases. The addition of AK to the T4 nucleic acid ligases can be seen clearly by the size 
difference between the ligases. The expected sizes of each ligase are: T4Dnl 55 kDa, AKDnl 78 
kDa, T4Rnl1 43 kDa, AKRnl1 67 kDa, T4Rnl2 37.5 kDa and AKRnl2 61 kDa.  
 
4.3.3. Characterisation of the AK-ligases 
4.3.3.1 End point ligation analysis 
The three T4 ligases and the three AK-T4ligases were analysed using the end point 
ligation assay to determine whether the substrate profile for the ligases was altered. 
These profiles were also used to calculate the percentage ligation for each of the AK-
ligases with the 8 different double stranded substrates (Figure 4.10).  
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Figure 4.10. Urea-PAGE denaturation gels for the end point ligation reactions. These 
were used to determine substrate specificity and to calculate total ligation percentage of A) 
T4Dnl, B) AKDnl, C) T4Rnl1, D) AKRnl1 E) T4Rnl2 and F) AKRnl2 for each substrate. All of the 
ligated products are 20 bases in length, slight differences in their position in the gels was caused 
by the substrate composition (DNA/RNA). 
Chapter 4: Construction and Analysis of Adenylate Kinase-Ligases 
117 
 
Figure 4.11. Total ligation percentage from end point analysis. Ligation with double 
stranded substrates 1-8, with 1 mM ATP at 37 °C for 60 minutes. In each reaction 70 pmol of 
ligase and 45 pmol of substrate was added. The reactions were carried out in triplicate and 
analysed using Urea-PAGE and the bands on the gels were quantified using ImageJ.  
 
Addition of adenylate kinase at the N- terminal of the ligases does not appear to affect 
the total amount of ligated product when using a high amount of ligase compared to 
substrate (Figure 4.9).  
 
4.3.3.2 Initial rate of reaction analysis.  
When determining the rates of ligation, the amounts used were 2 pmol for T4Dnl and 
T4Rnl2 (and AKDnl and AKRnl2) and 600 pmol for T4Rnl1 (and AKRnl1) as per results by 
Bullard and Bowater (2006). The time course analysis was carried out as detailed in 
Chapter 2.4.2 for each of the enzymes and performed in triplicate to generate the error 
bars. The aliquots for each time point run on urea polyacrylamide gels (Figure 4.12) (See 
2.4.3) and the gel image data quantified using ImageJ software (Figure 4.13).  
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Figure 4.12. An example of time course ligation Urea-PAGE. Time course ligation for 2 
pmol T4Dnl with 540 pmol substrate 7, incubated at 37 °C with ligation buffer containing ATP 
(Table 2.5) analysed using 15% acrylamide urea gels. The ligation reactions were run for 30 
minutes as the reaction goes to completion at this point (Figure 3.18). 
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Figure 4.13. Time course ligation analysis for the T4 NA ligases and the AK-ligases. 
Carried out over 30 minutes at 37 ⁰C, comparing each T4 nucleic acid ligase with the new AK-
ligases; using 540 pmol of substrate 7 with 2 pmol of T4Dnl, AKDnl, T4Rnl2 and AKRnl2; and 600 
pmol T4Rnl1 and AKRnl1. Each ligation was performed in triplicate to determine the standard 
deviation used create the error bars. The ligated and non-ligated bands from time course gels 
were quantified using ImageJ software to calculate the percentage of ligated substrate.  
 
 
The time course ligation analysis was used to determine the rate of ligation for the initial 
4 minutes of the incubated reaction. Different amounts of enzyme were used (2 pmol 
or 600 pmol) to obtain a similar ligation percentage over the initial 4 minutes of the 
reaction (Figure 4.12 and 4.13). The results are presented and discussed in Table 4.2.   
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Figure 4.14. Initial ligation rate analysis of the T4 ligases and the AK-ligases. For the time 
course reactions 2 pmol of T4Dnl, AKDnl, T4Rnl2 and AKRnl2 was used; and 600 pmol of T4Rnl1 
and AKRnl1 (inset results). The percentage of ligated product was calculated from the time 
course gels using ImageJ. From this it was possible to determine the amount of ligated substrate 
in pmol. This number was divided by the amount of substrate used in pmol to give the amount 
ligated (mol nicks joined/ mol protein). The amount ligated in the first 5 minutes of the time 
course reactions in much lower with Rnl1 and AKRnl1 (inset), Dnl, AKDnl, Rnl2 and AKRnl2 
showed comparable amounts of ligated substrate 7. The initial rate of reactions demonstrate a 
linear relationship, indicating the constant utilisation of 20 b substrate 7 to form repaired 20 b 
substrate 7.  
 
4.3.4 Adenylate Kinase Activity 
Analysis of cofactor utilisation was carried out using end point ligation with 1 mM of 
either ADP or ATP added to the buffer. A control sample containing no ADP or ATP was 
also set up to demonstrate necessity of the co-factor for ligation with substrate 7 (Figure 
4.15).  
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Figure 4.15. End point ligation analysis of the T4 nucleic acid ligases and the AK-ligases 
with ADP and ATP. To determine whether the AK-ligases could utilise both ADP and ATP for 
ligation. The end point ligation reactions were set up with the different ligases (70 pmol) and 
with 45 pmol of substrate 7 at 37 °C using buffer with no co-factor, 1 mM ADP or 1 mM ATP. The 
reactions were incubated for 30 minutes before quenching with 10 µl 1x stop solution and 
analysed using urea-PAGE. The AK-ligases could utilise ADP or ATP for ligation, while the T4 
ligases could only use ATP. Ligation was not possible when there was no cofactor.   
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Buffer containing ADP instead of ATP was utilised by the AK-ligases, converting ADP to 
ATP for incorporation by the ligases for phosphodiester bond formation. Where no co-
factor was included in the buffer, no ligation was noted (Figure 4.15).  
 
4.3.5 Ligation Rates with ADP as cofactor 
The initial rates of ligation were compared when using both ADP and ATP as a cofactor 
for the AK-ligases (Figure 4.15). All reactions were repeated in triplicate with error bars 
showing the standard deviation. The rates of ligation for the AK-ligases when using ADP 
or ATP are comparable, with AKDnl and AKRnl1 working slightly better with ADP (Table 
4.2).  
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Figure 4.16. Rates of ligation for A) AKDnl, B) AKRnl1 and C) AKRnl2. All rates were 
carried out in triplicate with double stranded substrate 7 using either ADP or ATP as the co-
factor for phosphodiester bond formation. The amount ligated by the AK-ligases is comparable 
when using either ADP or ATP. AKDnl and AKRnl1 had better rates of ligation when using ADP.  
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Table 4.2. Rates of nick joining in double-stranded substrate 7. The AK-ligases used both 
ADP and ATP as the co-factor for ligation. The rates of ligation suggest the AK-ligases are able 
to utilise both ADP and ATP for phosphodiester bond formation.  
Ligase Rate of ligation at 37 ⁰C 
(mol nicks joined/mol protein/min) 
1 mM ADP 1 mM ATP 
T4Dnl - 28.59 (+/- 2.2) 
T4Rnl1 - 0.11 (+/- 0.005) 
T4Rnl2 - 26.28 (+/- 7.9) 
AKDnl 39.513 (+/- 1.75) 29.54 (+/- 8.3) 
AKRnl1 0.11 (+/- 0.018) 0.09 (+/- 0.015) 
AKRnl2 34.95 (+/- 4.68) 34.8 (+/- 1.04) 
 
4.3.6 AKRn1 specific analysis 
Total ligation percentage with AKRnl1 was notably higher than that of T4Rnl1 when 
carrying out the time course experiments (Figure 4.13), the addition of AK to T4Dnl and 
T4Rnl2 resulted in little difference in the total ligation percentage. Further analysis was 
carried out by using lower amounts of both ligases (60, 150, 300 and 600 pmol) with 540 
pmol of substrate 7 over 30 minutes, in the case of AKRnl1 both ADP and ATP were used 
(Figure 4.17).  
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Figure 4.17. The effect of different concentrations of T4Rnl1 and AKRnl1 for ligation of 
standard substrate 7. A) Urea-PAGE denaturation analysis of Rnl1 and AKRnl1, with 1 mM  
ADP or 1 mM ATP for end point ligation analysis with 540 pmol of substrate 7; B) triplicate 
analysis of the end point ligation with different amounts of Rnl1 and AKRnl1. When using 150 
pmol of AKRnl1 with both ADP and ATP, total ligation remains at 75 %, compared to 45 % with 
150 pmol of T4Rnl1 using 1 mM ATP.  
 
When utilising either ADP or ATP, AKRnl1 was shown to work at the same capacity 
when using ¼ of the amount of enzyme. To obtain 70 % ligation of substrate 7, 600 
pmol of T4Rnl1 was needed, while 150 pmol of AKRnl1 was used. The same result was 
observed for AKRnl1 with both ADP and ATP (Figure 4.17).  
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Another substrate to consider is the hairpin substrate which mimics the structure 
T4Rnl1 would encounter in vivo. In vivo T4Rnl1 ligates nicks in the tRNA anticodon loop 
(Amitsur, Levitz and Kaufmann, 1987). A synthesised version of this structure, made up 
of 18-mer and 15-mer oligonucleotides, with fluorescein attached to the 15-mer 
oligonucleotide, was also tested with each of the ligases. The addition of AK to T4Rnl1 
does not affect the efficiency of ligation for the hairpin substrate (Figure 4.18).  
 
 
Figure 4.18. Ligation of the hair pin substrate with each of the original T4 nucleic acid 
ligases and the new AK-ligases. The 33-mer band indicates ligated substrate, 70 pmol of each 
enzyme was incubated with 45 pmol of hairpin substrate and ligase buffer with ATP at 37 °C for 
30 minutes. Urea-PAGE analysis was carried out for each ligase/substrate reaction. The addition 
of AK to Rnl1 does not affect the ligation of the hairpin substrate. 
 
4. 4 Discussion  
The joining of adenylate kinase to the three different T4 ligase enzymes was successful 
in generating chimeric enzymes with altered biochemical activities. The construction of 
these novel enzymes has resulted in a new set of T4 RNA ligases that are able to use ADP 
as a cofactor for ligation instead of ATP at the same, if not a better rate than the original 
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ligases. The methods used to create these new functional chimeric enzymes 
demonstrate that traditional cloning methods, restriction enzyme digestion and ligation, 
are still a robust way to make constructs when inserting whole genes. As each of the T4 
ligases are distinctly different from each other it is important to consider the AK-ligases 
as individual enzymes and asses the rates and function of these new enzymes when 
compared to their original ligase counterpart. 
 
4.4.1 AK-ligase functionality and protein purification 
The original paper published with AK as a solubility tag for T4Dnl reported an increased 
amount of soluble protein when using AK as an N- terminal tag (Liu et al., 2015). Protein 
solubility was not something that was calculated when adding AK to the T4-ligases. The 
effect of the AK-ligase fusions and the concentration of IPTG required for induction was 
checked (Figure 4.7). It was not possible to calculate solubility from these gel because 
the gels do not contain known protein concentrations as a standard. Also the gel lanes 
are quite smeary, making it difficult to single out the bands corresponding to the ligases 
and ligase fusions only. Obtaining enough purified protein for each of the T4 ligases is 
not something I’ve identified as an issue and in all instances more than enough protein 
was purified for the ligation reactions. Comparison of purified protein for the AK-ligases 
when compared to the original T4 nucleic acid ligases from this work was difficult to 
determine because the two preparations and purifications for each protein yield such 
different amounts of protein. This is an issue that has been well reported (Petsev et al., 
2000; Bondos and Bicknell, 2003; Golovanov et al., 2004) and while the addition of AK 
to the ligases in no way hindered the purification, it was not possible in this instance to 
comment on improvement to solubility of the T4 nucleic acid ligases. It is possible that 
differences in purification methods by the published data (Liu et al., 2015) and the 
methods used in this work may result in differences in solubility and therefore amount 
of purified protein. 
 
The three adenylate kinase fusions were able to not only ligate double stranded 
substrates but also used ADP as the co-factor for phosphodiester bond formation. The 
T4 nucleic acid ligases are usually only able to form this bond using ATP, the T4 nucleic 
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acid ligases with no co-factor or with ADP as the co-factor were unable to successfully 
ligate the double stranded substrates. The AK-ligases were able to ligate the double 
stranded substrates with both ADP and ATP, confirming functionality of both parts of 
these new fusion ligases. In all instances, both the T4 NA ligases and the AK-ligases were 
unable to create a phosphodiester bond between the 8-mer and 12-mer 
oligonucleotides when no co-factor was included in the ligation buffer. There is no 
difference in ligation profile from end point ligation for the AK-ligases and the original 
T4 ligases with different double stranded DNA/RNA combination substrates.  
 
4.4.2 Rates of ligation for the AK-ligases 
The rates of the new AK-ligases are comparable to the rates of the unmodified T4 nucleic 
acid ligases. The addition of another functional enzyme at the N- terminus of the T4 
nucleic acid ligases permits ligation by the ligase part and also adds the function of 
converting ADP to ATP for phosphodiester bond formation.   
 
The initial rate of AKRnl1 is similar to that of T4Rnl1, however it is very clearly seen that 
the total amount of ligation carried out by this enzyme when carrying out the time 
course ligation was higher than the T4Rnl1. Further analysis into this showed that in fact 
ligation could continue to go to 70 % using only 150 pmol of AKRnl1 in the reaction, 
which was ¼ of the amount required when using T4Rnl1 (Figure 4.14). The rate of 
ligation for AKDnl and AKRnl2 were both slightly increased when compared to the 
unmodified T4 ligase (Figure 4.11). Addition of AK to the N- terminus of the ligases, does 
not alter the rate of ligation of the AK-ligases. 
 
4.4.3 ADP vs ATP as a cofactor 
For all of the AK-ligases, the ligation assay was carried out using ADP in place of ATP as 
the cofactor in the buffer. For all AK-ligases it was clear that in the presence of ADP with 
the adenylate kinase attached the ligase portion of the enzyme was able to ligate, the 
T4 NA ligases were used as the control for this with all enzymes tested with no cofactor, 
ADP and ATP (Figure 4.12). The rates of ligation for each new AK-ligase with ADP or ATP 
were then performed in triplicate, an interesting observation for both AKDnl and AKRnl1 
Chapter 4: Construction and Analysis of Adenylate Kinase-Ligases 
129 
 
is that these ligases have an improved rate of ligation when using ADP as the co-factor 
for ligation (Figure 4.13). This may be due to localisation of ATP for these new enzymes, 
it was immediately ready for the ligases to use in phosphodiester bond formation. The 
T4 nucleic acid ligases create a ligase-ATP intermediate before forming the 
phosphodiester bond. The lysine residue in motif I binds to the ATP, localisation of the 
ATP for use by the ligase may contribute to improved activity as the same reaction using 
ATP only.  
 
4.5 Conclusion 
This is the first time chimeric versions of the T4 RNA ligases have been constructed and 
shown to be functional. A lot of work has previously focussed on changing or modifying 
T4 DNA ligase as this is a more commonly used enzyme in molecular biology techniques. 
The T4 RNA ligases are also useful tools in a number of techniques and as such it is 
important to explore ways to improve these ligases. This work has demonstrated that 
addition of another protein at the N- terminus of the T4 nucleic acid ligases yields 
functional enzyme fusions. In this instance the addition of AK allows for phosphodiester 
bond formation from ADP, where AK can readily convert ADP to ATP for use by the ligase 
part of the fusion.  
 
Not only are these fusion enzymes functional, but in the case of AKRnl1 a lower amount 
of ligase can be used to obtain the same ligation result as the unmodified version. From 
an industrial perspective, this provides a way to lower costs for production of this ligase, 
from each round of purification of AKRnl1, ¼ of the amount of ligase is needed for 
successful ligation, therefore a single purification technically allows for 4 times more 
ligation activity. The additional function for all of the AK-ligases to utilise ADP and ATP  
was also desirable and remedies some issues with co-factor degradation in buffer 
(Hulett, 1970). This successful protein-protein fusion opens the way to other fusions 
with the T4 nucleic acid ligases and the possibility to remedy some of the issues with 
these ligases by addition of another functional protein to the ligases.  
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Chapter 5: Fusion of T4 Polynucleotide Kinase and NA 
Ligases 
 
5.1.1 T4 Polynucleotide Kinase 
Polynucleotide Kinase (T4Pnk) is an enzyme found in the genomes of both T7 and T4 
bacteriophages. It was originally discovered in E. coli that had been infected with T-even 
phage, specifically T2 and T4, which were able to transfer the γ-phosphate from ATP to 
the 5’-hydroxyl terminus of a polynucleotide (Richardson, 1965). T4Pnk is a transferase 
responsible for converting 5’OH and 3’PO4 to 5’PO4 and 3’OH from broken ends of DNA 
and RNA which primarily involves the removal and reattachment of phosphate (Wang 
and Shuman, 2001), once altered it is possible for the break to be repaired by the T4 
ligases.  Polynucleotide kinases/phosphatases with similar biochemical functions are 
found in other organisms; there are conserved residues amongst these enzymes but 
there are significant differences in the DNA binding sites especially when comparing 
eukaryotic and phage polynucleotide kinases/phosphatases (Galburt et al., 2002; 
Weinfeld et al., 2011).  
Figure 5.1. T4Pnk and T4Rnl1 DNA/RNA strand repair and ligation. For phosphodiester 
bond formation between the break, the PO4 must be at the 5’ position. In E.coli this DNA/RNA 
break can be found in the tRNA anticodon loop. Structures, 1LTQ (T4Pnk) and 2C5U (T4Rnl1), 
illustrated using CCP4MG software.  
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T4Pnk is a vital enzyme required during viral replication and phosphodiester bond 
formation alongside the T4 DNA and RNA ligases. The T4Pnk protein in vivo is part of the 
virus response to host defences: when the T4 bacteriophage infects E. coli, the 
bacterium responds by causing breaks in its own tRNA anticodon loop and initiating its 
own death (Sirotkin et al., 1978; Galburt et al., 2002). T4 phages have short polypeptides 
on their surface called Stp polypeptides. These Stp polypeptides activate an anticodon 
nuclease which cleaves the bacterial tRNA and, as a consequence of host cell death, viral 
protein synthesis is also halted (See section 1.5.2) (Penner et al., 1995; Blanga-Kanfi et 
al., 2006). To combat this host response system the T4 bacteriophage repairs these 
breaks using the T4Pnk protein and T4Rnl1 (Figure 5.1). The T4Pnk is able to correctly 
prime the ends of DNA and RNA to ensure the 5’ PO4 and 3’ OH are available for 
phosphodiester bond formation by the ligase (Penner et al., 1995; Galburt et al., 2002; 
Wang et al., 2002).  
 
        10         20         30         40         50 
MKKIILTIGC PGSGKSTWAR EFIAKNPGFY NINRDDYRQS IMAHEERDEY  
        60         70         80         90        100 
KYTKKKEGIV TGMQFDTAKS ILYGGDSVKG VIISDTNLNP ERRLAWETFA  
       110        120        130        140        150 
KEYGWKVEHK VFDVPWTELV KRNSKRGTKA VPIDVLRSMY KSMREYLGLP  
       160        170        180        190        200 
VYNGTPGKPK AVIFDVDGTL AKMNGRGPYD LEKCDTDVIN PMVVELSKMY  
       210        220        230        240        250 
ALMGYQIVVV SGRESGTKED PTKYYRMTRK WVEDIAGVPL VMQCQREQGD  
       260        270        280        290        300 
TRKDDVVKEE IFWKHIAPHF DVKLAIDDRT QVVEMWRRIG VECWQVASGD  
 
F                 
Figure 5.2. The amino acid sequence for T4Pnk. The residues required for 5’ kinase activity 
(green) and 3’ phosphatase activity (blue) (Galburt et al., 2002; Wang, Lima and Shuman, 2002). 
Amino acids are designated following the standard single letter abbreviations. 
 
T4Pnk is involved in two distinct biochemical activities, kinase and phosphatase which 
are separated by localisation to either the N- or C- terminus (Figures 5.2 and 5.3). T4Pnk 
requires magnesium for these two distinct activities (Galburt et al., 2002). The N-
terminus is responsible for kinase activity through the addition of phosphate. The amino 
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acids identified as crucial for this reaction are K15, S16, D35, R38 and R126 (Figure 5.2); 
mutagenesis of these residues to alanine resulted in a total loss of kinase activity but 
had no effect on phosphatase activity (Galburt et al., 2002; Wang, 2002). The active site 
tunnel includes residues K15, S16, D35 and R126, the AMP phosphate makes contact 
with the side chains of R38 (Galburt et al., 2002).   
 
The phosphatase activity, removal of phosphate, is localised to the C- terminus; 
mutagenesis studies have shown that the amino acids involved in this site’s activity are 
D165, D167, R176, R213, D254 and D278 (Figure 5.2). Mutation of these residues to 
alanine inactivate phosphatase activity but had no impact on kinase activity (Galburt et 
al., 2002; Wang, Lima and Shuman, 2002). When transferring phosphate, D165 is 
responsible for attacking the 3’ phosphorous, the phosphate oxygen’s make contact 
with D167 which goes on to form a salt bridge with R213 (Galburt et al., 2002). D254 is 
involved in substrate binding, D278 is involved in metal binding and was modelled in 
close proximity to the magnesium ion; the role of R176 is unclear, it is furthest from the 
binding site (Galburt et al., 2002).  
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Figure 5.3. The crystallographic structure of T4Pnk. The N- terminus with amino acids 
responsible for kinase activity highlighted (green) and the C- terminus with the phosphatase 
activity amino acids highlighted (blue). PDB file 1LTQ illustrated using CCP4MG software.  
 
5.1.2 Molecular techniques that use Polynucleotide Kinase 
T4Pnk is also  widely used for in vitro molecular biology protocols that manipulate DNA 
and RNA, with the following processes being identified: end-labelling of DNA and RNA 
for use as probes and nucleic acid sequencing (Chaconas and van de Sande, 1980); 
addition of 5'-phosphates to oligonucleotides to allow subsequent ligation into DNAs 
and removal of 3'-phosphoryl groups (Weinfeld et al., 2011).  
 
5.1.3 A T4Pnk-ligase fusion for Next Generation Sequencing  
A type of small RNA (sRNA) molecule called micro RNAs (miRNA) have a significant role 
in gene expression; miRNAs are usually 17-22 nucleotides long and can bind to  mRNA 
to prevent translation or cause mRNA decay (Motameny et al., 2010; Martin, Wani and 
Steptoe, 2014). A number of pathways involve miRNAs and recent research has started 
quantifying different miRNAs associated with a number of pathological conditions – 
offering a non-invasive method for disease identification and monitoring (Zhao et al., 
2010; Pogue et al., 2014; Hill and Lukiw, 2016; Agrawal et al., 2018). Identification and 
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quantification of miRNAs relies heavily on the technique of next generation sequencing 
(NGS) (Xu et al., 2015). NGS is comprised of 4 main steps: library preparation, cluster 
generation, sequencing and data analysis. One of the first steps in library preparation of 
miRNAs is adenylation of adapters and miRNAs, and ligation of the adapters to the 
miRNAs (Figure 5.4). This process uses the T4 nucleic acid ligases to attach the adapters, 
and the choice of ligase is often dependent on manufacturer’s products, master mixes 
and protocols (Head et al., 2014).  
 
 
Figure 5.4. The ligation of adapters to miRNAs. The T4 RNA ligases are both used for 
adapter ligation to miRNAs. A truncated version of T4Rnl2 is used for the first step to ensure 
only pre-adenylated 3’ adapters can be ligated, and this is followed by ligation with T4Rnl1 to 
ligate the 5’ adapter (Head et al., 2014). 
 
The changes in levels of miRNAs have been suggested as a diagnostic tool for different 
cancers, including breast, pancreatic and ovarian cancers (Mitchell et al., 2008; Taylor 
and Gercel-Taylor, 2008; Zhao et al., 2010). When sequencing miRNAs though it was 
noted that there were frequent miscalculations of the number of miRNAs, sometimes 
by as much as 4 orders of magnitude, resulting in differences between the actual 
abundance of miRNAs and the calculated amount (Hafner et al., 2011). Adapter addition 
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to miRNAs is only possible when the ends are correctly primed and the miRNA has 5’PO4 
(Head et al., 2014). In instances where the 5’ end is not PO4 ligation cannot occur and 
quantification results would show lower levels of miRNAs being detected. From the 
current NGS methods it is not possible to determine whether low levels of quantified 
miRNA are attributed to amounts of miRNA produced in the sample or whether the 
miRNA was not fully ligated to the adapter and, therefore, not detected. This 
problem would not be apparent with current methodologies as the focus has been on 
adapter ligation bias (Xu et al., 2015) and modifying adapters to improve adapter/miRNA 
ligation for miRNA quantification.  
 
Parkinson’s Disease (PD) is often an age related condition where in older age the Dicer 
enzyme, involved in miRNA maturation, may be down regulated resulting in a reduction 
in the number of miRNAs processed (Vinnikov and Domanskyi, 2017). Another enzyme 
involved in miRNA maturation is the ribonuclease II enzyme, Drosha, which cleaves and 
determines the 5’ and 3’ nucleotides. It seems sensible to deduce that if either Dicer or 
Drosha are not working correctly then there may be mis-priming of the miRNA  (Tulay 
and Sengupta, 2016). These miRNAs would not be detected using current methodologies 
as the T4 ligases would not be able to ligate the adapters to the miRNA for quantification 
or detection.  A study has shown that removing the proteins required for preparation of 
mature miRNAs has an effect on miRNA levels and may lead to incorrect end priming 
(Kumar et al., 2007). At present the protocols for adapter-miRNA ligation do not include 
a miRNA priming step, which would ensure that all miRNAs in the sample could be 
ligated and detected for quantification. As levels of miRNA have been attributed to 
certain diseases it would be of interest to understand whether this change in miRNA 
amount is an actual lower amount of miRNA or whether miRNAs are incorrectly 
processed and, as such, use the latter as a possible therapeutic target.  
 
5.1.4 Other uses for a T4Pnk-ligase fusion 
It is proposed that a chimeric enzyme, which is a combined version of T4Pnk and the T4 
nucleic acid ligases, would ensure the ligation step in adapter attachment during NGS is 
successful and any bias encountered is not due to incorrectly primed ends, saving time 
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and money for researchers using this technique. The T4Pnk-fusions would become a 
time saving step for any methodologies that use T4Pnk and the T4 ligases at separate 
steps.  
 
The uses of this chimeric enzyme would not be limited to NGS and could be used for 
ligation in dumbbell shaped DNA probes too (Qing et al., 2017). Another technique that 
utilises both T4Pnk and T4Rnl1 is high-throughput sequencing of RNA isolated by 
crosslinking immunoprecipitation (HITS-CLIP) (Darnell, 2010). HITS-CLIP is a technique 
that uses both T4 RNA ligases and T4Pnk to map protein-RNA binding sites and RNA 
modification (Figure 5.5). This technique has successfully demonstrated RNA-protein 
interactions in the brains of mice and was also used to look at RNA binding capacity of a 
90 kDa RNA binding protein (RNABP), a mutated protein in a recessively inherited 
Parkinson’s-like disorder (Chi et al., 2009; Darnell, 2010). HITS-CLIP has also been used 
to identify miRNA-mRNA interactions (Thomson, Bracken and Goodall, 2011).  
 
Figure 5.5. HITS-CLIP mRNA protocol (Thomson, Bracken and Goodall, 2011). Each step 
modifies the mRNA for sequencing. Prior to step 1 the mRNA is cross linked, immunoprecipitated 
and treated with RNAse A and Alkaline Phosphatase. Step 1: Addition of the 3’ RNA adapter with 
either T4 RNA ligase; 2) T4Pnk addition to prime the 5’ end for ligation; 3 and 4) SDS-PAGE and 
gel extraction; 5) Addition of the 5’ adapter using a either T4 RNA ligase. After step 5 the mRNA 
undergoes reverse transcription, PCR and deep sequencing.  
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Another more common use for both T4Pnk and the T4 nucleic acid ligases is blunt end 
ligation (Gao et al., 2015). Blunt ended inserts from restriction enzyme digestion are 
already phosphorylated but blunt ended inserts produced by PCR need to be 
phosphorylated and this is often achieved with T4Pnk (Gao et al., 2015). After this step 
the ligation reaction can be set up and T4Dnl is used for this ligation step. As there are a 
number of methodologies that use both T4Pnk and the T4 nucleic acid ligases, it would 
be beneficial to have fusion T4Pnk-ligases. This is particularly the case when these 
enzymes are often used in subsequent steps because a fusion T4Pnk-ligase would mean 
a one-step process, saving time and costs. 
 
5.2 Construction of T4Pnk-ligases 
5.2.1 Recombinant Plasmid Construction 
The T4 polynucleotide kinase gene (pseT) was ordered from (Genscript) and synthesised 
on the plasmid pUC57. The pseT gene was added to the N- terminus of the T4 NA ligase 
plasmids (pRB255, pRB256 and pRB257) by restriction digestion and ligation. 
 
5.2.1.1 Restriction Digestion and PCR 
The synthetic gene was designed with the NcoI cut site at the N- terminus and NdeI at 
the C- terminus. This allowed double digestion using NdeI and NcoI (ThermoFisher) and 
ligation cloning into the pET16b vectors containing the different T4 NA ligases (pRB255, 
pRB256 and pRB257). The new constructs were denoted pRB560 (PnkDnl) pRB561 
(PnkRnl1) and pRB562 (PnkRnl2) (Figures 5.6, 5.7 and 5.8). The pseT gene was also 
cloned into pET16b on its own, named pRB576. To isolate the pseT gene for cloning into 
pRB576, PCR was used to insert the BamHI cut site at the C- terminus of the gene (Table 
5.1). The NEB Q5 mutagenesis kit was used as per the manufacturer’s instructions, the 
primers were designed and ordered from Eurogentec and an annealing temperature of 
59 °C was used. This allowed for double digestion using NcoI (ThermoFisher) and BamHI 
(ThermoFisher) to isolate the pseT gene, the pET16b plasmid was also digested with 
these enzymes. The reactions were set up with 12 µl plasmid DNA (up to 1 µg), 1.25 µl 
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BamHI, 1.25 µl NcoI, and 2.5 µl FD buffer. The digestions underwent incubation at 37 ⁰C, 
180 rpm for up to 2.5 hours.  
 
Table 5.1. The primers designed for BamHI insertion at the C- terminus of pseT; the 
lower case sequences (red) is the BamHI cut site.  
Primer Name Primer sequence 5’ to 3’ 
PnkBamHI F ggatccCATATGATTCTTAAAATTCTGAACG 
PnkBamHI R AAAATCTCCCGAAGCGAC 
 
 
5.2.1.2 Agarose Gel Extraction 
The digested linearised plasmids (pRB255, pRB256 and pRB257) and the pseT gene were 
extracted using the Bioline Isolate II PCR & Gel Kit (see Section 2.2.4). The 
manufacturer’s protocol was followed and the DNA quantified using the Thermo 
Scientific Nanodrop one quantification system.  
 
5.2.1.3 Ligating the pseT gene into pRB255, pRB256 and pRB257 
The pseT insert and pET16b cut plasmid were ligated using T4 DNA ligase using the same 
process as the AK-ligases (see Section 4.2.3). The resultant ligation was transformed into 
50 µl α-select E. coli cells (available from Bioline, see Section 2.2.6). 
 
5.2.1.4 Confirmation of the recombinant pseT-ligase plasmids 
The new plasmids containing pseT at the N- terminus of each of the T4 nucleic acid 
ligases (pRB560, pRB561 and pRB562) (Figures 5.6, 5.7 and 5.8) underwent double 
digestion with NcoI and BamHI (see Section 2.2.5) to confirm a change in size of the 
sequence between these cut sites (Figure 5.10). The plasmids were also sent to Eurofins 
for Sanger sequencing (i54 Business Park, Valiant Way, Wolverhampton, WV9 5BG, UK). 
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Figure 5.6. Plasmid map for the fusion of Pnk and T4Dnl to make PnkDnl (pRB560). This 
map details the addition of T4Pnk at the N- terminus of T4Dnl using the NcoI and NdeI restriction 
sites. Plasmid maps were created using SnapGene software. 
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Figure 5.7. Plasmid map for the fusion of Pnk and T4Rnl1 (pRB561). The map details the 
addition of T4Pnk at the N- terminus of T4Rnl1 using the NcoI and NdeI restriction sites. Plasmid 
maps were created using SnapGene software. 
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Figure 5.8. Plasmid maps for the fusion of Pnk and T4Rnl2 (pRB562). The map details the 
addition of T4Pnk at the N- terminus of CT4Rnl2 using the NcoI and NdeI restriction sites. Plasmid 
maps were created using SnapGene software.
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5.2.2 Protein Characterisation 
The plasmids were transformed into E. coli BL21 (DE3) cells for protein synthesis (see 
Section 2.2.6). The new proteins, with T4Pnk at the N- terminus, were induced and 
synthesised in 1 L of selective LB media (see Sections 2.3.1, 2.3.2 and 2.3.3). Western 
blot analysis was carried out (see Section 2.3.7) to confirm the 10x His tag was still 
present for purification (Figure 5.11). The soluble fraction was purified using a Ni-Hi Trap 
column (see Section 2.3.4) and fractions 4-6 pooled and the salt removed using a PD10 
column (see Section 2.3.5). The purification fractions were analysed using 10 % SDS-
PAGE (Figures 5.9 and 5.10) (see Section 2.3.6). The amount of purified T4Pnk-ligase 
protein was quantified using the Bradford Assay (see Section 2.3.8). 
 
5.2.3. Protein Analysis and activity 
A number of ligation assays were set up (see Sections 5.2.3.1 and 5.2.3.2) and analysed 
using urea-PAGE (see Section 2.4.3) and ImageJ software.  
 
5.2.3.1 Endpoint Ligation Analysis 
The end point ligation assays were carried out as stated in chapter 2 (see Section 2.4.1). 
A second set of substrates were made using modified versions of the DNA and RNA 
oligonucleotides (Table 5.2). The Pnk versions of LigSub1 and LigSub2 contained a 
phosphate at the 3’ end of LigSub1 and no modification to LigSub2. (Tables 5.2 and 5.3, 
Figure 5.9) This allowed activity of the Pnk part of the fusion to be tested because, for 
the ligase to form the phosphodiester bond, the phosphate needs to be in the 5’ 
position. These oligonucleotides were combined as stated in Chapter 2 (see Section 2.4, 
Figures 2.4 and 5.9) to make 8 different 20-mer/40-mer substrates that were a 
combination of DNA and RNA (Table 5.3). The large oligonucleotides (18b and 22b) were 
used to make longer versions of substrate 1 and 7 only.
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 Table 5.2. The oligonucleotides used to create the Pnk substrates. The 20-mer/40mer 
backbone was the same as the one used for the standard 20 bend point ligation substrates (Table 
2.3). Where oligonucleotides include ‘+Flu’ – addition of fluorescein or ‘+P’ – addition of 
phosphate, denotes a specific modification at the 5’ position. The 18 b and 22 b oligonucleotides 
were used to make a 40 b substrates. 
 
 
 
 
 
 
 
 
Oligonucleotide 
Name 
Backbone Sequence 5’ – 3’ Modification 
PnkLigSub1 (8b) DNA GGC-CAG-TG Flu at 5’ end 
Phosphate at 3’ end 
PnkLigSub2 (12b) DNA AAT-TCG-AGC-TCG - 
PnkLigSub1 (18b) DNA GTA-AAA-CGA-CGG-CCA-
GTG 
Flu at 5’ end 
Phosphate at 3’ end 
PnkLigSub2 (22b) DNA AAT-TCG-AGC-TCG-GTA-
CCC-GGG-G 
- 
PnkRNALigSub1 
(8b) 
RNA GGC-CAG-UG Flu at 5’ end 
Phosphate at 3’ end 
PnkRNALigSub2 
(12b) 
RNA AAU-UCG-AGC-UCG - 
PnkRNALigSub1 
(18b) 
RNA GUA-AAA-CGA-CGG-GCA-
GUG 
Flu at 5’ end 
Phosphate at 3’ end 
PnkRNALigSub2 
(22b) 
RNA AAU-UCG-AGC-UCG-GUA-
CCC-GGG-G 
- 
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Table 5.3. The eight 20 b Pnk substrates created using the Pnk oligonucleotides. The 
three components for each substrate are PnkLigSub1 (blue, Table 5.2), PnkLigSub2 (red, Table 
5.2) and the LigSub1+2 (purple) complementary strand from Table 2.3. The phosphate (P) is at 
the 3’ end of PnkLigSub1 (Figure 5.9) for transfer to the 5’ end of PnkLigSub2 before ligation can 
occur. 
Name Substrate (filled = DNA, hatched = RNA) 
Pnk 
Substrate 1 
5’ P  3’ 
3’ 5’  
Pnk 
Substrate 2 
5’ P    3’ 
3’ 5’ 
Pnk 
Substrate 3 
5’ P 3’ 
3’ 5’ 
Pnk 
Substrate 4 
5’ P    3’ 
3’ 5’ 
Pnk 
Substrate 5 
5’ P 3’ 
3’ 5’ 
Pnk 
Substrate 6 
5’                               P                                    3’ 
3’ 5’ 
Pnk 
Substrate 7 
5’ P 3’ 
3’ 5’ 
Pnk 
Substrate 8  
5’ P 3’ 
3’ 5’ 
 
Figure 5.9. Pnk Substrate ligation. When forming the Pnk substrates, the 3 oligonucleotides 
are heated to 95 °C for 5 minutes and allowed to cool overnight while covered from light. The 
Pnk substrates used in ligation reactions undergo modification from the Pnk part of the fusion 
before ligation with the T4 ligases in the fusion. 
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5.2.3.2 Time Course Ligation Analysis 
The end point analysis of different versions of substrate 7 with the Pnk-ligases (Figure 
5.14) showed that only PnkRnl2 worked efficiently for ligation when there was an 
abundance of ligase to each substrate. The ligation rate for PnkRnl2 was determined 
using time course ligation analysis (see Section 2.4.2). Two versions of substrate 7, the 
standard substrate 7 (Figure 2.4) and Pnk substrate 7 (Table 5.3, Figure 5.9), were used 
to determine the initial rate of PnkRnl2. Two types of substrate 7 were required to test 
each enzyme, T4Pnk and the ligase.  
 
5.2.4. Phosphate release assay  
The 3’ phosphatase part of T4Pnk should result in release of phosphate (which may be 
released free in solution or transferred to the 5’OH (Caldecott, 2002; Galburt et al., 
2002)). While the 5’ kinase part attaches phosphate, which may be provided by ATP or 
directly transferred from the 3’ phosphate, to the 5’ OH. Detection of free phosphate 
was measured when carrying out ligation using Pnk substrate 7 (20-mer and 40-mer) 
with ligation buffer containing 1 mM ATP. The phosphate release assay was set up with 
the reaction conditions to be the same as the end point ligation assay (see Section 2.4.1) 
and nuclease free water added to a final volume of 50 µl in a PCR plate (Figure 5.10), 
sealed and incubated at 37 ⁰C for one hour. A standard curve was also constructed by 
using 10 M KH2PO4 to prepare samples at the following concentrations (wells 4 and 5 A 
– H): 1 mM, 500 µM, 250 µM, 125 µM, 62.5 µM, 31.3 µM, 15.7 µM and 7.85 µM in a 
total volume of 50 µl. After one hour 50 µl of Phosphate release assay developing 
solution (4 parts Ammonium molybdate-sulphuric acid solution: 1 part Ferrous sulphate 
solution, Table 2.5) was added and incubated at room temperature for 10 minutes. The 
whole reaction mixture was then transferred to a round bottom plate microplate 
(ThermoFisher). The absorbance was measured at 700 nm using the Hidex Sense 
Microplate reader. From the recorded absorbance values it was possible to calculate the 
amount of free phosphate in solution for each of the reactions, and to correct for the 
absorbance value of the buffer, and buffer + substrate. 
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Figure 5.10. The phosphate release plate assay. Performed with each end point ligation 
repeated in triplicate with both 20-mer and 40-mer Pnk substrate 7.  
 
5.3 Characterisation of the T4Pnk-ligases 
5.3.1. Confirmation of the T4Pnk-ligase constructs  
To confirm the pseT gene had been incorporated into each of the recombinant plasmids, 
the new plasmids were subjected to double digestion with NcoI and BamHI, the digested 
plasmids were analysed by agarose gel electrophoresis (Figure 5.11) and were also sent 
for Sanger sequencing at Eurofins. The fragment sizes and sequencing results were as 
expected.  
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Figure 5.11. Analysis of the new plasmids pRB560, pRB561 and pRB562. The pseT-ligase 
inserts digested with NcoI and BamHI, compared to the T4 nucleic acid ligases T4Dnl (pRB255), 
T4Rnl1 (pRB256) and T4Rnl2 (pRB257) to confirm the expected sizes of the cloned genes. The 
expected sizes were: T4Dnl gene (pRB255) 1473 bp PnkDnl gene (pRB560) 2444 bp, T4Rnl1 gene 
(pRB256) 1134 bp, PnkRnl1 gene (pRB561) 2105 bp, T4Rnl2 gene (pRB257) 1014 bp, PnkRnl2 
gene (pRB562) 1985 bp and the Pnk gene (pRB576) 971 bp. Analysed using a 1 % TAE agarose 
gel with 5µl 10 mg/ml ethidium bromide (see section 2.24). 
 
5.3.2. Protein purification 
The T4Pnk-ligases retained the His-tag for protein purification and were all soluble once 
purified. Western blot analysis did not detect the extra bands present during purification 
(Figure 5.12) indicating these proteins/degradation products did not contain the N-
terminal His-tag.  A clear increase in size for each of the T4Pnk-ligases was observed and 
the expected sizes were: PnkDnl – 89.9 kDa, PnkRnl1 – 78.1 kDa and PnkRnl2 – 72.2 kDa 
(Figure 5.13). The final concentrations for the purified proteins were: PnkDnl 177 µg/ml, 
PnkRnl1 784 µg/ml and PnkRnl2 1.38 mg/ml. 
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Figure 5.12. Western Blot and SDS-PAGE confirmation of the Pnk-ligases. Left hand side: 
Western Blot analysis using 2 µl of the monoclonal anti-poly histidine peroxidase antibody (from 
mouse) of the purification fractions. Right hand side: 10 % SDS-PAGE analysis of the purification 
elution fractions S1 and F1-F10 (See section 2.3.4)  for PnkDnl 89.9 kDa (A), PnkRnl1 78.1 kDa (B) 
and PnkRnl2 71.6 kDa (C).  
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Figure 5.13. Purified T4 and Pnk-ligases. SDS-PAGE analysis (10 % polyacrylamide) highlights 
the change in size of each T4 nucleic acid ligase and the T4Pnk-ligases. The expected sizes were: 
T4Dnl 55.3 kDa, PnkDnl 92.5 kDa, T4Rnl1 43.5 kDa, PnkRnl1 80.7 kDa, T4Rnl2 37.6 kDa and 
PnkRnl2 74.8 kDa.  
 
5.3.3. Characterisation of the T4Pnk-ligases 
A number of different substrates were used to check ligation activity of the T4Pnk-
ligases. This included the standard substrate set for end point ligation (Figure 5.14, Table 
2.4) and Pnk variations of these substrates using modified oligonucleotides (Table 5.2, 
Figure 5.9). For the time course reactions to determine initial rates, different versions of 
substrate 7 were used to determine which substrate the T4Pnk-ligases could ligate best 
(Figure 5.15), including a Pnk version of substrate 7 and two longer 40-mer substrates 
for the standard and Pnk versions of substrate 7. 
 
5.3.3.1. End point ligation  
The end point ligation assay was carried out with all new T4Pnk-ligases. PnkDnl showed 
the same ligation profile as T4Dnl (Figure 4.10), but some of the substrates (3, 5 and 6) 
had lower total ligation percentage (Figure 5.15). PnkRnl1 demonstrated the poorest 
end point ligation, with severely reduced ligation for the substrates that T4Rnl1 is usually 
able to ligate. Of the new T4Pnk-ligase fusions, the end point ligation analysis of PnkRnl2 
confirms the same profile as T4Rnl2. 
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Figure 5.14. End point ligation analysis of the Pnk-ligases with different substrates. 
Reactions were set up with both the standard 20 b substrates 1-8 and Pnk 20 b substrates 1-8 
for one hour at 37 °C and were analysed using 15 % urea polyacrylamide gels for A) PnkDnl, B) 
PnkRnl1 and C) PnkRnl2.  
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Figure 5.15. Quantification of the end point ligation analysis for the Pnk-ligases and 
different 20 base substrates. Each Pnk-ligase was tested with the standard 20 b substrates 1-
8: PnkDnl (blue), PnkRnl1 (green) and PnkRnl2 (red). The same reaction was also set up with the 
Pnk substrates 1-8: PnkDnl + PnkSub (blue striped), PnkRnl1 + PnkSub (green striped) and 
PnkRnl2 + PnkSub (red striped). The ligation reactions were set up in triplicate, as per section 
2.4.1 with 45 pmol of substrate and 70 pmol ligase. The gel images from Figure 5.13 were 
quantified using ImageJ software and the error bars indicate standard deviation.  
 
0
10
20
30
40
50
60
70
80
90
100
1 2 3 4 5 6 7 8
To
ta
l L
ig
at
io
n
 %
Substrate Number
PnkDnl
PnkDnl +
Pnksub
PnkRnl1
PnkRnl1 +
PnkSub
PnkRnl2
PnkRnl2 +
PnkSub
Chapter 5: Fusion of T4 Polynucleotide Kinase and NA Ligases 
153 
 
 
Figure 5.16. Further ligation analysis using 20 base and 40 base variants of substrate 7 
and Pnk Substrate7. The T4 ligases and the Pnk-ligases underwent end point ligation analysis 
with the standard ligation buffer with 1 mM ATP at 37 ⁰C for one hour (see Section 2.4.1). PnkDnl 
(A) and PnkRnl1 (B) could ligate a 40 base substrate 7 but not the Pnk version of this substrate 
(middle panels on A and B respectively). PnkRnl2 (C) could successfully ligate both the standard 
and Pnk 40 base substrates, the standard 20 b and Pnk 20 b substrate 7 (middle panel). The T4 
ligases (left hand panels) and non-fused ligases: T4Dnl, T4Rnl1 and T4Rnl2 + Pnk (right hand 
panels) were controls for ligation of the standard and Pnk 20 base and 40 base substrates.  
Chapter 5: Fusion of T4 Polynucleotide Kinase and NA Ligases 
154 
 
The controls, where the Pnk and ligase were not fused, demonstrate the desired ligation 
capacity for the T4Pnk-ligases (Figure 5.16, last section on each gel). The T4 ligases were 
also controls to demonstrate that the T4 ligases cannot ligate the Pnk substrates, where 
there is mis-priming on the DNA/RNA strands, but can ligate the  standard 20 b version 
of substrate 7 (Figure 5.16, first section on each gel). Both PnkDnl and PnkRnl1 had low 
levels of ligation with the Pnk substrates, for both 20-mer and 40-mer; PnkDnl could 
ligate the  standard 20 b substrates while PnkRnl1 did not ligate the standard 20 b 
substrates fully (Figure 5.16, middle sections). PnkRnl2 ligated all 4 versions of substrate 
7, it worked best with the  standard 20 b substrate 7 20-mer, 40-mer and 20-mer Pnk 
substrate 7 (Figure 5.16, middle section on bottom gel). Since PnkRnl2 was the only 
T4Pnk-ligase able to ligate the Pnk substrates, it was the only T4Pnk-ligase that 
underwent time course ligation experiments.  
 
5.3.3.2. Time Course Analysis 
The time course ligation assay was carried out to determine the initial rates for the Pnk-
ligases.  The amount of enzyme used varied from 2-100 pmol and this was then used to 
determine the amount ligated per mol of protein (Figure 5.17).  
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 Figure 5.17. Time Course Analysis of PnkRnl2. Initial rates for PnkRnl2 were calculated with 
different versions of substrate 7, 540 pmol of substrate and 2-100 pmol of enzyme was used 
with ligation buffer containing 1 mM ATP; reactions were repeated in triplicate with the 
standard deviation shown as error bars. Non-fused Pnk + T4Rnl2 (red) demonstrates a curve, 
instead of a linear initial rate of reaction indicating a delay in modification of the DNA for ligation. 
Fused PnkRnl2 with standard 20 b substrate 7 (black), Pnk 20 b substrate 7 (blue) and 40 b 
substrate 7 (green) have a linear initial rate of reaction.   
 
Table 5.4. Rates of nick joining for PnkRnl2 and Pnk + T4Rnl2. PnkRnl2 time course 
analysis with 20 b and 40 b standard substrate 7, 20 b PnkSub7 and non-fused Pnk + T4Rnl2 with 
standard 20 b substrate 7.  
Substrate Rate of ligation at 37 ⁰C 
(mol nicks joined/mol 
protein/min) 
Sub 7 (20b) 2.44 (+/- 0.32) 
PnkSub7 (20b) 0.09 (+/- 0.02) 
Sub7 (40b)  0.45 (+/- 0.08) 
Pnk + T4Rnl2 PnkSub7 (20b) 4.53 (+-/ 0.26) 
 
The initial rates for PnkRnl2 with the substrate 7 variants indicated that Pnk and T4Rnl2 
separately has a better initial ligation rate than PnkRnl2 with Pnk substrate 7 (20-mer) 
(Figure 5.17, Table 5.4). The published rate for T4Rnl2 with substrate 7 is 46 (+/- 2.5) 
(Bullard and Bowater, 2006). T4Rnl2 alone will not ligate the Pnk version of this substrate 
(Figure 5.16) and this result is the best comparison for the rate of T4Rnl2. PnkRnl2 was 
able to ligate standard substrate 7 indicating the ligase part was functional, while Pnk 
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substrate 7 (20-mer) and the longer standard 40-mer version of substrate 7 showed the 
slowest rates of ligation.  
 
5.3.3.3 Analysis of free phosphate in solution 
The incomplete ligation of substrates in both the end point ligation and time course 
assays indicated that part of the Pnk-ligase fusion was inhibited or not functional, 
especially in the case of PnkDnl. A phosphate release assay was carried out to determine 
levels of free phosphate in solution (Figure 5.18). The phosphate release assay uses a 
developing solution that binds to the free phosphate to produce a colour change, which 
can be detected at 700 nm. Using the standard curve, it was possible to calculate the 
amount of free phosphate in solution for each of the reactions (Figure 5.19) and correct 
for the absorbance of buffer and buffer containing substrate. 
 
 
Figure 5.18. The schematic and plate picture of the phosphate release assay. In each 
reaction 70 pmol of ligase was used with 45 pmol of the 20-mer Pnk substrate 7 with standard 
ligation buffer containing 1 mM ATP, incubated for one hour at 37°C before the addition of the 
phosphate developing solution.  
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Figure 5.19. The amount of free phosphate in solution from the phosphate release 
assay. Average free phosphate in solution values with corrections for ligation buffer and 
substrate phosphate levels, each end point ligation was carried out in triplicate and error bars 
denote the standard deviation.  
 
Visualisation of the plates with both Pnk versions of substrate 7 (20-mer and 40-mer) 
show high levels of phosphate release with PnkDnl. All of the reactions release some 
phosphate into solution but this is 70-fold higher with PnkDnl compared to T4Pnk. T4Pnk 
on its own is able to attach and remove the phosphate with no hindrance, releasing a 
small amount into solution (Figure 5.19).  
 
5.4 Discussion 
Addition of enzymes at the N- terminus of the T4 nucleic acid ligases was previously 
successful in producing fusion ligases with added function (see Chapter 4) (Liu et al., 
2015). For the experiments described in this chapter though, more work needs to be 
done to assess the fusion site for Pnk and the T4 ligases. The 3 Pnk-ligases had varied 
results, PnkDnl and PnkRnl1 had reduced ligation with the standard 20 b and Pnk 20 b 
substrates 1-8 (Figures 5.14, 5.15 and 5.16). PnkRnl2 effectively ligated a number of the 
Pnk and standard 20 b substrates (Figures 5.14, 5.15 and 5.16). It is possible that addition 
of the ligase at the C- terminus of Pnk has inhibited access to one of the active sites, 
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which in turn produces less substrate that the ligases can ligate. The exception to this is 
PnkRnl2 and it is likely that, as the smallest of the T4 nucleic acid ligases (37kDa), it is 
causing less steric hindrance for Pnk. Steric hindrance of T4Pnk has been noted before 
when using pyrene attached to double stranded DNA (Song and Zhao, 2009).  
 
The end point ligation with the Pnk 20 b substrates (Figures 5.14, 5.15 and 5.16) showed 
that for PnkDnl and PnkRnl1 nearly all ligation capacity is diminished with the Pnk 
substrates. Ligation activity with the standard 20 b substrates was comparative to the 
ligation activity of the T4 ligases (Figure 3.15) indicating the lack of ligation with the Pnk 
substrates is caused by a problem with the Pnk part of the fusion. PnkDnl and PnkRnl1 
ligated the standard 20 b substrates but both had a reduced profile when compared to 
T4Dnl and T4Rnl1 (Figure 3.15). PnkDnl loses the ability to ligate standard 20 b substrate 
2 (double stranded RNA) (Figure 5.14). PnkRnl1 can no longer ligate standard 20 b 
substrates 2, 5 and 6 and showed lower ligation of standard 20 b substrate 7 when 
compared to T4Rnl1 (Figures 3.15 and 5.14). The ligase parts of the fusions were able to 
successfully ligate the standard substrates 1-8 and the profile produced matched that of 
the non-fused T4 nucleic acid ligases (Figures 4.9 and 5.14). The Pnk Substrate 7 (40-
mer) has lowered levels of ligation with all 3 Pnk-ligase fusions, yet these ligases are all 
able to successfully join the nick for the standard version of substrate 7 (40-mer). 
Therefore the length of the substrate does not hinder the ligase but likely affects the 
Pnk part of the fusion (Figure 5.16). T4Pnk normally forms a homotetramer of four 
subunits (Galburt et al., 2002), a tunnel conformation that allows T4Pnk to remove and 
attach phosphate at the same time (Caldecott, 2002; Galburt et al., 2002). Further end 
point analysis of the Pnk-ligases and the T4 ligases (Figure 5.16) with different versions 
of substrate 7 was carried out to determine which substrates would be suitable for time 
course ligation analysis. PnkDnl and PnkRnl1 did not ligate the Pnk substrates fully 
(Figure 5.16) and did not complement the activity seen with the enzymes when not 
fused. PnkRnl2 did ligate Pnk substrate 7 (20-mer) and a small amount of Pnk substrate 
7 (40-mer) (Figure 5.16), and as such only PnkRn2 was then analysed to determine the 
initial rate.  
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5.4.1 Phosphate Release Analysis 
The phosphate release assay demonstrated that the fusion of T4Pnk and T4Dnl resulted 
in phosphate removal from the substrate, and a functional C- terminus phosphatase of 
T4Pnk, but showed that phosphate was not added to the 5’ position on the 
oligonucleotide, indicating the N- terminus kinase activity was inhibited or non-
functional. This resulted in high amounts of free phosphate in solution (Figure 5.19) and 
ultimately affected the ability of the ligase to create the phosphodiester bond for the 
Pnk substrates (Figure 5.16). The non-bound Pnk and T4 ligases also released phosphate 
into solution (Figure 5.16), these offer a baseline for the different substrates. When 
considering enzymatic reactions, substrate (A) is catalysed into a product (B). In this 
instance there are two reactions occurring, one where the Pnk removes phosphate from 
the 3’ end of the break in the substrate and attaches phosphate to the 5’ part of the 
break (reaction A  B) and then a second reaction where the ligase seals the nick (i.e. 
product B is converted into a further product, C in reaction B  C). As A is used up, B is 
created and then used up to make C. A delay in the creation of B (modified DNA/RNA 
ends) results in a delay in the creation of C (ligated substrate) which may give the result 
seen in Figure 5.17 – where the rate of reaction isn’t linear. The ligase can only ligate the 
substrate once the phosphate has been removed from the 3’ part of the break and 
attached to the 5’ part. There is no way to know whether Pnk is only utilising the 
phosphate on the substrate or also using the ATP in the buffer and whether the 
phosphate in solution is from one or both of these sources.  
 
5.4.2 Analysis of PnkRnl2 
PnkRnl2 appears to function the most efficiently of the 3 T4Pnk-ligase fusions. The end 
point ligation profile remained the same as T4Rnl2 with the highest amount of ligation 
of the 3 T4Pnk-ligases with both versions of substrate 7 (20-mer). The ligation of 
PnkSub7 (40-mer) is limited by PnkRnl2, the length of the substrate has a very clear 
impact on ligation capacity of PnkRnl2. This is likely because T4Pnk feeds the DNA/RNA 
through a positively charged tunnel that runs through the middle of the enzyme, ATP is 
bound at one end and the DNA/RNA at the other just 3.3 A˚ apart, the phosphate is then 
transferred from the ATP to the 5’-OH (Caldecott, 2002; Galburt et al., 2002). It is 
possible to theorise that this mechanism would also work and the substrates with 
Chapter 5: Fusion of T4 Polynucleotide Kinase and NA Ligases 
160 
 
phosphate at the 3’ position passes this to the 5’ end as the DNA/RNA is already held in 
place in the tunnel active site.  
 
The non-fused T4Pnk and T4Rnl2 demonstrated the best initial rate of ligation (Figure 
5.18), however the end point ligation after one hour demonstrated that both the fused 
and non-fused proteins ligate 20-mer Pnk substrate 7 fully, when using 70 pmol of ligase 
and 45 pmol of substrate (Figure 5.16). The time course analysis indicated slower initial 
rates of ligation with Pnk substrate 7 (20-mer) and standard substrate 7 (40-mer) (Table 
5.3). This is possibly due to the length of the 40-mer substrate and for ligation of the Pnk 
substrate 7 (20-mer) both the ligase and T4Pnk parts are required to prime and then 
repair which may take longer than solely ligating the break. It is possible to theorise that, 
as the smallest of the 3 ligases, the addition of T4 Rnl2 at the 3’ end of T4Pnk still allows 
mobility in the second active site for removal of the phosphate from the 3’ position. 
When Pnk and T4Rnl2 were not fused, both the 20-mer and 40-mer Pnk substrates were 
ligated fully; likely the Pnk and ligase could catalyse their respective reactions without 
steric hindrance (Figures 5.16, 5.17 and 5.19). The rate of ligation when Pnk and T4Rnl2 
were unbound (Table 5.4) is double the rate of the bound PnkRnl2 with  standard 20 b 
substrate 7: 4.53 mol nicks joined/mol protein/min (+-/ 0.26) and 2.44 mol nicks 
joined/mol protein/min (+/- 0.32) respectively.  The published value for T4Rnl2 activity 
with this substrate is 46 mol nicks joined/mol protein/min (+/- 2.5) (Bullard and Bowater, 
2006); the bound and unbound versions of Pnk and T4Rnl2 have a much lower rate than 
this because the ligation is delayed until the DNA/RNA substrate has the phosphate 
removed and reattached by Pnk. 
 
5.4.3. PnkDnl and PnkRnl1 
 With both PnkDnl and PnkRnl1 there was reduced end point ligation with the standard 
20 b  and Pnk 20 b substrates (Figures 5.13, 5.14 and 5.15), when compared to the T4 
ligases end point ligation (Figure 4.10). PnkDnl and PnkRnl1 retain some ligation activity 
(Figure 5.15 and 5.16), but as both these ligases did not ligate the substrates fully it was 
not possible to obtain rates for these reactions. Both fusions with T4Dnl and T4Rnl1 
appear to limit the T4Pnk activity, especially with PnkDnl as there is a lot of free 
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phosphate in the reactions. The tunnel active site in T4Pnk usually localises ATP to the 
DNA/RNA end requiring repair (Caldecott, 2002; Galburt et al., 2002) and in theory this 
system could instead transfer the phosphate between the mis-primed strands, as these 
are already localised by their complementary strand. For PnkDnl though the active site 
that removes phosphate is functional releasing high levels of phosphate into solution 
(Table 5.4) but the part that attaches the phosphate at the 5’ position was less functional 
than T4Pnk with the ligases unbound (Figure 5.16). Further optimisation of this system 
could be carried out, whereby the ligases are joined using a linker between the 2 active 
sites of T4Pnk, although linker length and placement would need to be optimised. 
 
5.5 Conclusion 
The addition of Pnk to the T4 nucleic acid ligases did not totally demonstrate the aimed 
for result of an efficient fusion. Of the 3 fusions, PnkRnl2 functioned the best and would 
likely be of interest for industrial application and further study.  The phosphate release 
assay demonstrates that the fusion of T4Pnk and T4Dnl had the capacity to remove 
phosphate from the Pnk substrates but has lost the capacity to attach phosphate. While 
the levels of free phosphate in solution for PnkRnl1 were not as high as those for PnkDnl, 
PnkRnl1 also demonstrated the lowest levels of ligation from end point analysis (Figures 
5.13 and 5.14).  
 
Further analysis of PnkRnl2 could be carried out, especially analysis of NGS and adapter 
ligation to miRNAs. It is possible to theorise that miRNA identification levels may differ 
with the addition of T4Pnk to correctly prime ends for ligation. This is a new field of 
research and little work has been conducted to determine whether levels in miRNAs 
attributed to disease are conclusively lower because of low production levels or whether 
the levels are lower due to incorrectly primed miRNAs that would not be able to be 
ligated to the adapters. Theoretically this would only happen if mis-priming resulted in 
a mixed population of miRNAs – incorrectly and correctly primed. It would be interesting 
to test a panel of miRNAs under normal adapter-ligation conditions and also with 
PnkRnl2 in place of T4Rnl2 to see if differences in detectable and quantifiable amounts 
of miRNA are observed.  
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Another experiment that could be carried out with the PnkRnl2 fusion protein, would 
be to use labelled phosphate to show whether incorporation and removal of phosphate 
is from the ATP or from the 3’ end of the oligonucleotide. Another way to check 
phosphate incorporation would be to fuse Pnk to an NAD dependent ligase, eliminating 
the need for ATP in the buffer, and repeating the experiment to check whether the 
phosphate is moved from the 3’ part of the break to the 5’ part and then ligated. Other 
factors that could be optimised further include the buffer and its constituents. Salts 
present in buffers can have an effect on T4Pnk activity (Lillehaug and Kleppe, 1975) and 
the buffer used for the experiments detailed above was optimised for ligation. The 
addition of polymers to buffer also reverses activity loss seen with T4Pnk, notably the 
addition of PEG which acts via molecular crowding, and may help to improve ligation 
reactions for the T4Pnk-ligases with the Pnk substrates (Harrison and Zimmerman, 
1986). Using linkers to join Pnk to the T4 ligases is also an option, but length, linker type 
and linker location would all need optimisation and the time constraints of this project 
did not allow for work with linkers.  
 
The activity of T4Pnk was quantified using modified oligonucleotides and the phosphate 
release assay, which are indicative of T4Pnk activity but are not directly proportional to 
T4Pnk rate. It would be useful to consider other ways to robustly test T4Pnk activity. 
T4Pnk has been used as a model for a coupled λ exonuclease reaction that uses a 
graphene oxide  based sensing platform and showed that it could detect T4Pnk activity 
and inhibition (Lin et al., 2011). Another method for monitoring T4Pnk activity used a 
labelled hairpin probe coupled with λ exonuclease cleavage; when fluorescence was 
quenched, and upon phosphorylation by T4Pnk, the quencher was cleaved emitting 
fluorescence (Song and Zhao, 2009). More recently, detection of T4Pnk activity has been 
improved further using gold nanoparticles and β-cyclodextrin polymer to enhance 
fluorescence further (Huang et al., 2013; Song et al., 2015). All of these methodologies 
would provide a more accurate way of quantifying T4Pnk rate for the T4Pnk-ligase 
fusions.  
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In conclusion, there are numerous uses for T4Pnk-ligase fusions, but further work needs 
to be carried out to determine how best to join Pnk and the T4 ligases for both enzymes 
to remain functional. In the case of PnkRnl2, further analysis of this new enzyme needs 
to be implemented to define whether or not it could be used to improve current 
methodologies that use both T4Pnk and T4 ligases. 
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Chapter 6: Modifications to Mycobacterium smegmatis 
ligase LigD 
6.1.1 Bacterial Ligases 
Bacterial ligases can either be NAD dependent or ATP-dependent, with all bacteria 
containing a replicative NAD-dependent ligase, LigA, and most bacteria containing 
accessory ATP-dependent ligases (Wilkinson, Day and Bowater, 2001; Pergolizzi, Wagner 
and Bowater, 2016; Williamson, Hjerde and Kahlke, 2016). The first bacterial ATP-
dependent ligase was discovered in Haemophilus influenenzae (Cheng and Shuman, 
1997) and since this discovery ATP-dependent ligases have been found in many different 
bacteria. There are several different types of bacterial ATP-dependent ligases, split into 
6 sub-groups, LigB, LigC, LigD1, LigD2, LigD3 and LigE. These different classes of bacterial 
ATP-dependent ligases are characterised by different domain arrangements and domain 
conservation (Pergolizzi, Wagner and Bowater, 2016; Williamson, Hjerde and Kahlke, 
2016) (Figure 6.1).  
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Figure 6.1. The conserved domains in bacterial ATP-dependent ligases. Each ATP-
dependent ligase sub group with different conserved domains. The Pfam (PF) domain sequences 
from the Pfam database (Finn et al., 2014) give specific information on families of proteins. 
Available at http://pfam.xfam.org/. The different conserved domains have different functions 
and include combinations of an ATP-dependent DNA ligase domain (PF01068), a DNA ligase OB 
domain (PF14743), an ATP-dependent ligase C- terminal region (PF04679), a DNA polymerase 
(PF13298), a DNA primase unit (PF01896) and a DNA ligase N- terminus found in some ATP-
dependent ligases (PF04675). PF01068 contains the nucleotidyl transferase conserved 
polypeptide motifs I, III, IIIa, IV and V.  
 
6.1.2. Non Homologous End Joining with LigD 
One system that uses these bacterial ATP-dependent ligases is Non homologous end 
joining (NHEJ) (Brissett and Doherty, 2009; Matthews and Simmons, 2014). There are a 
number of causes for DNA damage, including spontaneous breaks during replication and 
exogenous damaging agents; one type of break that occurs are DNA double stranded 
breaks (DSBs) (Hefferin and Tomkinson, 2005). DSBs are lethal to the cell when 
unrepaired and may result in carcinogenesis and cell death in mammalian cells (Pitcher, 
Brissett and Doherty, 2007; Shuman and Glickman, 2007; Brissett and Doherty, 2009). 
There are two pathways to repair DSBs: homologous recombination – where a DNA 
template provides sequence homology to repair the DSBs, leaving no mutation to the 
sequence, this is considered an accurate form of repair (Shuman and Glickman, 2007); 
and NHEJ – where end joining occurs without sequence homology and can introduce 
Chapter 6: Modifications to Mycobacterium smegmatis ligase LigD 
167 
 
changes to the sequence, including addition or deletion of bases, this is considered to 
be error-prone repair (Hefferin and Tomkinson, 2005). Recent studies have questioned 
whether the error prone nature of NHEJ occurs for a specific reason and have considered 
a more detailed classification with highlighted advantages of adaptability of the NHEJ 
systems (Bétermier, Bertrand and Lopez, 2014).  
 
NHEJ repair systems are not specific to bacteria, they were first characterised in 
mammals and other eukaryotes and can be found in yeasts too (Matthews and 
Simmons, 2014). The different NHEJ repair systems utilise different proteins to carry out 
the end joining process but this usually involves the Ku protein, and a specialised DNA 
ligase, LigD 1, 2 and 3 in bacteria (Hefferin and Tomkinson, 2005; Shuman and Glickman, 
2007). The Ku protein acts as a block on the ends of DSBs, allowing repair and ligation 
by LigD, and when Ku is missing in M. smegmatis two other pathways are upregulated – 
homologous end joining and single strand annealing (Gupta et al., 2011). Mycobacteria 
have LigA and 3 additional ATP-dependent ligases: LigB, LigC and LigD. These were first 
discovered in M. tuberculosis where LigB, C and D were shown to be accessory ATP-
dependent ligases (Cole et al., 1998; Gong et al., 2004; Płociński et al., 2017). The 
frequencies of the different proteins involved in NHEJ differs from organism to 
organism, for example M. tuberculosis has single copies of Ku, LigD and LigC, while M. 
smegmatis has one Ku, one LigD and two LigC’s (Shuman and Glickman, 2007). LigB was 
first discovered in M. tuberculosis and was found not to be involved in NHEJ, whereas 
ΔLigD M. tuberculosis strains demonstrated an inability to carry out NHEJ(Bhattarai, 
Gupta and Glickman, 2014). LigC in M. tuberculosis and M. smegmatis was involved in a 
NHEJ minor pathway when LigD was deleted (Gong et al., 2004; Bhattarai, Gupta and 
Glickman, 2014). M. smegmatis LigD was especially of interest for this work as it is a 
naturally occurring, poly-functional enzyme.  
 
6.1.3. Mycobacterium smegmatis LigD 
LigD from M. smegmatis (MsLigD) is comprised of 3 domains (a DNA polymerase, 
phosphoesterase (PE) and a DNA ligase (Gong et al., 2005)) and is 762 amino acids in 
length (Figure 6.2). MsLigD doesn’t fully fit the Pfam bacterial ligase classification (Figure 
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6.1), as it is most similar to the LigD1 group containing a polymerase domain (PF13298, 
purple) and a ligase domain (PF01068, red). MsLigD also contains a PE domain instead 
of a primase unit (PF01896, yellow). Mutational analysis of MsLigD revealed that its 
deletion affected NHEJ. When the critical lysine residue at position 484 in motif I (Figure 
6.3), was changed to alanine, DSB repair was not greatly affected and was likely 
supported by MsLigC (Gong et al., 2005; Akey et al., 2006). Removal of both MsLigB and 
MsLigC eradicated NHEJ in the M. smegmatis strain K484A (Shuman and Glickman, 
2007). The upstream polymerase and PE are involved in the repair of DSB ends before 
the ligase seals the nick (Shuman and Glickman, 2007; Aniukwu, Glickman and Shuman, 
2008; Williamson, Hjerde and Kahlke, 2016). The addition of single nucleotides at the 
blunt end of the DSB is catalysed by the polymerase domain (Della et al., 2004; Gong et 
al., 2005; Shuman and Glickman, 2007). The polymerase domain may also fill in 
ribonucleotides at a 5’ overhang (Gong et al., 2005; Shuman and Glickman, 2007). It has 
also been noted that the polymerase part of LigD in Pseudomonas aeruginosa shows a 
preference to ribonucleotides over deoxyribonucleotides in vitro and inserts 
ribonucleotides more quickly into DSBs (Yakovleva and Shuman, 2006). Further point 
mutations of the non-functional polymerase domain, D136A and D138A mutants, to M. 
smegmatis ΔLigD resulted in increased blunt repair of DSBs and eliminated nucleotide 
insertions, demonstrating a unique role for this polymerase (Zhu et al., 2006; Shuman 
and Glickman, 2007). The PE domain is responsible for resecting ribonucleotides until 
the 3’ strand has one ribonucleotide. This occurs via a 2-step process whereby the 
nucleoside is removed leaving a primer strand that has a 3’-PO4, followed by hydrolysis 
of the 3’-PO4 to 3’-OH (Zhu, Wang and Shuman, 2005; Zhu and Shuman, 2006; Shuman 
and Glickman, 2007). Mutations to PE in MsLigD did not affect NHEJ and it is thought the 
PE domain in MsLigD offers a way to repair ends that cannot be extended by the 
polymerase or joined by the ligase, for example DSBs with 3’-PO4  that would not 
normally occur in NHEJ  (Shuman and Glickman, 2007).  
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        10         20         30         40         50 
MARHPWGMER YERVRLTNPD KVLYPATGTT KAEVFDYYLS IAQVMVPHIA  
        60         70         80         90        100 
GRPVTRKRWP NGVAEEAFFE KQLASSAPSW LERGSITHKS GTTTYPIINT  
       110        120        130        140        150 
REGLAWVAQQ ASLEVHVPQW RFEDGDQGPA TRIVFDLDPG EGVTMTQLCE  
       160        170        180        190        200 
IAHEVRALMT DLDLETYPLT SGSKGLHLYV PLAEPISSRG ASVLARRVAQ  
       210        220        230        240        250 
QLEQAMPKLV TATMTKSLRA GKVFLDWSQN NAAKTTIAPY SLRGRDHPTV  
       260        270        280        290        300 
AAPRTWDEIA DPELRHLRFD EVLDRLDEYG DLLAPLDADA PIADKLTTYR  
       310        320        330        340        350 
SMRDASKTPE PVPKEIPKTG NNDKFVIQEH HARRLHYDLR LERDGVLVSF  
       360        370        380        390        400 
AVPKNLPETT AENRLAVHTE DHPIEYLAFH GSIPKGEYGA GDMVIWDSGS  
       410        420        430        440        450 
YETEKFRVPE ELDNPDDSHG EIIVTLHGEK VDGRYALIQT KGKNWLAHRM  
       460        470        480        490        500 
KDQKNARPED FAPMLATEGS VAKYKAKQWA FEGKWDGYRV IIDADHGQLQ  
       510        520        530        540        550 
IRSRTGREVT GEYPQFKALA ADLAEHHVVL DGEAVALDES GVPSFGQMQN  
       560        570        580        590        600 
RARSTRVEFW AFDILWLDGR SLLRAKYSDR RKILEALADG GGLIVPDQLP  
       610        620        630        640        650 
GDGPEAMEHV RKKRFEGVVA KKWDSTYQPG RRSSSWIKDK IWNTQEVVIG  
       660        670        680        690        700 
GWRQGEGGRS SGIGALVLGI PGPEGLQFVG RVGTGFTEKE LSKLKDMLKP  
       710        720        730        740        750 
LHTDESPFNA PLPKVDARGV TFVRPELVGE VRYSERTSDG RLRQPSWRGL  
       760  
RPDKTPDEVV WE                                           
Figure 6.2. M. smegmatis LigD sequence. MsLigD is made up of 3 domains which code for a 
DNA repair polymerase domain (purple), a 3’ phosphoesterase domain (light green) and a DNA 
ligase domain (red). Amino acids are designated following the standard single letter 
abbreviations.  
 
It therefore seems logical that these specific protein activities would be grouped 
together, although in some organisms the different activities are not always in one 
protein and, while not essential for bacterial growth, LigD (and in some instances LigC) 
along with the Ku protein provide some protection against DNA damage. Related NHEJ 
systems are found in a number of other bacteria and LigD homologs specifically can also 
be found in B. subtilis, P. aeruginosa, M. smegmatis, M. tuberculosis and M. bovis and it 
made sense to align these proteins (Figure 6.3) - previous alignment analysis aligned 
LigD from M. smegmatis and M. tuberculosis only (Gong et al., 2004). The ligase part of 
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LigD is highly conserved and contains the nucleotidyl transferase conserved motifs I, III, 
IIIa, IV and V, as well as the OB domain and motif VI (Figure 6.3). 
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T4Dnl    KNIKFPAFAQLKADGARCFAEVRGDELDDVRLLSRAGNEYLGLDLLKEELIKMTAEARQI      207 
BSLigD   PPIGAEWRYEVKYDGYRCILRIHS---SGVTLTSRNGVELSSTFPEITQFAKTAF-QHLE       68 
PaLigD   QPPRGEWAYELKLDGYRLMSRIED---GHVRLLTRNGHDWTERLPHLEKALAGLG-----      278 
MSLigD   KYKAKQWAFEGKWDGYRVIIDADH---GQLQIRSRTGREVTGEYPQFKALAADLA-----      524 
MtLigD   GLKASQWAFEGKWDGYRLLVEADH---GAVRLRSRSGRDVTAEYPQLRALAEDLA-----      521 
                   Motif I                    
 
T4Dnl    HPEGVLIDGELVYHEQVKKEPEGLDFLFDAYPENSKAKEFAEVAESRTASNGIANKSLKG      267 
BSLigD   KELPLTLDGEIVCLVNPCR----AD--------------FEHLQVRGR--LKRPDK-IQ-      106 
PaLigD   -LQRSWLDGELVVLDEEGR----PD--------------FQALQNAFE--EG--------      309 
MSLigD   -EHHVVLDGEAVALDESGV----PS--------------FGQMQNR-----A--------      552 
MtLigD   -DHHVVLDGEAVVLDSSGV----PS--------------FSQMQNR-----G--------      549 
            Motif IIIa 
 
T4Dnl    TISEKEAQCMKFQVWDYVPLVEIYSLPAFRLKYDVRFSKLEQMTSGYDKVILIEN-----      322 
BSLigD   -ESA-NARPCCFLAFDLLE---RSGEDVTLLSYLDRKKSLRELISAAKLPA--SPDPYAK      159 
PaLigD   -----RGENILYVLFDLPY---HEGEDLRDVALEERRARLEALLEGRDEDPLRFSATLA-      360 
MSLigD   -----RSTRVEFWAFDILW---LDGRSLLRAKYSDRRKILEALADGGG---LIVPDQLP-      600 
MtLigD   -----RDTRVEFWAFDLLY---LDGRALLGTRYQDRRKLLETLANATS---LTVPELLP-      597 
                   Motif IIIb              
 
T4Dnl    ---QVVNNLDEAKVIYKKYIDQGLEGIILKNIDGLWEN-ARSKNLYKFKEVIDVDLKIVG      378 
BSLigD   ETIQSIPCYDHFDQLWEMVIKYDGEGIVAKKTNSKWLEKKRSSDWLKYKNFKQAYVCITG      219 
PaLigD   ---------EDPRDLLASACKLGLEGVIGKRLGSAYRS-RRSNDWIKLKCQLRQEFVIVG      410 
MSLigD   ---------GDGPEAMEHVRKKRFEGVVAKKWDSTYQPGRRSSSWIKDKIWNTQEVVIGG      651 
MtLigD   ---------GDGAQAFACSRKHGWEGVIAKRRDSRYQPGRRCASWVKDKHWNTQEVVIGG      648 
                                Motif IV            Motif V 
 
T4Dnl    IYPHRKDPTKAGGFILESECGKI-------KVNAGSGLKDKAGVKSHELDRTRIM-----      426 
BSLigD   FNPNNGFLT--VSVLKNGIMTPI--------ASVSHGMRDEEKSAIREIMEQHGHQT---      266 
PaLigD   YTEPKGSR-RHIGALLLGLYSPDEERRLRYAGKVGSGFTAASLKKVRERLEPLAVRSSPL      469 
MSLigD   WRQGEGGRSSGIGALVLGIPGPE---GLQFVGRVGTGFTEKELSKLKDMLKPLHTDESPF      708 
MtLigD   WRAGEGGRSSGVGSLLMGIPGPG---GLQFAGRVGTGLSERELANLKEMLAPLHTDESPF      705 
            
 
T4Dnl    --------ENQNYYIGKILECECNGW-LKSDGRTDYVKLFLPIAIRLREDKTKAN-TFED      476 
BSLigD   --------PSGEFTLEPSICAAVQYLTI-LQGTL-----REVSFIGFEFQMDWTECTYAQ      312 
PaLigD   AKVPPARETGSVQWVRPQQLCEVSYAQMTRGGII-----RQAVFHGLREDKPAREVTGER      524 
MSLigD   NAPLPKVDARGVTFVRPELVGEVRYSERTSDGRL-----RQPSWRGLRPDKTPDEVVWE-      762 
MtLigD   DVPLPARDAKGITYVKPALVAEVRYSEWTPEGRL-----RQSSWRGLRPDKKPSEVVRE-      759 
                                         Motif VI 
Figure 6.3. Sequence alignment for the ligase part of MsLigD to other LigD proteins and 
T4Dnl. The ligase from LigD proteins involved in NHEJ from B. subtilis (BsLigD), P. aeruginosa 
(PaLigD), M. smegmatis (MsLigD) and M. tuberculosis (MtLigD); and T4DNA ligase (T4Dnl) 
showing conserved motifs I (dark yellow), IIIa (light blue), IIIb (purple), IV (yellow), V (green) and 
VI (blue). The always conserved residues (grey) and highly conserved residues (teal). Alignments 
performed using Clustal Omega, https://www.ebi.ac.uk/Tools/msa/clustalo/ amino acids are 
designated following standard single letter abbreviations. 
 
Mutagenic analysis of the polymerase domain in MsLigD demonstrated its ability to 
recognise 5’-phosphate on the ends of DNA without the other domains (PE and ligase) 
or the Ku protein (Pitcher et al., 2007). The MsLigC enzyme can work with the 
polymerase domain from MsLigD and the Ku protein to form a NHEJ complex when the 
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PE and ligase domains are non-functional (Bhattarai, Gupta and Glickman, 2014). The 
polymerase and PE domains have a specific role in repairing DSBs caused by ionizing 
radiation and the polymerase domain specifically repairs damage caused by ionising 
radiation in the late stationary phase (Bhattarai, Gupta and Glickman, 2014). As it is 
possible to separate the activities for the poly-functional protein MsLigD it seemed 
logical that it would be possible to remove the original DNA ligase part of MsLigD and 
replace this with the different T4 nucleic acid ligases. MsLigD can only utilise ATP for nick 
sealing – not NAD and it has been noted that 1 mM of ATP causes an abundance of 
adenylate DNA (app-DNA) intermediates, whereby the ligase dissociates from app-DNA 
and reacts with ATP to form ligase-AMP which is unable to rebind to the app-DNA (Gong 
et al., 2004). This prevents the final ligation step – phosphodiester bond formation. This 
phenomenon is called the ATP trapping phenomenon and causes low ligation efficiency 
which can be improved somewhat, but not fully, by lowering the ATP concentration 
(Gong et al., 2004; Williamson et al., 2016). There was the possibility to improve the 
efficiency of the ligase portion of this poly-functional enzyme in higher ATP 
concentrations by replacing the current ligase with one of the T4 nucleic acid ligases. 
These fusions would also act as proof of principle for fusion with an NAD dependent 
ligase, omitting the need for ATP in the ligation buffer. These new ligases may also be of 
interest as molecular biology tools offering an alternative to multiple step reactions to 
repair double stranded DNA/RNA breaks. 
 
6.2 Construction of LigD with T4 nucleic acid ligases 
6.2.1 Recombinant plasmid construction 
The gene for MsLigD was pre-ordered and synthesised in pUC57 (Genscript, USA) with 
the addition of cut sites for NcoI, NdeI and BamHI to allow for cloning into the pET-16b 
plasmids (Figure 6.4). An NcoI site was identified at position 1769 of the gene for MsLigD, 
5’-GCCATGGAG-3’, coding for Ala-Met-Glu. The sequence was changed to 5’-
GCAATGGAG-3’, still coding for Ala-Met-Glu while removing the NcoI site to make 
cloning into the pET16b plasmids easier.  
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6.2.1.1 Restriction Digestion  
The T4 NA ligase plasmids (pRB255, pRB256 and pRB257) and the pUC57 plasmid with 
synthesised MsLigD (pRB571) were digested with NdeI (ThermoFisher) and NcoI 
(ThermoFisher). Double digestion with NcoI and BamHI (ThermoFisher) was also set up 
with pRB571 to isolate the full length msLigD gene for insertion into the pET16b vector 
system. The double digestions were set up as follows: 10 µl plasmid DNA (up to 1 µg), 
10 µl sterile water, 1.25 µl NcoI, 1.25 µl NdeI/BamHI and 2.5 µl ThermoFisher FD buffer. 
This was then incubated at 37 °C for 2.5 hours. To confirm the digestions had been 
successful the samples were analysed on a 1 % agarose gel with ethidium bromide 
(Figures 6.4 and 6.8).  
 
Figure 6.4. The T4 nucleic acid ligase variants of MsLigD. The restriction enzyme cut sites 
required to move the T4 ligases to the C- terminus of MSLigD, resulting in LigDDnl, LigDRnl1 and 
LigDRnl2, with the new gene sizes included. Each domain is highlighted: the MsLigD polymerase 
domain (purple), the PE domain (light green) and the different ligase domains (red). The solid 
red section is MsLigD ligase, the patterned areas represent T4Dnl (striped) T4Rnl1 (squares) and 
T4Rnl2 (wavy lines). 
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6.2.1.2. Gel Extraction 
The Bioline isolate II PCR & Gel Kit was used as per the manufacturer’s instructions to 
isolate the DNA for the linearised vector and T4 NA ligase, MsLigD gene and truncated 
Polymerase and PE domains from MsLigD. The amount of DNA was quantified using the 
Thermo Scientific Nanodrop one quantification system.  
 
6.2.1.3. Ligating the truncated and normal MsLigD gene into pET16b 
The truncated MsLigD was ligated into each of the linearised T4 NA ligase and pET16b 
vector (Figure 6.4) and full MsLigD was ligated into linearised pET16b, the ratios set up 
were calculated using the same process as the adenylate kinase-ligases (see Section 
4.2.3). The T4 DNA ligase (ThermoFisher) and ligase buffer with ATP (Table 2.5) were 
used.   
 
6.2.1.4. Confirmation of recombinant LigD plasmids 
The new plasmids containing truncated MsLigD + the T4 NA ligases and full length 
MsLigD were extracted (see Section 2.2.2) and underwent double digestion with BamHI 
and NcoI (see Section 2.2.5) to analyse the change in size of the gene fragment (Figure 
6.8). The new plasmids (Figures 6.5, 6.6 and 6.7) were also sent to Eurofins for Sanger 
sequencing (i54 Business Park, Valiant Way, Wolverhampton, WV9 5BG, UK). 
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Figure 6.5. The vector map for the fusion of truncated MsLigD and T4Dnl to form 
LigDDnl (pRB572). The MsLigD polymerase and phosphoesterase domains were between the 
NcoI and NdeI restriction sites and the T4Dnl gene between the NdeI and BamHI restriction sites. 
This map was created using the SnapGene software.  
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Figure 6.6. The vector map for the fusion of truncated MsLigD and T4Rnl1 to form 
LigDRnl1 (pRB573). The MsLigD polymerase and phosphoesterase domains were between the 
NcoI and NdeI restriction sites and the T4Rnl1 gene between the NdeI and BamHI restriction 
sites. This map was created using the SnapGene software.  
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Figure 6.7. The vector map for the fusion of truncated MsLigD to T4Rnl2 to form 
LigDRnl2 (pRB574). The MsLigD polymerase and phosphoesterase domains were between the 
NcoI and NdeI restriction sites and the T4Rnl2 gene between the NdeI and BamHI restriction 
sites. This map was created using the SnapGene software.  
 
 
 
 
 
 
 
 
 
 
Chapter 6: Modifications to Mycobacterium smegmatis ligase LigD 
178 
 
6.2.2. Protein Characterisation  
While purification of Mycobacterium proteins encoded by genes from Mycobacteria is 
difficult because mycobacterial genomes are G + C rich, it is not impossible and soluble 
protein has been obtained using E. coli as the bacterium for protein synthesis and 
expression (Weller et al., 2002). The plasmids were transformed into E. coli BL21 (DE3) 
cells for protein synthesis (see Section 2.2.6). The new proteins were induced and 
synthesised in 1 L of selective LB media (see Sections 2.3.1, 2.3.2 and 2.3.3). Western 
blot analysis was carried out (see Section 2.3.7) to confirm the 10x His tag was still 
present as this is required for purification. The soluble fractions were purified using a Ni-
Hi Trap column (see Section 2.3.4) and the salt removed using a PD10 column (see 
Section 2.3.5). The purification fractions were analysed using 10 % SDS-PAGE (see 
Section 2.3.6 and Figure 6.7). The amount of each purified LigD protein was quantified 
using the Bradford Assay (see Section 2.3.8). 
 
6.2.3. Characterisation of biochemical activities  
A number of ligation assays were set up (see Sections 6.2.3.1 and 6.2.3.2) and analysed 
using urea-PAGE (see Section 2.4.3) and ImageJ software. The end point ligation assays 
were carried out as stated in chapter 2 (see Section 2.4.1) with double stranded 
substrates 1-8 (Table 2.4). The ligation rate for LigDDnl was determined using time 
course ligation analysis (see Section 2.4.2) with substrate 1 (double stranded DNA), since 
this was the one that it worked with best.  
 
6.3 Analysis of the MsLigD-T4 ligase fusions 
6.3.1. Recombinant plasmid analysis 
To assess the addition of MsLigD polymerase and PE domains, Sanger sequencing 
(Eurofins) and double digestion analysis were carried out. Double digestions of the new 
recombinant plasmids and the original T4 ligase plasmids with NcoI and BamHI (see 
Section 2.2.5) showed clear and expected changes in size to the gene fragments sites 
(Figures 6.4 and 6.8). 
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Figure 6.8. Analysis of MSLigD and T4 ligase variants. Double digestions comparisons of 
full length plasmids containing the genes MsLigD (pRB575), T4Dnl (pRB255), T4Rnl1 (pRB256), 
T4Rnl2 (pRB257), LigDDnl (pRB572), LigDRnl1 (pRB573) and LigDRnl2 (pRB574). Plasmids were 
digested with NcoI and BamHI for 2.5 hours at 37 °C. The expected sizes were: MsLigD 2295 bp, 
T4Dnl 1474 bp, LigDDnl 2835 bp, T4Rnl1 1134 bp, LigDRnl1 1496 bp T4Rnl2 1014 bp and LigDRnl2 
2376 bp. 
 
6.3.2. Protein solubility and purification. 
All of the LigD-T4 NA ligase fusions were soluble (Figure 6.9), and the protein 
concentrations calculated (see Section 2.3.8), the MsLigD purification yield was low 
(Figure 6.10). The LigD-T4 protein fusions show a clear change in size (Figure 6.10), the 
expected sizes are: full length MsLigD - 85.5 kDa and the expected sizes for the LigD-T4 
fusions are: LigDDnl – 106.5 kDa, LigDRnl1 – 94.8 kDa and LigDRnl2 88.8 kDa. A number 
of extra bands were present when analysing the LigD fusions, it is not known whether 
these are contaminating proteins or degradation products.  
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Figure 6.9. Purifications of the LigD-T4 ligases. A) LigDDnl fractions 1-10, approx. protein 
size 106.5 KDa; B) LigDRnl1 fractions 1-10, approx. protein size 94.7KDa C) LigDRnl2 fractions 1-
10, approx. protein size 88.3KDa; all fractions were analysed using 10 % SDS-PAGE, full length 
proteins indicated by the arrows.  
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Figure 6.10. Comparison of the purified T4 ligases and variations of MsLigD ligases. 
SDS-PAGE analysis of the change in size for each of the fully purified T4 NA ligases, MsLigD and 
the recombinant LigD fusions. The expected molecular weights were: T4Dnl 55.3 kDa, LigDDnl 
106.5 kDa, T4Rnl1 43.5 kDa, LigDRnl1 94.76 kDa, T4Rnl2 37.6 kDa and LigDRnl2 88.83 kDa. The 
correct band sizes are circled. The theoretical molecular weights were calculated using the 
Expasy compute pI/Mw tool available at https://web.expasy.org/compute_pi/. These proteins 
were used in the ligation experiments.  
 
6.3.3. Characterisation of the LigD-T4 NA ligases 
6.3.3.1 End point ligation analysis 
End point ligation analysis was carried out for full length MsLigD, LigDDnl, LigDRnl1 and 
LigDRnl2 (Figure 6.11). Each of the ligases was incubated with the 8 different 20-mer 
double stranded substrates (Table 2.4), and MsLigD was also incubated with the 40-mer 
version of substrate 1 (Figure 6.11 D and E). Of the 8 double stranded 20-mer substrates, 
LigDDnl could ligate substrate 1 best and ligated a small amount of substrate 7 (Figure 
6.11 A and E). There were very low levels of ligation observed with substrates 5 and 7 
for LigDRnl1 and LigDRnl2 (Figure 6.11 B, C and E) but the total ligation was too low and 
no further analysis was conducted.   
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Figure 6.11. End point Ligation Analysis of the LigD-T4 ligases. End point ligation for A) 
LigDDnl, B) LigDRnl1 and C) LigDRnl2 D) MsLigD with double stranded substrates 1-8 (20-mer) 
and a 40-mer substrate 1 for MsLigD and E) Analysis of ligation with substrates 1, 5 and 7. All 
reactions were incubated at 37 °C for 1 hour with ligation buffer containing 1 mM ATP.  
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6.3.3.2 Initial rate analysis of LigDDnl 
The rate of ligation for LigDDnl (Table 6.1) was calculated from quantification of the time 
course analysis using urea-PAGE (Figure 6.12A) with the ImageJ software (Figure 6.12B).  
 
Figure 6.12. Initial rate analysis for LigDDnl. Analysed on 15 % urea-PAGE; A)Quantification 
of time course ligation analysis repeated in triplicate, with standard deviation included; B) Initial 
rate analysis, from the triplicate time course ligations with 540 pmol substrate 1 (20-mer) 
incubated at 37 °C. The line of best fit suggest a non-linear relationship indicating the substrate 
is ligated quickly at the beginning but the rate then slows after 2 minutes.  
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Table 6.1. Rate of nick joining in double stranded substrate 1. Ligation of substrate 1 (20-
mer) with LigDDnl at 37 °C.  
Ligase Rate of ligation at 37 ⁰C 
(mol nicks joined/mol protein/min) 
LigDDnl 5.18 (+/- 1.11) 
 
6.4 Discussion 
Purification analysis of the 3 new LigD recombinant proteins showed a number of extra 
bands on the SDS-gels.  These bands are likely to be truncated versions of MsLigD 
without the N- terminal His-tag – there were no other bands present on the Western 
blot analysis. One knock-on effect of these contaminating MsLigD variants is that the 
concentration of protein will not be all in the expected full-length (fully active) form. 
This means that any ligation rates are likely to be under-estimates of the actual rates 
although it is possible the truncated forms may be active (this wasn’t tested for). 
LigDRnl1 and LigDRnl2 showed severely reduced ligation activity with the double 
stranded 20-mer substrates (Figure 6.11) and no further analysis was conducted with 
these proteins. Full length MsLigD ligated small amounts of 20-mer substrates 1 and 7 
(Figure 6.11). Even with a large amount of MsLigD compared to the amount of substrate 
the total ligation was poor (Figure 6.11), and it was therefore not possible to determine 
a rate for MsLigD with any of the 20-mer substrates or 40-mer substrate 1. LigDDnl 
showed robust ligation activity with double stranded substrate 1 (DNA) and reduced 
ligation of substrate 7 (DNA/RNA combination) (Figure 6.11); initial rates of ligation were 
calculated using the 20-mer double stranded substrate 1. 
 
6.4.1 LigDDnl as an MsLigD alternative 
Full optimisation of the conditions required for ligation was not possible, therefore the 
standard ligation buffer was used in order to compare the MsLigD ligases and the T4 NA 
ligases. It is possible that the buffer used to determine MsLigD substrate specificity and 
ligation activity contained too much ATP for optimal ligation activity of the enzyme. 
Previous studies have suggested that 1 mM of ATP causes ATP trapping which results in 
reduced ligation efficiency as the final phosphodiester bond formation step is not 
catalysed. By lowering the concentration of ATP, nick sealing with MsLigD was improved 
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(Gong et al., 2005; Williamson, Hjerde and Kahlke, 2016). Swapping the ligase part of 
the enzyme to T4Dnl resulted in an altered substrate profile and, when comparing the 
profiles for MsLigD and LigDDnl (Figure 6.11), it was observed LigDDnl successfully joins 
nicks in double stranded substrate 1 with 1 mM ATP and that the ATP trapping 
phenomenon seen with MsLigD was omitted. Another buffer constituent that may need 
changing for optimised MsLigD activity is the addition of magnesium as it is noted that 
Agrobacterium tumefaciens LigD utilises manganese more readily than magnesium in 
nick joining (Zhu and Shuman, 2007; Unciuleac and Shuman, 2013). Both M. smegmatis 
LigD and A. tumefaciens LigD consist of polymerase, PE and ligase domains and appear 
to function similarly (Zhu and Shuman, 2007). It was not possible to align these two LigD 
proteins as a sequence for A. tumefaciens LigD could not be sourced.  
 
LigDDnl was able to successfully ligate double stranded substrate 1 and this substrate 
was used to calculate the initial ligation rate (Table 6.1, Figure 6.12). All components 
that make up substrate 1 are DNA and it is well published that MsLigD is a DNA ligase, 
ligating broken strands of DNA in NHEJ (Della et al., 2004; Gong et al., 2004; Korycka-
Machala et al., 2007). Rate analysis was carried out with LigDDnl and 20-mer substrate 
1. LigDDnl achieved ~90 % ligation of substrate 1 over 30 minutes at 37 °C (Figure 6.12A) 
and an initial rate of 5.18 mol nicks joined/mol protein/min (Table 6.1) which is lower 
than the rate calculated for T4Dnl (Table 4.2). Due to the extra proteins present in the 
purified fractions this is likely to be an underestimation of the rate for LigDDnl. Published 
data for the rate of ligation for full length MsLigD is currently not available and it was 
not possible to calculate a rate for MsLigD in this body of work without first optimising 
the ligation buffer. Ideally the rate of LigDDnl should be compared to the rate of full 
length MsLigD to ascertain whether LigDDnl works better as a ligase than full length 
MsLigD, this preliminary data suggests it is likely to be.   
 
A number of follow up experiments need to be carried out to complete this work, 
including optimised buffer constituents for MsLigD ligation, improved MsLigD protein 
solubility studies, initial rate analysis of MsLigD, LigDDnl ligation with 40-mer double 
stranded substrates and procedures to check the activity of the polymerase and PE 
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domains with the T4 DNA ligase in LigDDnl. It may also be possible to fuse truncated 
MsLigD with an NAD dependent ligase to totally remove the need for ATP in buffers and 
prevent ATP-trapping when ligating DNA/RNA. Fusions with the T4 ligases offer a proof 
of concept for this type of work and an NAD dependent ligase fusion could also act as 
the control for altering levels of ATP. This body of work opens up further research that 
could be conducted with these MsLigD variants and could possibly identify LigDDnl as a 
novel biotechnology resource. If all parts of LigDDnl are functional, this enzyme could 
provide an efficient polymerase, PE and ligase for molecular and synthetic biology 
applications. A number of experiments with M. smegmatis have identified a phenotype 
for knockouts of MsLigD (Korycka-Machala et al., 2006), it would be interesting to see if 
LigDDnl could complement the phenotype(s) seen in that strain.  
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Chapter 7: General Discussion 
 
The results and important conclusions for each chapter have been discussed within 
them. Therefore, this chapter provides an overview of this body of work and details the 
possible wider impact of these research outcomes. 
 
This body of work was part of a BBSRC iCASE studentship with Inspiralis, who produce a 
number of different enzymes for use in academia and the pharmaceutical industry. They 
retail all of the T4 ligases (T4Dnl, T4Rnl1 and T4Rnl2) and requested novel ligases. The 
research in this thesis has explored ways to modify the activities of T4 NA ligases using 
a combination of amino acid substitutions, domain swapping and protein fusions. The 
T4 NA ligases and different enzymes outlined in this body of work are common place 
tools for a range of different molecular biological techniques. These techniques are not 
only crucial for current molecular research methodologies but are also used in protocols 
for the identification of a number of human and plant diseases (Zhang, Dahlberg and 
Tam, 2007; Pogue et al., 2014; Hill and Lukiw, 2016). A number of different cloning 
approaches were used to substitute amino acids in specific motifs, swap whole motifs 
and create fusion-ligases with enzymes that could provide additional biochemical 
activities. These modifications to the T4 NA ligase enzymes have demonstrated that 
chimeric versions of these enzymes have the ability to ligate using new cofactors, to 
ligate new substrates and that it is possible to create functional chimeras of viral-
bacterial enzymes. 
 
7.1. Modifying the T4 NA ligases 
The nick joining activities of the T4 NA ligases for double stranded DNA/RNA substrates 
demonstrated preferences for specific combinations of DNA and RNA (Bullard and 
Bowater, 2006). Analysis of ligation bias encountered in NGS revealed a structural bias 
within the T4 RNA ligases (Sorefan et al., 2012; Zhuang et al., 2012; Song, Liu and Wang, 
2014). Current publications show attempts to reduce this bias in NGS have focussed on 
altering the adapters to which miRNAs are ligated (Xu et al., 2015) and little work has 
been carried out to alter the ligases to reduce this bias.  
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The amino acid substitutions experiments carried out aimed to identify substrate 
specific amino acids in motif I and to alter substrate specificity by mutating these amino 
acids. Previous research had identified that the amino acids in position 6 of motif I, 
arginine (R) for T4Dnl, leucine (L) for T4Rnl1 and asparagine (N) for T4Rnl2, were 
involved in interactions with the ribose sugar (Shuman and Lima, 2004). This was based 
on structural analysis of the T4 RNA ligases and sequence analysis of T4Dnl. Site directed 
mutational analysis had been carried out extensively on the T4 RNA ligases (Wang et al., 
2003; Nandakumar et al., 2004; Pascal, 2008). The other amino acids considered for 
substitution in motif I of T4Rnl1 and T4Rnl2 – aspartate and histidine, respectively – have 
not been identified as residues that make contact with the nucleotide substrate but are 
always conserved in proteins that are Rnl1-like or Rnl2-like. Ligation analysis for each of 
these ligases demonstrated how single amino acid changes impact ligation activity, 
notably a total loss of activity for T4Rnl1L104R. Reduced ligation was noted with 
T4DnlR164N, T4DnlR164L, T4Rnl1D101H and T4Rnl2N40R.  
 
Truncation of T4Rnl2 and substitution of Lys227 to Glu (K227Q) reduced the formation 
of unwanted ligation products (Viollet et al., 2011). It was this type of substitution that 
inspired the amino acid substitutions made to motif I. The results (Chapter 3) 
demonstrated that the residues in the motifs may now be too evolutionarily defined and 
distinct from each other. Changing these specific residues does not positively alter the 
ligase activity or specificity but it may be possible using other residues. It is likely the 
residues selected in Chapter 3 interact so specifically with other residues in the 
nucleotide binding pocket that altering them affects one or multiple steps in the ligation 
reaction. The Arg164 residue in T4Dnl interacts with the nucleotide phosphate group at 
the 3’ position (Shi et al., 2018) during step 2 of the ligation reaction. Changing this 
residue to leucine and asparagine may have affected this interaction resulting in the 
reduced ligation profiles seen (Figures 3.15 and 3.16). Structural data of the ligases may 
offer a way around this, for example, using structures where DNA/RNA is bound or 
unbound would give insight into conformational changes that occur with specific amino 
acid residues. In T4Rnl2, the phosphate from AMP makes contact with both Lys255 in 
motif V and Lys35, which then make contact with Lys227 during step 1 of the ligation 
reaction (Nandakumar, Shuman and Lima, 2006). Targeting residues in the other motifs, 
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e.g. Lys255, that interact in the reaction may be a way to alter substrate specificity. In 
T4Rnl2, Arg55 is involved in nick recognition, by severing contact with the ribose in step 
2 of the ligation reaction (Nandakumar, Shuman and Lima, 2006). Arg55 isn’t in one of 
the conserved polypeptide motifs and raises an interesting point about the residues 
between motifs also playing a key role in the ligation reaction and substrate recognition. 
 
Motif switching and addition of the OB domain to T4Rnl1 and T4Rnl2 was achieved using 
GGC. Creating the recombinant DNA was relatively straightforward and GGC as a 
technique is quick and reliable, the most time consuming part was primer design. While 
engineering the recombinant DNA was successful, the new proteins were either 
insoluble (T4Rnl2M1 and T4Rnl2OB) or inactive (T4Rnl1M1 and T4Rnl1OB). This type of 
inactivity has been seen before when directly binding protein domains (Bai, Ann and 
Shen, 2005; Klein et al., 2014). While some success has been seen with addition of 
archaeal DNA binding domains to T4Dnl to improve ligation (Wilson et al., 2013), it is 
apparent that a more targeted approach needs to be applied to modify the T4 RNA 
ligases. There are many more substitutions of specific amino acids in each of the 
different motifs that could be tried. For example, by changing amino acids one at a time 
it could be possible to understand better how each residue interacts with the substrate 
and other residues in the nucleotide binding pocket.  
 
7.2. Chimeric T4 NA ligases 
Generation of chimeric ligases seemed a logical next step, due to previous successful 
examples, adenylate kinase fused to T4Dnl (Liu et al., 2015), T4Dnl fused to DNA binding 
proteins (Wilson et al., 2013) and fusion of a polymerase to a DNA binding protein to 
improve nucleic acid modifying proteins (Wang et al., 2004). Published work had 
focussed heavily on fusions with T4Dnl, but there were no efforts to do the same with 
the T4 RNA ligases. The T4 RNA ligases are used less frequently in molecular biology 
techniques but are still important tools – especially in NGS and other sequencing 
techniques. Two different sets of chimeric ligases were created, one set with adenylate 
kinase at the N- terminus, which generated chimeric AK-ligases that could ligate using 
ADP instead of ATP. The second set had polynucleotide kinase at the N- terminus of the 
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ligases, whereby the chimeric enzyme would be able to transfer phosphate and correctly 
prime the ends of the DNA/RNA for ligation. There was noted success with both sets of 
these fusion proteins, all of the fusion ligases were soluble and most retained ligation 
activity. These fusions resulted in novel ligases with specific new activities. Notably all 
of the AK-ligases could utilise ADP for nick sealing double stranded substrates (Figure 
4.13, Table 4.2). In the instance of AKRnl1, a much smaller amount of the new fusion 
enzyme was used to achieve the same total ligation percentage, 150 pmol could be used 
instead of 600 pmol (Figure 4.14).  
 
The fusion of Pnk to the N- terminus of the T4 ligases elicited mixed results. While all of 
these fusion enzymes were soluble, there were large differences in the activities of the 
Pnk-ligases. The ligase part of the fusion remained functional in PnkDnl and PnkRnl2 
(Figures 5.14 and 5.15), but PnkRnl1 displayed a severe reduction in ligation of the 
double stranded substrates (Figure 5.14). A second set of substrates were also used to 
test the Pnk part of these fusions, and of the three Pnk-ligase fusions only PnkRnl2 was 
able to successfully ligate these substrates under the conditions tested. These Pnk 
substrates were double stranded and included nicks where the ends were 3’ phosphate 
and 5’ OH, and required the Pnk to remove the phosphate from the 3’ end and add 
phosphate to the 5’ end for ligation to be possible. Further analysis of the Pnk-ligases 
was carried out and the amount of phosphate in solution measured (Figure 5.19). A 
more structural based-design approach should be used when considering ways to 
improve these Pnk-ligases. The use of linkers to join Pnk to the T4 ligases is one possible 
method. Often linkers are used as a way to immobilise enzymes to a structure or surface, 
these linkers can be chemical or peptide linkers (Wu et al., 2018). A number of factors 
need to be considered when using linkers, e.g. the linker length affects the distance 
between the two proteins and can affect substrate binding (Bai, Ann and Shen, 2005; 
Klein et al., 2014). Naturally occurring linkers average a length of 10 +/- 5.8 residues 
(George and Heringa, 2003). Linkers fall into 3 groups: flexible, cleavable and rigid (Klein 
et al., 2014). Flexible linkers contain Gly, Ser and Thr; a common flexible linker is Gly4Sern 
although flexible linkers can limit domain separation (Klein et al., 2014). A factor to 
consider when designing or choosing rigid linkers is whether they are helical or non-
helical. Helical linkers rigidly separate two domains; non-helical linkers, while also rigid,  
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are proline-rich which isolates the linker from the domains it joins (George and Heringa, 
2003). These points offer a multitude of options to consider when joining Pnk to the T4 
ligases – especially T4Dnl and T4Rnl1 which are larger and may require a rigid, non-
helical linker to keep the nucleotide binding sites available.  
 
It was noted that PnkDnl had high levels of free phosphate in solution, indicating that 
the part of the enzyme that removed phosphate was functional but the second active 
site, for attaching phosphate, was not. As the largest of the T4 NA ligases it is possible 
that T4Dnl is causing steric inhibition of Pnk resulting in phosphate removal but not 
phosphate attachment. While AKDnl demonstrated a successful T4Dnl fusion, a high 
resolution, crystallographic structure for T4Dnl would help in identifying where best to 
create fusions with larger more complex enzymes, like Pnk. Considering how readily 
available T4Dnl is and that it is a commonly used molecular biology tool, it is surprising 
that there is no crystallographic structure available. Efforts to create a theoretical model 
using the Phyre2 software (Appendix 2) yielded questionable results because T4Dnl is 
modelled against human DNA ligase which is a much larger eukaryotic enzyme.  Given 
the importance of T4Dnl it would be incredibly worthwhile for someone to obtain the 
structure; however the fact that a structure is not available suggests it may be difficult 
to achieve.  
 
At the time of submission of this work a crystal structure at 1.40 Å resolution for T4Dnl 
in complex with a 21 base duplex DNA was published (Shi et al., 2018). This study is 
important because it not only demonstrates  the structure of T4Dnl but also how T4Dnl 
interacts with DNA (Figure 7.1A) (Shi et al., 2018). Had this structure been available 
before completion of this work, it would have provided much needed guidance and 
insight into the binding capacity of T4Dnl and where best to make modifications to this 
ligase. The Arg164 residue, which was mutagenized in Chapter 3, was previously thought 
to interact with the ribose sugar on the DNA (Shuman and Lima, 2004). The structural 
model of DNA bound to T4Dnl shows Arg164 in fact interacts with the nucleotides 
phosphate group at 3’ position (Shi et al., 2018). This structural model also provides 
information about the OB domain and motif VI residues which make contact with the 
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DNA substrate (Shi et al., 2018). The OB domain is essential for transferring AMP to the 
lysine in motif I, Lys159, in step 1 of the ligation reaction. The OB domain also positions 
the DNA for steps 2 and 3 of the ligation reaction by making contacts with the DNA 
backbone (Shi et al., 2018). This information would have provided much needed 
guidance when trying to make changes to T4Dnl and would have impacted the decision 
to move the OB domain, including motif VI, to the T4 RNA ligases (Chapter 3). A number 
of residues in the OB domain (residues 387-487) have specific roles in the ligation 
reaction. Asn404, Ser447, Asp448, Arg450 and Lys455,  interact with the DNA backbone 
(Shi et al., 2018) and may be potential targets to alter the substrate specificity of T4Dnl. 
Three residues identified in motif VI Arg465, Asp476 and Lys468 also make contact with 
the DNA strands (Shi et al., 2018). These residues were not targeted and on reflection it 
seems this domain may be the best way to change the substrate specificity of T4Dnl. 
Due to the significant interactions of the OB domain and its interactions with the DNA, 
it would be better to look at how the OB domain in other T4Dnl-like ligases functions. It 
does not seem logical to reattempt to attach this large domain to the T4 RNA ligases 
which lack this region and are sequentially different from T4Dnl (Figure 3.3). 
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Figure 7.1. Comparison of T4Dnl, Chlorella virus ligase and Human Ligase I. A) Human 
ligase I, T4Dnl and Chlorella virus ligase in complex with DNA. The DNA binding domains 
of Human liase I (red) and T4Dnl (blue). B) The DNA binding domains of human ligase I 
and T4Dnl and C) superposition of these two binding domains (Shi et al., 2018). 
Comparison of these ligases and their domains demonstrates the similarity of T4Dnl to 
Human ligase 1. 
 
The model constructed using Phyre2 software (Appendix 2) was most similar to human 
ligase I, this is supported by the published structural model which was described as being 
evolutionarily similar to eukaryotic ligases DNA-binding mechanism (Figure 7.1) (Shi et 
al., 2018). Comparison of Human ligase I, T4Dnl and Chlorella virus ligase revealed a DNA 
binding domain that is absent in Chlorella virus (Shi et al., 2018). Furthermore, 
superposition of the DNA binding domains from Human ligase I and T4Dnl (Figure 7.1) 
demonstrated the high degree of similarity between these two protein domains. This 
DNA binding domain in T4Dnl lacks some of the structural elements found in eukaryotic 
and archaeal ligases (Shi et al., 2018).  
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As successful fusion ligases were created with proteins from different organisms, it 
seemed sensible to consider naturally occurring fusions (with multiple activities) for 
biological engineering. An enzyme that demonstrates multiple biochemical activities is 
LigD from M. smegmatis. MsLigD contains a primase, phosphoesterase and a ligase 
(Gong et al., 2004) and  plays a vital role in NHEJ of DSBs; each of the different enzyme 
activities that make up MsLigD have different functions in the nick sealing process 
(Aniukwu, Glickman and Shuman, 2008). Studies have demonstrated that, while 
functional, the ligase part of MsLigD is not very active (Gong et al., 2005; Zhu and 
Shuman, 2006; Aniukwu, Glickman and Shuman, 2008) and, as such, it is of little value 
as a molecular biological tool. It may become valuable if the ligation activity could be 
improved, by replacing the ligase part of MsLigD with the T4 NA ligases it may be 
possible to achieve improved ligation. All of the T4LigD fusions were soluble but 
significant ligation activity was only seen with LigDDnl (Figure 6.11 A and E), which was 
able to ligate 90 % of substrate 1 over a 30 minute incubation at 37 °C (Figure 6.12), a 
noted improvement as MsLigD ligated very small amounts of substrates 1 and 7 in 
comparison (Figure 6.11). LigDRnl2 showed some nick sealing of substrates 5 and 7, but 
this was at a very low level considering there was an abundance of ligase in the end 
point reaction (Figure 6.11 D and E).   
 
LigDDnl offers a possible solution to the ATP trapping-phenomenon detailed in Chapter 
6. ATP trapping occurs when the ligase dissociates from the app-DNA and reacts with 
ATP to form ligase-AMP which is unable to rebind to the app-DNA and complete the 
ligation reaction. This results in no phosphodiester bond formation (Gong et al., 2004). 
It is well known that T4Dnl works well with 1 mM ATP – nearly all commercial buffers 
contain ATP at this concentration (New England Biolabs and Sigma both suggest using 
this concentration of ATP in ligation reactions). Creating LigDDnl provides an enzyme 
that has three separate nucleic acid modifying functions that work well at an ATP 
concentration of 1 mM. Another way to omit ATP-trapping would be the addition of 
truncated MsLigD to an NAD-dependent ligase.NAD-dependent ligases use NAD instead 
of ATP for phosphodiester bond formation in DNA breaks, removing the need for ATP in 
the reaction. The polymerase and PE domains in MsLigD do not require ATP to carry out 
their modifications to the DNA break. The addition of the T4 ligases offers proof of 
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principle that the ligase part of MsLigD can be replaced and the ligases remain 
functional.  
 
7.3. Future work 
The work detailed in this thesis has started the biochemical analysis of these different 
enzyme fusions, but there is further work that could be carried out. It would be 
interesting to see if, like AKRnl1, lower amounts of AKDnl and AKRnl2 can be used to 
achieve the same total ligation. It would also be beneficial to check whether the addition 
of AK to each of the T4 ligases has improved solubility. As an iCASE funded studentship 
it would also be interesting to note how desirable these new fusion ligases are for 
research and commercial purposes – by contacting different institutions (both in 
academia and in pharmaceuticals) for feedback on ligase issues. For PnkRnl2, more work 
could be carried out to determine the quantifiable data for NGS using this enzyme. It 
would be interesting to test a panel of miRNAs, using both normal adapter ligation 
protocols and PnkRnl2 in place of T4Rnl2. Analysing both sets of  quantifiable data would 
help to determine whether the differences in miRNA levels used to identify disease 
(Zhao et al., 2010) are caused by definite mis-regulated miRNA production or by a 
problem with the maturation process of miRNAs resulting in different forms of miRNA. 
There are a number of enzymes involved in the miRNA maturation process, with one 
pathway in eukaryotes (Figure 7.2) utilising Dicer and Drosha to form the 22-nt mature 
miRNA needed for mRNA transcription (Mendes, Freitas and Sagot, 2009). Analysis of a 
number of miRNAs showed that some play a role in a number of cancers and that it is 
unclear whether different cancers associated with the same miRNAs have the same 
miRNA dysfunction (deletion, up-regulation, down-regulation and mutation) (Lu et al., 
2008). It is important to remember the T4 ligases require 5’ phosphate and 3’OH for 
ligation (Sirotkin et al., 1978; Wang and Shuman, 2001; Sriskanda, 2002; Wang et al., 
2003) and cannot ligate nicks in DNA or RNA when the nicked strands do not have this. 
Similarly, miRNAs that do not mature correctly and do not have a 5’ phosphate will never 
be ligated to the adapter, giving a false result for down regulation of the miRNA – when 
in fact the miRNA is incorrectly formed. There are a number of pathways, such as 
signalling pathways, which utilise a number of genes, dysfunction of any single gene in 
the pathway can result in the same disease and a similar rationale has been revealed 
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with miRNA sets (miRNAs implicated in the same disease). If a large proportion of the 
miRNAs in the set are associated with a disease, the other members also have a higher 
probability to be associated with that disease too (Lu et al., 2008). 
 
Figure 7.2. A pathway for miRNA maturation in eukaryotic cells. In the nucleus, the pri-
miRNA is cleaved by Drosha to give rise to pre-miRNA; the pre-miRNA is transported to the 
cytosol by Exportin 5 (Exp5). Dicer then cleaves the double stranded stem to give a 22-nt 
miRNA:miRNA duplex. The duplex unwinds and the miRNA strand is incorporated into the 
miRNA Induced silencing Complex (miRISC).  
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Accurate miRNA detection is vital in not only life threatening conditions but also 
conditions that are debilitating and hard to diagnose. For example, endometriosis is an 
inflammatory condition which causes severe and chronic pain in sufferers and can take 
anywhere between 8 and 12 years to diagnose (Agrawal et al., 2018). A number of mis-
regulated miRNAs are associated with endometriosis and offer a promising non-invasive 
detection method (Agrawal et al., 2018) but only if current NGS miRNA detection and 
quantification methods improve. As stated above, for PnkDnl and PnkRnl1 it may be 
possible to create fusion enzymes using a number of different linkers. T4Dnl and T4Rnl1 
are slightly bigger ligases and a linker would allow for more flexibility and distance 
between the two enzymes which may prevent steric inhibition. Steric inhibition was 
identified with Chlorella virus DNA ligase when the DNA contained a bulky methyl group 
at the nick (Zhu and Shuman, 2008), a much smaller structure than addition of another 
protein to the ligase. This addition of a linker is something that would be possible with 
a large industrial partner who could screen ligases with linkers using high-throughput 
analysis.  
 
It would be useful to see whether the primase and phosphoesterase parts of the T4LigD 
variants are still functional, especially for LigDDnl as this was the most efficient LigD 
fusion, and to identify the different types of substrates that this new fusion could ligate. 
Experiments could also be carried out with LigDRnl1 to ascertain if it is able to ligate the 
hairpin structure or if all activity has been lost. The hairpin substrate relates to tRNAs 
which seem to be an in vivo target for T4Rnl1 and it would be interesting to see if these 
new ligases could work in vivo.   
 
The ligation buffer used for MsLigD and the LigD variants may need optimising, as 
previous research has shown that MsLigD prefers manganese to magnesium (Unciuleac 
and Shuman, 2013) and that 1 mM ATP causes an ATP trapping phenomenon (Gong et 
al., 2004; Williamson, Hjerde and Kahlke, 2016). The buffer used may be the reason 
MsLigD could not ligate any of the double stranded substrates fully. There is also the 
option to carry out complementation assays with LigDDnl in M. smegmatis to observe 
the effect this new ligase has on NHEJ in vivo. Another way to check the effect of ATP 
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would be to use an NAD dependent enzyme with the truncated version of LigD. This 
would omit the need for ATP for ligation and could act as a control when altering the 
concentrations of ATP in the buffer.  
 
To summarise, the work outlined in this thesis demonstrates the ability to create novel 
ligases using a variety of molecular and synthetic biology methods. Amino acid 
substitutions produced a variety of active ligases but none with novel ligation activities. 
Using a more targeted, structural approach to amino acid substitutions might be a better 
way to create novel ligases. Domain swapping was logical on paper, but it often resulted 
in insoluble and inactive enzymes; considering the recently published structure of T4Dnl 
(Shi et al., 2018) and the structural differences of the T4 ligases, a more targeted 
approach could now be used to attempt to successfully carry out these types of domain 
swaps. Chimeric fusion enzymes were a more successful way of creating novel ligases 
where both parts of the fusion were functional. This also opens up the possibility of 
exploring the use of linkers in the future, as a way to join the ligases to larger enzymes 
and create proteins with new ligation activities or improved efficiencies. These new 
ligases spark endless possibilities of chimeric enzymes, where both enzymes are used in 
specific protocols or utilising specific activities of different enzymes to improve the T4 
NA ligases. 
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Chapter 9: Appendices 
9.1. Appendix 1  
Primer design for the addition of the BsaI cut sites to the T4 RNA ligases and the T4Dnl 
OB domain.  
 
T4Dnl Gene: 
catatgattcttaaaattctgaacgaaatagcatctattggttcaactaaacagaagca
agcaattcttgaaaagaataaagataatgaattgcttaaacgagtatatcgtctgactt
attctcgtgggttacagtattatatcaagaaatggcctaaacctggtattgctacccag
agttttggaatgttgactcttaccgatatgcttgacttcattgaattcacattagctac
tcggaaattgactggaaatgcagcaattgaggaattaactggatatatcaccgatggta
aaaaagatgatgttgaagttttgcgtcgagtgatgatgcgagaccttgaatgtggtgct
tcagtatctattgcaaacaaagtttggccaggtttaattcctgaacaacctcaaatgct
cgcaagttcttatgatgaaaaaggcattaataagaatatcaaatttccagcctttgctc
agttaaaagctgatggagctcggtgttttgctgaagttagaggtgatgaattagatgat
gttcgtcttttatcacgagctggtaatgaatatctaggattagatcttcttaaggaaga
gttaattaaaatgaccgctgaagcccgccagattcatccagaaggtgtgttgattgatg
gcgaattggtataccatgagcaagttaaaaaggagccagaaggcctagattttcttttt
gatgcttatcctgaaaacagtaaagctaaagaattcgccgaagtagctgaatcacgtac
tgcttctaatggaatcgccaataaatctttaaagggaaccatttctgaaaaagaagcac
aatgcatgaagtttcaggtctgggattatgtcccgttggtagaaatatacagtcttcct
gcatttcgtttgaaatatgatgtacgtttttctaaactagaacaaatgacatctggata
tgataaagtaattttaattgaaaaccaggtagtaaataacctagatgaagctaaggtaa
tttataaaaagtatattgaccaaggtcttgaaggtattattctcaaaaatatcgatgga
ttatgggaaaatgctcgttcaaaaaatctttataaatttaaagaagtaattgatgttga
tttaaaaattgtaggaatttatcctcaccgtaaagaccctactaaagcgggtggattta
ttcttgagtcagagtgtggaaaaattaaggtaaatgctggttcaggcttaaaagataaa
gccggtgtaaaatcgcatgaacttgaccgtactcgcattatggaaaaccaaaattatta
tattggaaaaattctagagtgcgaatgcaacggttggttaaaatctgatggccgcactg
attacgttaaattatttcttccgattgcgattcgtttacgtgaagataaaactaaagct
aatacattcgaagatgtatttggtgattttcatgaggtaactggtctatgaggatcc 
 
BsaI site 
 
TGGTCTCT BsaI recognition site plus extra nucleotides 
CATC  First 4 nucleotides of his tag 
ACCC  4 nucleotides of RBS 
Forward Primer: 
TGGTCTCTgaagtaattgatgttgatttaaaaattgtaggaatttatcc 
Chapter 9: Appendices 
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Tm = 63.4 °C 
Reverse Primer: atgaggtaactggtctatgaggatccCATC 
Reverse Compliment:TGGTCTCT GATGggatcctcatagaccagttacctcat 
Tm = 63 °C 
 
T4 Rnl1 gene: 
catatgcaagaactttttaacaatttaatggaactatgtaaggattcgcagcgtaagtt
tttttactcagatgatgtaagtgcatctggaagaacttacagaattttctcatataatt
atgcatcttattctgattggttacttccagatgcactagaatgtcgtggaattatgttt
gaaatggatggagaaaaaccagtaagaattgcttctcgtcctatggaaaagttttttaa
cttgaatgaaaatccgttcacgatgaatatcgatttaaacgatgttgattatattctaa
caaaagaagacgggtctttggtatcaacttatttagacggtgatgaaattctgttcaaa
tcaaagggttcaatcaaatctgagcaggctttaatggctaatggaattttgatgaatat
taatcaccatcggttgcgtgatagacttaaagaattagctgaagatggatttactgcta
acttcgaattcgttgccccgacgaatagaatcgttcttgcttatcaagagatgaaaatt
attttactgaatgttcgtgaaaacgaaacgggtgaatacatttcatacgatgatattta
taaagatgctactcttcgtccgtatctagttgaacgatacgaaatcgatagccctaaat
ggatagaagaagctaaaaatgcagaaaacatcgaaggctatgttgctgtgatgaaagat
ggttctcattttaaaattaagtctgactggtacgtgtctcttcatagtacaaaaagttc
attagataatccagaaaaattgtttaagactattattgatggtgcatcagatgatctta
aagcaatgtatgctgacgatgaatattcatacagaaaaattgaagcatttgaaacgact
tatctgaagtacttagaccgagctctgtttttagttcttgactgtcataataagcattg
cggtaaggatagaaagacttatgcaatggaagcacaaggtgttgctaaaggtgctggaa
tggatcacctgttcggtatcatcatgagcttataccaggggtacgatagtcaagaaaag
gtcatgtgtgaaatcgaacagaattttttgaaaaattataaaaaatttatcccagaagg
atactaaggatcc 
 
Forward Primer: TGGTCTCT 
ACCCatgcaagaactttttaacaatttaatggaactatg 
Tm = 61 °C  
Reverse Primer: ttgctgtgatgaaagatggttctcattttaaaattaaggaag 
Reverse Compliment: 
TGGTCTCTcttccttaattttaaaatgagaaccatctttcatcacag 
Tm = 62 °C 
 
T4Rnl2 gene: 
catatgtttaaaaagtatagcagtcttgaaaatcattacaactctaaatttattgaaaa
actttatagcttgggattgactggtggggagtgggtagctcgtgaaaagattcacggca
caaatttctcattgattattgagcgtgataaagtgacttgcgctaaacgcactggaccg
attcttcctgctgaagatttctttgggtatgaaattattttgaagaattatgctgattc
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cattaaagctgtacaagatattatggaaacctcagcggttgtatcttatcaagtctttg
gcgaattcgctggacctggcattcagaagaatgttgattatGgtgataaagatttttat
gtatttgacattattgttactacagaaagcggtgatgtgacttatgtagatgattatat
gatggaatcattctgtaatacatttaaatttaaaatggctccacttttaggtcgcggta
aatttgaagagcttattaaattgccaaatgatttagattctgtcgtccaagattataat
tttacagtagaccatgctggattagttgatgcaaataaatgcgtttggaatgccgaagc
aaaaggcgaagtatttactgctgaaggatatgtattgaaaccttgttatccttcttggc
ttcgtaatggaaatcgtgtagcgattaaatgcaagaactctaaatttagtgaaaagaaa
aagtctgataagcctattaaagctaaagttgagctatcagaagctgataacaaattggt
gggaattttagcttgttacgttacactgaaccgcgtaaataacgttatttctaaaattg
gcgaaattggtccaaaggattttggaaaggtgatggggctaactgttcaagatattttg
gaagaaacttctcgtgaaggtattactctaactcaagcagataatccttctttgattaa
aaaggaattagttaaaatggtacaagatgtacttcgtccagcttggattgagttggtaa
gttaaggatcc 
 
Forward Primer: 
TGGTCTCTACCCatgtttaaaaagtatagcagtcttgaaaatcattac 
Tm = 61.5 °C 
Reverse Primer: ggaaatcgtgtagcgattaaatgcaaggaag 
Reverse Compliment: TGGTCTCTcttccttgcatttaatcgctacacgatttcc 
Tm = 61.9 °C 
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9.2. Appendix 2 
A predicted structure forT4Dnl generated using Phyre2 software, available at 
http://www.sbg.bio.ic.ac.uk/phyre2/html/page.cgi?id=index and illustrated using 
CCP4MG software. The amino acid sequence for T4Dnl was uploaded to the Phyre2 
website, an image is generated from this sequence based on its similarity to the 
sequences of other published structures. When this image was created, the structure 
for T4Dnl was not solved and the most similar sequence to T4Dnl was human ligase I 
(PDB 1X9N) (Pascal et al., 2004) which this model is based on. The generated image file 
was edited in the CCP4MG software. The polypeptide motifs are highlighted: motif I 
(red), motif III (orange), motif IIIb (pink), motif IV (blue), motif V (green) and the OB 
domain (purple).  
 
 
 
 
 
 
 
